Dr. Pletser’s experience includes 30 years of working with the European Space Agency as a Senior Physicist/Engineer and coordinating their parabolic flight campaigns, and he is the Guinness World Record holder for the most number of aircraft flown (12) in parabolas, personally logging more than 7,300 parabolas.
\\n\\n
Seeing the 5,000th book published makes us at the same time proud, happy, humble, and grateful. This is a great opportunity to stop and celebrate what we have done so far, but is also an opportunity to engage even more, grow, and succeed. It wouldn't be possible to get here without the synergy of team members’ hard work and authors and editors who devote time and their expertise into Open Access book publishing with us.
\\n\\n
Over these years, we have gone from pioneering the scientific Open Access book publishing field to being the world’s largest Open Access book publisher. Nonetheless, our vision has remained the same: to meet the challenges of making relevant knowledge available to the worldwide community under the Open Access model.
\\n\\n
We are excited about the present, and we look forward to sharing many more successes in the future.
\\n\\n
Thank you all for being part of the journey. 5,000 times thank you!
\\n\\n
Now with 5,000 titles available Open Access, which one will you read next?
Preparation of Space Experiments edited by international leading expert Dr. Vladimir Pletser, Director of Space Training Operations at Blue Abyss is the 5,000th Open Access book published by IntechOpen and our milestone publication!
\n\n
"This book presents some of the current trends in space microgravity research. The eleven chapters introduce various facets of space research in physical sciences, human physiology and technology developed using the microgravity environment not only to improve our fundamental understanding in these domains but also to adapt this new knowledge for application on earth." says the editor. Listen what else Dr. Pletser has to say...
\n\n\n\n
Dr. Pletser’s experience includes 30 years of working with the European Space Agency as a Senior Physicist/Engineer and coordinating their parabolic flight campaigns, and he is the Guinness World Record holder for the most number of aircraft flown (12) in parabolas, personally logging more than 7,300 parabolas.
\n\n
Seeing the 5,000th book published makes us at the same time proud, happy, humble, and grateful. This is a great opportunity to stop and celebrate what we have done so far, but is also an opportunity to engage even more, grow, and succeed. It wouldn't be possible to get here without the synergy of team members’ hard work and authors and editors who devote time and their expertise into Open Access book publishing with us.
\n\n
Over these years, we have gone from pioneering the scientific Open Access book publishing field to being the world’s largest Open Access book publisher. Nonetheless, our vision has remained the same: to meet the challenges of making relevant knowledge available to the worldwide community under the Open Access model.
\n\n
We are excited about the present, and we look forward to sharing many more successes in the future.
\n\n
Thank you all for being part of the journey. 5,000 times thank you!
\n\n
Now with 5,000 titles available Open Access, which one will you read next?
\n'}],latestNews:[{slug:"webinar-introduction-to-open-science-wednesday-18-may-1-pm-cest-20220518",title:"Webinar: Introduction to Open Science | Wednesday 18 May, 1 PM CEST"},{slug:"step-in-the-right-direction-intechopen-launches-a-portfolio-of-open-science-journals-20220414",title:"Step in the Right Direction: IntechOpen Launches a Portfolio of Open Science Journals"},{slug:"let-s-meet-at-london-book-fair-5-7-april-2022-olympia-london-20220321",title:"Let’s meet at London Book Fair, 5-7 April 2022, Olympia London"},{slug:"50-books-published-as-part-of-intechopen-and-knowledge-unlatched-ku-collaboration-20220316",title:"50 Books published as part of IntechOpen and Knowledge Unlatched (KU) Collaboration"},{slug:"intechopen-joins-the-united-nations-sustainable-development-goals-publishers-compact-20221702",title:"IntechOpen joins the United Nations Sustainable Development Goals Publishers Compact"},{slug:"intechopen-signs-exclusive-representation-agreement-with-lsr-libros-servicios-y-representaciones-s-a-de-c-v-20211123",title:"IntechOpen Signs Exclusive Representation Agreement with LSR Libros Servicios y Representaciones S.A. de C.V"},{slug:"intechopen-expands-partnership-with-research4life-20211110",title:"IntechOpen Expands Partnership with Research4Life"},{slug:"introducing-intechopen-book-series-a-new-publishing-format-for-oa-books-20210915",title:"Introducing IntechOpen Book Series - A New Publishing Format for OA Books"}]},book:{item:{type:"book",id:"5708",leadTitle:null,fullTitle:"Computational and Experimental Studies of Acoustic Waves",title:"Computational and Experimental Studies of Acoustic Waves",subtitle:null,reviewType:"peer-reviewed",abstract:"This book presents recent studies of acoustic wave propagation through different media including the atmosphere, Earth's subsurface, complex dusty plasmas, porous materials, and flexible structures. Mathematical models of the underlying physical phenomena are introduced and studied in detail. With its seven chapters, the book brings together important contributions from renowned international researchers to provide an excellent survey of recent computational and experimental studies of acoustic waves. The first section consists of four chapters that focus on computational studies, while the next section is composed of three chapters that center on experimental studies.",isbn:"978-953-51-3716-0",printIsbn:"978-953-51-3715-3",pdfIsbn:"978-953-51-3970-6",doi:"10.5772/65135",price:119,priceEur:129,priceUsd:155,slug:"computational-and-experimental-studies-of-acoustic-waves",numberOfPages:154,isOpenForSubmission:!1,isInWos:1,isInBkci:!1,hash:"518d2ac3c49f5c4c48d4f3f3b0729232",bookSignature:"Mahmut Reyhanoglu",publishedDate:"January 4th 2018",coverURL:"https://cdn.intechopen.com/books/images_new/5708.jpg",numberOfDownloads:9519,numberOfWosCitations:8,numberOfCrossrefCitations:8,numberOfCrossrefCitationsByBook:1,numberOfDimensionsCitations:19,numberOfDimensionsCitationsByBook:1,hasAltmetrics:0,numberOfTotalCitations:35,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"November 21st 2016",dateEndSecondStepPublish:"December 12th 2016",dateEndThirdStepPublish:"September 3rd 2017",dateEndFourthStepPublish:"October 3rd 2017",dateEndFifthStepPublish:"December 3rd 2017",currentStepOfPublishingProcess:5,indexedIn:"1,2,3,4,5,6,7",editedByType:"Edited by",kuFlag:!1,featuredMarkup:null,editors:[{id:"15068",title:"Dr.",name:"Mahmut",middleName:null,surname:"Reyhanoglu",slug:"mahmut-reyhanoglu",fullName:"Mahmut Reyhanoglu",profilePictureURL:"https://mts.intechopen.com/storage/users/15068/images/system/15068.jpg",biography:"Mahmut Reyhanoglu is currently Director of Robotics Engineering, Columbus State University (CSU), Georgia, USA. Prior to joining CSU, he was the Glaxo Wellcome Distinguished Professor of Engineering, University of North Carolina at Asheville, USA. His extensive research makes use of advanced mathematical techniques and models that arise from fundamental physical principles. His major research interests are in the areas of nonlinear dynamical systems and control theory, with particular emphasis on applications to mechanical and aerospace systems, robotics, and mechatronics. He has edited five books and authored/co-authored five book chapters and more than 140 peer-reviewed journal/proceedings papers. He served on the Transactions on Automatic Control Editorial Board and the Control Systems Society Conference Editorial Board of the Institute of Electrical and Electronics Engineers (IEEE). He also served as a member of the International Program Committee for several conferences and as a member of the Guidance, Navigation, and Control Technical Committee of the American Institute of Aeronautics and Astronautics (AIAA). He is currently an editor of the International Journal of Aerospace Engineering and Electronics.",institutionString:"Columbus State University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"4",totalChapterViews:"0",totalEditedBooks:"5",institution:{name:"Columbus State University",institutionURL:null,country:{name:"United States of America"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"680",title:"Mathematical Modeling",slug:"engineering-acoustical-engineering-mathematical-modeling"}],chapters:[{id:"57674",title:"Optimized Finite Difference Methods for Seismic Acoustic Wave Modeling",doi:"10.5772/intechopen.71647",slug:"optimized-finite-difference-methods-for-seismic-acoustic-wave-modeling",totalDownloads:1500,totalCrossrefCites:1,totalDimensionsCites:3,hasAltmetrics:0,abstract:"The finite difference (FD) methods are widely used for approximating the partial derivatives in the acoustic/elastic wave equation. Grid dispersion is one of the key numerical problems and will directly influence the accuracy of the result because of the discretization of the partial derivatives in the wave equation. Therefore, it is of great importance to suppress the grid dispersion by optimizing the FD coefficient. Various optimized methods are introduced in this chapter to determine the FD coefficient. Usually, the identical staggered grid finite difference operator is used for all of the first-order spatial derivatives in the first-order wave equation. In this chapter, we introduce a new staggered grid FD scheme which can improve the efficiency while still preserving high accuracy for the first-order acoustic/elastic wave equation modeling. It uses different staggered grid FD operators for different spatial derivatives in the first-order wave equation. The staggered grid FD coefficients of the new FD scheme can be obtained with a linear method. At last, numerical experiments were done to demonstrate the effectiveness of the introduced method.",signatures:"Yanfei Wang and Wenquan Liang",downloadPdfUrl:"/chapter/pdf-download/57674",previewPdfUrl:"/chapter/pdf-preview/57674",authors:[{id:"218676",title:"Prof.",name:"Yanfei",surname:"Wang",slug:"yanfei-wang",fullName:"Yanfei Wang"}],corrections:null},{id:"56289",title:"Acoustic Analysis of Enclosed Sound Space as well as Its Coupling with Flexible Boundary Structure",doi:"10.5772/intechopen.69967",slug:"acoustic-analysis-of-enclosed-sound-space-as-well-as-its-coupling-with-flexible-boundary-structure",totalDownloads:1280,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"Combustion instability is often encountered in various power systems, a good understanding on the sound field in acoustic cavity as well as its coupling with boundary flexible structure will be of great help for the reliability design of such combustion system. An improved Fourier series method is presented for the acoustic/vibro-acoustic modelling of acoustic cavity as well as the panel-cavity coupling system. The structural-acoustic coupling system is described in a unified pattern using the energy principle. With the aim to construct the admissible functions sufficiently smooth for the enclosed sound space as well as the flexible boundary structure, the boundary-smoothed auxiliary functions are introduced to the standard multi-dimensional Fourier series. All the unknown coefficients and higher order variables are determined in conjunction with Rayleigh-Ritz procedure and differential operation term by term. Numerical examples are then presented to show the correctness and effectiveness of the current model. The model is verified through the comparison with those from analytic solution and other approaches. Based on the model established, the influence of boundary conditions on the acoustic and/or vibro-acoustic characteristics of the structural-acoustic coupling system is addressed and investigated.",signatures:"Jingtao Du, Yang Liu and Long Liu",downloadPdfUrl:"/chapter/pdf-download/56289",previewPdfUrl:"/chapter/pdf-preview/56289",authors:[{id:"203133",title:"Prof.",name:"Jingtao",surname:"Du",slug:"jingtao-du",fullName:"Jingtao Du"},{id:"203657",title:"Dr.",name:"Yang",surname:"Liu",slug:"yang-liu",fullName:"Yang Liu"},{id:"203658",title:"Dr.",name:"Long",surname:"Liu",slug:"long-liu",fullName:"Long Liu"}],corrections:null},{id:"57258",title:"Sound Waves in Complex (Dusty) Plasmas",doi:"10.5772/intechopen.71203",slug:"sound-waves-in-complex-dusty-plasmas",totalDownloads:1381,totalCrossrefCites:5,totalDimensionsCites:5,hasAltmetrics:0,abstract:"Wave properties of strongly coupled complex dusty (SCCD) plasmas evaluated using the equilibrium molecular dynamics (EMD) simulation technique. In this work, the plasma normalized longitudinal current correlation function CL(k,t) and transverse current CT(k,t) are calculated for a large range of plasma parameters of Coulomb coupling parameter (Γ) and screening strength (κ) with varying wave’s number (k). In EMD simulations, we have analysed different modes of wave propagation in SCCD plasmas with increasing and decreasing sequences of different combinations of plasmas parameters (κ, Γ) at varying simulation time step (Δt). Our simulation results show that the fluctuation of waves increases with an increase of Γ and decreases with increasing κ. Additional test shows that the presented results for waves are slightly dependent on number of particles (N). The amplitude and time period of CL(k,t) and CT(k,t) also depend on different influenced parameters of κ, Γ, k and N. The new results obtained through the presented EMD method for complex dusty plasma discussed and compared with earlier simulation results based on different numerical methods. It is demonstrated that the presented model is the best tool for estimating the behaviour of waves in strongly coupled complex system (dusty plasmas) over a suitable range of parameters.",signatures:"Aamir Shahzad, Muhammad Asif Shakoori, Maogang He and Sajid\nBashir",downloadPdfUrl:"/chapter/pdf-download/57258",previewPdfUrl:"/chapter/pdf-preview/57258",authors:[{id:"288354",title:"Dr.",name:"Aamir",surname:"Shahzad",slug:"aamir-shahzad",fullName:"Aamir Shahzad"}],corrections:null},{id:"56872",title:"Acoustic Wave Monitoring of Fluid Dynamics in the Rock Massif with Anomaly Density, Stressed and Plastic Hierarchic Inclusions",doi:"10.5772/intechopen.70590",slug:"acoustic-wave-monitoring-of-fluid-dynamics-in-the-rock-massif-with-anomaly-density-stressed-and-plas",totalDownloads:1094,totalCrossrefCites:1,totalDimensionsCites:5,hasAltmetrics:0,abstract:"The geological environment is an open system, on which external and internal factors act. They lead it to an unstable state, which, as a rule, manifests itself locally in the form of zones, called dynamically active elements, which are indicators of potential catastrophic sources. These objects differ from the host geological environment by structural forms, which are often forming of a hierarchical type. The process of their activation can be observed using monitoring with wave fields, for mathematical support of which new modeling algorithms have been developed using the method of integral and integral-differential equations. A new approach to the interpretation of wave fields has been developed, to determine contours or surfaces of locally stressed hierarchical objects. An iterative process of solving the theoretical inverse problem for the case of determining configurations of 2D hierarchical inclusions of the k-th rank is developed. When interpreting monitoring results, it is necessary to use data from such monitoring systems that are tuned to study the hierarchical structure of the environment.",signatures:"Olga Hachay and Andrey Khachay",downloadPdfUrl:"/chapter/pdf-download/56872",previewPdfUrl:"/chapter/pdf-preview/56872",authors:[{id:"150801",title:"Prof.",name:"Olga",surname:"Hachay",slug:"olga-hachay",fullName:"Olga Hachay"},{id:"219182",title:"MSc.",name:"Andrey",surname:"Khachay",slug:"andrey-khachay",fullName:"Andrey Khachay"}],corrections:null},{id:"57603",title:"In-Fiber Acousto-Optic Interaction Based on Flexural Acoustic Waves and Its Application to Fiber Modulators",doi:"10.5772/intechopen.71411",slug:"in-fiber-acousto-optic-interaction-based-on-flexural-acoustic-waves-and-its-application-to-fiber-mod",totalDownloads:1305,totalCrossrefCites:0,totalDimensionsCites:1,hasAltmetrics:0,abstract:"The design and implementation of in-fiber acousto-optic (AO) devices based on acoustic flexural waves are presented. The AO interaction is demonstrated to be an efficient mechanism for the development of AO tunable filters and modulators. The implementation of tapered optical fibers is proposed to shape the spectral response of in-fiber AO devices. Experimental results demonstrate that the geometry of the tapered fiber can be regarded as an extra degree of freedom for the design of AO tunable attenuation filters (AOTAFs). In addition, with the objective of expanding the application of AOTAFs to operate as an amplitude modulator, acoustic reflection was intentionally induced. Hence, a standing acoustic wave is generated which produces an amplitude modulation at twice the acoustic frequency. As a particular case, an in-fiber AO modulator composed of a double-ended tapered fiber was reported. The fiber taper was prepared using a standard fusion and pulling technique, and it was tapered down to a fiber diameter of 70 μm. The device exhibits an amplitude modulation at 2.313 MHz, which is two times the acoustic frequency used (1.1565 MHz); a maximum modulation depth of 60%, 1.3 dB of insertion loss, and 40 nm of modulation bandwidth were obtained. These results are within the best results reported in the framework of in-fiber AO modulators.",signatures:"Miguel Ángel Bello Jiménez, Gustavo Ramírez-Meléndez, Erika\nHernández-Escobar, Andrés Camarillo-Avilés, Rosa López-Estopier,\nOlivier Pottiez, Cristian Cuadrado-Laborde, Antonio Díez, José L.\nCruz and Miguel V. Andrés",downloadPdfUrl:"/chapter/pdf-download/57603",previewPdfUrl:"/chapter/pdf-preview/57603",authors:[{id:"46578",title:"Dr.",name:"Miguel V.",surname:"Andrés",slug:"miguel-v.-andres",fullName:"Miguel V. Andrés"},{id:"46579",title:"Dr.",name:"Antonio",surname:"Diez",slug:"antonio-diez",fullName:"Antonio Diez"},{id:"46580",title:"Dr.",name:"José L.",surname:"Cruz",slug:"jose-l.-cruz",fullName:"José L. Cruz"},{id:"160262",title:"Dr.",name:"Olivier Jean Michel",surname:"Pottiez",slug:"olivier-jean-michel-pottiez",fullName:"Olivier Jean Michel Pottiez"},{id:"160283",title:"Dr.",name:"Miguel",surname:"Bello-Jiménez",slug:"miguel-bello-jimenez",fullName:"Miguel Bello-Jiménez"},{id:"182010",title:"Dr.",name:"R.",surname:"López-Estopier",slug:"r.-lopez-estopier",fullName:"R. López-Estopier"},{id:"220895",title:"MSc.",name:"Gustavo",surname:"Ramírez-Meléndez",slug:"gustavo-ramirez-melendez",fullName:"Gustavo Ramírez-Meléndez"},{id:"220896",title:"MSc.",name:"Erika",surname:"Hernández-Escobar",slug:"erika-hernandez-escobar",fullName:"Erika Hernández-Escobar"},{id:"220897",title:"BSc.",name:"Andrés",surname:"Camarillo-Avilés",slug:"andres-camarillo-aviles",fullName:"Andrés Camarillo-Avilés"},{id:"220902",title:"Dr.",name:"Christian",surname:"Cuadrado-Laborde",slug:"christian-cuadrado-laborde",fullName:"Christian Cuadrado-Laborde"}],corrections:null},{id:"58101",title:"Wave Propagation in Porous Materials",doi:"10.5772/intechopen.72215",slug:"wave-propagation-in-porous-materials",totalDownloads:1547,totalCrossrefCites:1,totalDimensionsCites:5,hasAltmetrics:0,abstract:"This chapter provides different models for the acoustic wave propagation in porous materials having a rigid and an elastic frames. The direct problem of reflection and transmission of acoustic waves by a slab of porous material is studied. The inverse problem is solved using experimental reflected and transmitted signals. Both high- and low-frequency domains are studied. Different acoustic methods are proposed for measuring physical parameters describing the acoustic propagation as porosity, tortuosity, viscous and thermal characteristic length, and flow resistivity. Some advantages and perspectives of this method are discussed.",signatures:"Zine El Abiddine Fellah, Mohamed Fellah, Claude Depollier, Erick\nOgam and Farid G. Mitri",downloadPdfUrl:"/chapter/pdf-download/58101",previewPdfUrl:"/chapter/pdf-preview/58101",authors:[{id:"143693",title:"Dr.",name:"Zine El Abiddine",surname:"Fellah",slug:"zine-el-abiddine-fellah",fullName:"Zine El Abiddine Fellah"},{id:"144519",title:"Prof.",name:"Claude",surname:"Depollier",slug:"claude-depollier",fullName:"Claude Depollier"},{id:"178778",title:"Prof.",name:"Mohamed",surname:"Fellah",slug:"mohamed-fellah",fullName:"Mohamed Fellah"},{id:"209074",title:"Dr.",name:"Erick",surname:"Ogam",slug:"erick-ogam",fullName:"Erick Ogam"},{id:"227468",title:"Dr.",name:"Farid G",surname:"Mitri",slug:"farid-g-mitri",fullName:"Farid G Mitri"}],corrections:null},{id:"57214",title:"A Novel Idea of Coherent Acoustic Wave-Induced Atmospheric Refractivity Fluctuation and Its Applications",doi:"10.5772/intechopen.70996",slug:"a-novel-idea-of-coherent-acoustic-wave-induced-atmospheric-refractivity-fluctuation-and-its-applicat",totalDownloads:1412,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,abstract:"The physical mechanism of generating the lasting tropospheric refractivity fluctuation with a stable array-distributed structure by coherent acoustic waves is investigated. An example of the quantitative calculation of atmospheric refractive index is given and analyzed. Based on the theory of electromagnetic wave propagation and scattering in the troposphere, the feasibility to purposefully affect radio wave propagation is qualitatively demonstrated by the experiment of the coherent acoustic source-induced laser interference fringe change. The potential application aspects of synthetically controlling the radio wave propagation by the artificial refractivity fluctuation structure are preliminarily proposed. This chapter will promote the development of the coherent acoustic wave-induced tropospheric refractivity fluctuation, and it has the important theoretical significance and potential application value to purposely apply the positive or negative effects on radio wave propagation.",signatures:"Shuhong Gong, Yu Liu, Muyu Hou and Lixin Guo",downloadPdfUrl:"/chapter/pdf-download/57214",previewPdfUrl:"/chapter/pdf-preview/57214",authors:[{id:"218965",title:"Dr.",name:"Shuhong",surname:"Gong",slug:"shuhong-gong",fullName:"Shuhong Gong"},{id:"220994",title:"BSc.",name:"Yu",surname:"Liu",slug:"yu-liu",fullName:"Yu Liu"},{id:"220995",title:"BSc.",name:"Muyu",surname:"Hou",slug:"muyu-hou",fullName:"Muyu Hou"},{id:"220996",title:"Dr.",name:"Lixin",surname:"Guo",slug:"lixin-guo",fullName:"Lixin Guo"}],corrections:null}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},subseries:null,tags:null},relatedBooks:[{type:"book",id:"5513",title:"Dynamical Systems",subtitle:"Analytical and Computational Techniques",isOpenForSubmission:!1,hash:"9ba4129f30ef1b92fd4b7ae193781183",slug:"dynamical-systems-analytical-and-computational-techniques",bookSignature:"Mahmut Reyhanoglu",coverURL:"https://cdn.intechopen.com/books/images_new/5513.jpg",editedByType:"Edited by",editors:[{id:"15068",title:"Dr.",name:"Mahmut",surname:"Reyhanoglu",slug:"mahmut-reyhanoglu",fullName:"Mahmut Reyhanoglu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6651",title:"Nonlinear Systems",subtitle:"Modeling, Estimation, and Stability",isOpenForSubmission:!1,hash:"085cfe19a4bd48a9e8034b2e5cc17172",slug:"nonlinear-systems-modeling-estimation-and-stability",bookSignature:"Mahmut Reyhanoglu",coverURL:"https://cdn.intechopen.com/books/images_new/6651.jpg",editedByType:"Edited by",editors:[{id:"15068",title:"Dr.",name:"Mahmut",surname:"Reyhanoglu",slug:"mahmut-reyhanoglu",fullName:"Mahmut Reyhanoglu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7792",title:"Unmanned Robotic Systems and Applications",subtitle:null,isOpenForSubmission:!1,hash:"53805f091c3107536edd2579c9987649",slug:"unmanned-robotic-systems-and-applications",bookSignature:"Mahmut Reyhanoglu and Geert De Cubber",coverURL:"https://cdn.intechopen.com/books/images_new/7792.jpg",editedByType:"Edited by",editors:[{id:"15068",title:"Dr.",name:"Mahmut",surname:"Reyhanoglu",slug:"mahmut-reyhanoglu",fullName:"Mahmut Reyhanoglu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophile",surname:"Theophanides",slug:"theophile-theophanides",fullName:"Theophile Theophanides"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"314",title:"Regenerative Medicine and Tissue Engineering",subtitle:"Cells and Biomaterials",isOpenForSubmission:!1,hash:"bb67e80e480c86bb8315458012d65686",slug:"regenerative-medicine-and-tissue-engineering-cells-and-biomaterials",bookSignature:"Daniel Eberli",coverURL:"https://cdn.intechopen.com/books/images_new/314.jpg",editedByType:"Edited by",editors:[{id:"6495",title:"Dr.",name:"Daniel",surname:"Eberli",slug:"daniel-eberli",fullName:"Daniel Eberli"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"57",title:"Physics and Applications of Graphene",subtitle:"Experiments",isOpenForSubmission:!1,hash:"0e6622a71cf4f02f45bfdd5691e1189a",slug:"physics-and-applications-of-graphene-experiments",bookSignature:"Sergey Mikhailov",coverURL:"https://cdn.intechopen.com/books/images_new/57.jpg",editedByType:"Edited by",editors:[{id:"16042",title:"Dr.",name:"Sergey",surname:"Mikhailov",slug:"sergey-mikhailov",fullName:"Sergey Mikhailov"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],ofsBooks:[]},correction:{item:{id:"64729",slug:"erratum-toward-the-development-of-a-monitoring-and-feedback-system-for-predicting-poor-adjustment-to",title:"Erratum - Toward the Development of a Monitoring and Feedback System for Predicting Poor Adjustment to Grief",doi:null,correctionPDFUrl:"https://cdn.intechopen.com/pdfs/64729.pdf",downloadPdfUrl:"/chapter/pdf-download/64729",previewPdfUrl:"/chapter/pdf-preview/64729",totalDownloads:null,totalCrossrefCites:null,bibtexUrl:"/chapter/bibtex/64729",risUrl:"/chapter/ris/64729",chapter:{id:"57127",slug:"toward-the-development-of-a-monitoring-and-feedback-system-for-predicting-poor-adjustment-to-grief",signatures:"Wan Jou She, Laurie Burke, Robert A. Neimyer, Kailey Roberts,\nWendy Lichtenthal, Jun Hu and Matthias Rauterberg",dateSubmitted:"September 5th 2017",dateReviewed:null,datePrePublished:null,datePublished:"October 18th 2017",book:{id:"6456",title:"Proceedings of the Conference on Design and Semantics of Form and Movement",subtitle:"Sense and Sensitivity, DeSForM 2017",fullTitle:"Proceedings of the Conference on Design and Semantics of Form and Movement - Sense and Sensitivity, DeSForM 2017",slug:"proceedings-of-the-conference-on-design-and-semantics-of-form-and-movement-sense-and-sensitivity-desform-2017",publishedDate:"October 18th 2017",bookSignature:"Miguel Bruns Alonso and Elif Ozcan",coverURL:"https://cdn.intechopen.com/books/images_new/6456.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"156855",title:"Dr.",name:"Elif",middleName:null,surname:"Ozcan",slug:"elif-ozcan",fullName:"Elif Ozcan"}],productType:{id:"2",title:"Proceeding",chapterContentType:"conference paper",authoredCaption:"Edited by"}},authors:[{id:"221149",title:"Dr.",name:"Wan Jou",middleName:null,surname:"She",fullName:"Wan Jou She",slug:"wan-jou-she",email:"lave@lavendershe.com",position:null,institution:null}]}},chapter:{id:"57127",slug:"toward-the-development-of-a-monitoring-and-feedback-system-for-predicting-poor-adjustment-to-grief",signatures:"Wan Jou She, Laurie Burke, Robert A. Neimyer, Kailey Roberts,\nWendy Lichtenthal, Jun Hu and Matthias Rauterberg",dateSubmitted:"September 5th 2017",dateReviewed:null,datePrePublished:null,datePublished:"October 18th 2017",book:{id:"6456",title:"Proceedings of the Conference on Design and Semantics of Form and Movement",subtitle:"Sense and Sensitivity, DeSForM 2017",fullTitle:"Proceedings of the Conference on Design and Semantics of Form and Movement - Sense and Sensitivity, DeSForM 2017",slug:"proceedings-of-the-conference-on-design-and-semantics-of-form-and-movement-sense-and-sensitivity-desform-2017",publishedDate:"October 18th 2017",bookSignature:"Miguel Bruns Alonso and Elif Ozcan",coverURL:"https://cdn.intechopen.com/books/images_new/6456.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"156855",title:"Dr.",name:"Elif",middleName:null,surname:"Ozcan",slug:"elif-ozcan",fullName:"Elif Ozcan"}],productType:{id:"2",title:"Proceeding",chapterContentType:"conference paper",authoredCaption:"Edited by"}},authors:[{id:"221149",title:"Dr.",name:"Wan Jou",middleName:null,surname:"She",fullName:"Wan Jou She",slug:"wan-jou-she",email:"lave@lavendershe.com",position:null,institution:null}]},book:{id:"6456",title:"Proceedings of the Conference on Design and Semantics of Form and Movement",subtitle:"Sense and Sensitivity, DeSForM 2017",fullTitle:"Proceedings of the Conference on Design and Semantics of Form and Movement - Sense and Sensitivity, DeSForM 2017",slug:"proceedings-of-the-conference-on-design-and-semantics-of-form-and-movement-sense-and-sensitivity-desform-2017",publishedDate:"October 18th 2017",bookSignature:"Miguel Bruns Alonso and Elif Ozcan",coverURL:"https://cdn.intechopen.com/books/images_new/6456.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"156855",title:"Dr.",name:"Elif",middleName:null,surname:"Ozcan",slug:"elif-ozcan",fullName:"Elif Ozcan"}],productType:{id:"2",title:"Proceeding",chapterContentType:"conference paper",authoredCaption:"Edited by"}}},ofsBook:{item:{type:"book",id:"11598",leadTitle:null,title:"Recent Advances, New Perspectives and Applications in the Treatment of Ovarian Cancer",subtitle:null,reviewType:"peer-reviewed",abstract:"
\r\n\tRecent Advances, New Perspectives, and Applications in the Treatment of Ovarian Cancer should present a review of the significant advances in tumor biology and the treatment of ovarian cancer. Ovarian cancer is a heterogeneous disease with multiple distinct molecular and clinical subtypes.
\r\n
\r\n\tIn the first part of this book, the molecular profiles especially of the high-grade ovarian cancer will be described, and especially the clinical implications will be discussed.
\r\n
\r\n\tThe second part of the book will focus on the role of cytoreductive surgery, especially concerning the significant shift from primary cytoreductive surgery to neoadjuvant chemotherapy followed by interval debulking surgery in patients with advanced ovarian cancer knowing that optimal debulking surgery with R0-resection remains the gold standard. In this context, the current data and recommendations for the use of HIPEC will be discussed.
\r\n
\r\n\tLast but not least, the book will focus on systemic treatment beginning with chemotherapy like neoadjuvant strategies and ending with targeted treatment like PARP-inhibition and new aspects to immunobiological therapies.
",isbn:"978-1-80356-519-4",printIsbn:"978-1-80356-518-7",pdfIsbn:"978-1-80356-520-0",doi:null,price:0,priceEur:0,priceUsd:0,slug:null,numberOfPages:0,isOpenForSubmission:!0,isSalesforceBook:!1,hash:"326ce75672f3a0f7ef014ba3ac7f6318",bookSignature:"Prof. Michael Friedrich",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/11598.jpg",keywords:"Molecular Profile, BRCA Mutation, Parp Inhibition, Antiangiogenesis, Checkpoint Inhibition, Antihormonal Treatment, Intraperitoneal Chemotherapy, HIPEC, Primary Debulking Surgery, Interval Debulking Surgery, Recurrent Ovarian Cancer, Targeted Treatment",numberOfDownloads:null,numberOfWosCitations:0,numberOfCrossrefCitations:null,numberOfDimensionsCitations:null,numberOfTotalCitations:null,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"March 9th 2022",dateEndSecondStepPublish:"May 11th 2022",dateEndThirdStepPublish:"July 10th 2022",dateEndFourthStepPublish:"September 28th 2022",dateEndFifthStepPublish:"November 27th 2022",remainingDaysToSecondStep:"8 days",secondStepPassed:!0,currentStepOfPublishingProcess:3,editedByType:null,kuFlag:!1,biosketch:"Director of the HELIOS Klinikum Krefeld, a highly active academic researcher with an h index of 25, was previously affiliated with the University of Tübingen and the University of Aachen. Dr. Friedrich is a member of the ISSVD, ESGO, IGCS, ESMO, EUSOMA, ASCO, DGS, AGO, and the Society of Reconstructive Surgery in Gynecology (AWO-Gyn).",coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"278677",title:"Prof.",name:"Michael",middleName:null,surname:"Friedrich",slug:"michael-friedrich",fullName:"Michael Friedrich",profilePictureURL:"https://mts.intechopen.com/storage/users/278677/images/system/278677.jpg",biography:"Dr. Friedrich is the Director of the Department of Obstetrics and Gynecology of the Academic Teaching Hospital Krefeld. He is the author of more than 150 publications, mainly original contributions in peer-reviewed journals concerning gynecological malignancies and breast cancer as well as vitamin d metabolism. His main field of research activities is dealing with vitamin d metabolism in gynecological malignancies and in breast cancer. Another field of expertise is the interaction of DNA-mismatch repair and resistance to chemotherapy in gynecological malignancies. Further main points are the interstitial brachytherapy for recurrences of cervical cancer, the use of innovative therapies in gynecological malignancies, the technique of sentinel lymph node in gynecological malignancies especially in vulvar cancer, and the use of intraoperative intraperitoneal chemotherapy (HIPEC) in ovarian cancer.",institutionString:"HELIOS Klinikum Krefeld",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:null}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"16",title:"Medicine",slug:"medicine"}],chapters:null,productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"440204",firstName:"Ana",lastName:"Cink",middleName:null,title:"Ms.",imageUrl:"https://mts.intechopen.com/storage/users/440204/images/20006_n.jpg",email:"ana.c@intechopen.com",biography:"As an Author Service Manager my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review, to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"6550",title:"Cohort Studies in Health Sciences",subtitle:null,isOpenForSubmission:!1,hash:"01df5aba4fff1a84b37a2fdafa809660",slug:"cohort-studies-in-health-sciences",bookSignature:"R. Mauricio Barría",coverURL:"https://cdn.intechopen.com/books/images_new/6550.jpg",editedByType:"Edited by",editors:[{id:"88861",title:"Dr.",name:"R. Mauricio",surname:"Barría",slug:"r.-mauricio-barria",fullName:"R. Mauricio Barría"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9500",title:"Recent Advances in Bone Tumours and Osteoarthritis",subtitle:null,isOpenForSubmission:!1,hash:"ea4ec0d6ee01b88e264178886e3210ed",slug:"recent-advances-in-bone-tumours-and-osteoarthritis",bookSignature:"Hiran Amarasekera",coverURL:"https://cdn.intechopen.com/books/images_new/9500.jpg",editedByType:"Edited by",editors:[{id:"67634",title:"Dr.",name:"Hiran",surname:"Amarasekera",slug:"hiran-amarasekera",fullName:"Hiran Amarasekera"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophile",surname:"Theophanides",slug:"theophile-theophanides",fullName:"Theophile Theophanides"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"314",title:"Regenerative Medicine and Tissue Engineering",subtitle:"Cells and Biomaterials",isOpenForSubmission:!1,hash:"bb67e80e480c86bb8315458012d65686",slug:"regenerative-medicine-and-tissue-engineering-cells-and-biomaterials",bookSignature:"Daniel Eberli",coverURL:"https://cdn.intechopen.com/books/images_new/314.jpg",editedByType:"Edited by",editors:[{id:"6495",title:"Dr.",name:"Daniel",surname:"Eberli",slug:"daniel-eberli",fullName:"Daniel Eberli"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"57",title:"Physics and Applications of Graphene",subtitle:"Experiments",isOpenForSubmission:!1,hash:"0e6622a71cf4f02f45bfdd5691e1189a",slug:"physics-and-applications-of-graphene-experiments",bookSignature:"Sergey Mikhailov",coverURL:"https://cdn.intechopen.com/books/images_new/57.jpg",editedByType:"Edited by",editors:[{id:"16042",title:"Dr.",name:"Sergey",surname:"Mikhailov",slug:"sergey-mikhailov",fullName:"Sergey Mikhailov"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1373",title:"Ionic Liquids",subtitle:"Applications and Perspectives",isOpenForSubmission:!1,hash:"5e9ae5ae9167cde4b344e499a792c41c",slug:"ionic-liquids-applications-and-perspectives",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/1373.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"49611",title:"First-Transition Metal Oxocomplex–Surface-Modified Titanium(IV) Oxide for Solar Environmental Purification",doi:"10.5772/62008",slug:"first-transition-metal-oxocomplex-surface-modified-titanium-iv-oxide-for-solar-environmental-purific",body:'
1. Introduction
Environmental pollution is beyond limits, and the development of environmental catalysts is a critical subject for scientists and engineers all over the world. Here, the catalysts for purifying polluted water and air by utilizing the solar energy are termed as “solar environmental catalyst.” The TiO2 photocatalyst possesses great potential as the “solar environmental catalyst” owing to its strong oxidation ability, high physicochemical stability, abundance in nature, and nontoxicity [1,2]. Scheme 1 shows the fundamental reaction mechanism on the TiO2-photocatalyzed decomposition of organic pollutants with the characteristic time for each process [3]. UV-light absorption by TiO2 causes the excitation of electrons in the valence band (VB) to the conduction band (CB) in the order of femtoseconds. Most of the photogenerated charge carriers are lost by the recombination within ~100 ns. The charge carriers surviving the recombination are trapped at the TiO2 surface to induce the redox reactions. In general, the CB electrons reduce oxygen (O2), whereas the VB holes oxidize organic pollutants. The VB holes have a highly positive potential (+2.67 V versus standard hydrogen electrode (SHE) at pH 7) to oxidize most organic compounds. Conversely, the driving force for one-electron O2 reduction (standard potential, E0(O2/O2−) = −0.284 V versus SHE) by the CB electrons (−0.53 V versus SHE at pH 7) is small. Consequently, the O2 reduction reaction (ORR) is much slower (~ms) than the oxidation process (~100 ns). TiO2 usually takes crystal forms of rutile and anatase. The flatband potential of anatase is ~0.2 V, which is more negative than that of rutile, and anatase has a higher UV-light activity for the oxidation of organic compounds as compared with rutile [4]. This fact also points to the importance of the ORR in TiO2 photocatalytic reactions. Also, the coupling of anatase and rutile TiO2 can further increase the UV-light activity because of the enhancement of charge separation due to the interfacial electron transfer [5].
Sheme 1.
The basic mechanism on the TiO2 photocatalytic reaction (the surface trapping processes for the CB electrons and VB holes are abbreviated) with the characteristic time for each step shown.
Recently, the visible-light activation of TiO2 by its surface modification with metal oxide nanoparticles (NPs) or oxocomplexes has been developed [6,7]. This approach has a major advantage over the conventional doping [8–14], in that visible-light activation can be achieved by a simple procedure without the introduction of the impurity/vacancy levels into the bulk TiO2. To date, the impregnation method has been mainly used for the surface modification with metal oxide NPs, including chromium oxides [15], iron oxides [16–18], and copper oxides [19]. Unfortunately, the surface modification by the impregnation method is effective for rutile but less effective for anatase.
This chapter deals with our recent studies on the surface modification of anatase TiO2 with the first (3d) transition metal oxocomplexes (MOCs) by the chemisorption–calcination cycle technique (MOCs/TiO2) [20] and the characterization and photocatalytic activities for the degradation of organic pollutants. We show that some MOCs/TiO2 fulfill the requirements for the “solar environmental catalyst.”
2. Design for solar environmental catalysts
The requirements for the highly active TiO2-based “solar environmental catalyst” are described below. As shown in Figure 1, the excitation from the VB electrons to the CB needs UV-light irradiation, occupying only 3% of the incident sunlight. From a viewpoint of the effective use of the sunlight, the response to the visible-light occupying 45% of the solar energy (Figure 1) should be particularly imparted to anatase TiO2 and anatase–rutile-mixed TiO2 (Requirement 1). However, even if TiO2 can be endowed with the visible-light activity, it is usually much smaller than the UV-light activity. Therefore, the inherent excellent UV-light activity of TiO2 should be compatible with the visible-light activity (Requirement 2). For high levels of visible and UV-light activities to be achieved, the enhancement of the ORR is crucial because it is usually the rate-determining step in the TiO2-photocatalyzed reactions [21] (Requirement 3).
3. Catalyst preparation
3.1. Chemisorption–calcination cycle technique
The adsorption mechanism of metal acetylacetonates (acac) on TiO2 depends on the kind of complexes. As an example, Fe oxocomplex formation by the CCC technique is represented in Scheme 2. In the first step, Fe(acac)3 is chemisorbed on the TiO2 surface via the ligand exchange between the acac ligand and the surface Ti-OH group from the nonaqueous solution (Eq. 1) [22]:
Conversely, [Sn(acac)2]Cl2 is adsorbed on TiO2 via the ion exchange between H+ and [Sn(acac)2]2+ ion (Eq. 2) [23]. In each case, the adsorption apparently obeys the Langmuir model. The saturated adsorption amount and the adsorption constant for the adsorption of various metal acetylacetonates on TiO2 at 298 K are summarized in Table 1. The adsorption constants range from 102 to 104, indicating that they are strongly adsorbed on the TiO2 surface by chemical bonds. Exceptionally, Cr(acac)3 is not adsorbed because of its large ligand-field stabilization energy (1.2∆0).
Sheme 2.
Fe oxocomplex (Fe2O3) formation on the TiO2 surface by the CCC technique.
\n\t\t
\n\t\t
\n\t\t\t
\n\t\t\t\t\n\t\t\t
\n\t\t
\n\t
Table 1.
Adsorption properties of 3d metal acetylacetonates on TiO2 at 298 K.
In the second step, the oxidation of the acac ligands by heating the samples in air at 773 K yields iron oxides on the TiO2 surface. Further, these procedures are repeated to control the Fe-loading amount. Chemical analysis confirmed that all the Fe was confirmed to be present only on the TiO2 surface. The Fe-loading amount is expressed by the number of Fe ions per unit TiO2 surface area (Γ/ions nm−2).
3.2. Control of loading amount
A feature of the CCC technique is precise control of the loading amount of metal oxides. As an example, the manner in which the Fe-loading amount is controlled in the iron oxide/TiO2 system is described. Figure 2A shows the relation between Γ and initial complex concentration: black, Fe(acac)3 and blue, Mn(acac)3. In each case, the Γ gradually increases with an increase in the initial concentration. Figure 2B shows plots of Γ versus CCC cycle number (N): black, Fe(acac)3]0 = 0.65 mmol dm−3 (black) and blue, Mn(acac)3]0 = 8 mmol dm−3. The Γ further increases in proportional to N in both the systems. The linear Γ–N relation is also observed in the other metal oxide/TiO2 systems. In this manner, the loading amount of metal oxides can be controlled in a wide range using the precursor complex concentration and the cycle number.
4. Structure of surface metal oxocomplexes
Another feature of the CCC technique is the formation of molecular-scale metal oxide species on TiO2. Figure 3 shows transmission electron micrographs (TEMs) of iron oxide/TiO2 with varying Γ. No particulate deposits are observed on the TiO2 surface at Γ < 1 ions nm−2. This fact suggests that iron oxides exist as molecular-scale iron oxide species on the TiO2 surface.
Figure 2.
(A) Plots of Fe-loading amount (Γ/ions nm−2) versus initial concentration of the complex ([M(acac)3]0): M = Fe (black) and M = Mn (blue). (B) Plots of Γ versus cycle number (N) at Fe(acac)3]0 = 0.65 mmol dm−3 (black) and Mn(acac)3]0 = 8 mmol dm−3 (blue).
To obtain the detailed structural information, Fe K-edge X-ray absorption fine-structure spectra were measured for the iron oxide/TiO2 samples with varying Γ [24]. Figure 4A shows X-ray absorption near-edge structure (XANES) spectra for the iron oxide/TiO2 samples, and authentic Fe, Fe3O4, and α-Fe2O3 for comparison. The absorption edge of the iron oxide/TiO2 sample is in agreement with that of α-Fe2O3, indicating the oxidation number of the iron to be +3 (Table 1). Figure 4B shows the Fourier transforms of the k3-weighted X-ray absorption fine structure (EXAFS) for the iron oxide/TiO2 samples. The peaks around 1.6 Ǻ and 2.8 Ǻ arise from the scattering from the nearest neighbor O and Fe, respectively. It is worth noting that the latter peak becomes very weak at Γ ≤ 0.5. Evidently, the iron oxides exist as a mononuclear Fe oxocomplex on TiO2 designated as Fe2O3/TiO2 below.
Figure 3.
TEM images of Fe2O3/TiO2 with varying Γ : (A) Γ = 0 (P-25); (B) Γ = 0.23, (C) Γ = 0.38, (D) Γ = 0.54.
In this manner, MOCs are formed on the TiO2 surface in a highly dispersed state by the CCC technique, whereas the conventional impregnation method usually yields metal oxide NPs. As illustrated in Scheme 2, the molecular size of Fe(acac)3 (~0.5 nm2 complex−1) is much larger than the reciprocal number density of the Ti-OH groups on the TiO2 surface (~0.1 nm2 group−1) [25]. In the first step of the CCC process, Fe(acac)3 complexes are chemisorbed isolatedly each other owing to the bulky acac-ligands. Also, the strong bond between the complexes and the TiO2 surface suppresses the aggregation of the oxocomplexes during the second step. Consequently, mononuclear MOCs can be formed on the TiO2 surface.
Figure 4.
XANES and EXAFS spectra. (A) XANES spectra for Fe, Fe3O4, α-Fe2O3, and Fe2O3/TiO2 with varying Γ. (B) Fourier transforms of the k3-weighted EXAFS spectra for Fe2O3/TiO2. The figures were taken from Ref. 24.
5. Characteristics of metal oxocomplex–surface-modified TiO2
5.1. Optical property
The optical property is a fundamental factor affecting the photocatalytic activity. Figure 5 shows UV–visible absorption spectra for Fe oxocomplex–surface-modified mesoporous TiO2 nanocrystalline films (Fe2O3/mp-TiO2) with varying Γ. Impregnation samples usually have absorption approximately 470 nm in addition to absorption at 410 nm [16,17,26,27]. The former and latter absorptions can be attributed to the d–d transition and electronic transition from Fe3+ levels to the CB of TiO2, respectively [28]. A strong d–d absorption is also observed for a heavy-loading CCC sample (Fe2O3(Γ = 5.5)/mp-TiO2). In contrast, the absorption spectra of Fe2O3(Γ ≤ 2.1)/mp-TiO2 apparently show a marked bandgap narrowing from 3.3 to 2.85 eV with an increase in Γ, whereas the d–d transition absorption is very weak [24]. Similar spectra were previously observed for TiO2 doped with Cr [12] and N [13] prepared by ion implantation and magnetron sputtering. The weak d–d transition absorption is a common feature for the CCC samples including Co2O3/TiO2 [29], NiO/TiO2 [30,31], and CuO/TiO2 [32]. Clearly, the unique optical properties of the CCC samples originate from the highly dispersed MOCs on the TiO2 surface.
Figure 5.
UV–Vis absorption spectra of Fe2O3/mp-TiO2 prepared by the CCC technique.
5.2. Fine-tuning of band energy
The VB maximum determines the oxidation ability of the holes, and thus is a key factor for the decomposition of organic pollutants by semiconductor photocatalysts. The VB maximum level can be estimated from the VB-X-ray photoelectron spectroscopy (XPS) [24]. Since the VB maximum of TiO2 is almost independent of its crystal form and size, the VB maximum of MOC-modified TiO2 can be compared with respect to that of unmodified TiO2. Figure 6 shows the VB-XPS spectra for Fe2O3/TiO2 with varying Γ. The emission from the O 2p–VB extends from 2 to 9 eV. As a result of the surface modification, the top of VB rises, whereas the bottom remains invariant. Figure 6B compares the energy shift in the VB maximum level with respect to that of unmodified TiO2 (∆EVBM) as a function of Γ for the Fe2O3/TiO2, Co2O3/TiO2, NiO/TiO2, and SnO2/TiO2 systems. Interestingly, the ∆EVBM for the MOC-modified TiO2, except SnO2/TiO2, goes up with an increase in Γ, which means that the oxidation ability of the VB holes can be tuned by Γ. This is the most unique and important feature of the TiO2 modification with MOCs using the CCC technique.
Figure 6.
(A) VB-XPS spectra for Fe2O3/TiO2 with varying Γ. (B) Energy shift in the VB maximum level (∆EVBM) as a function Γ for various MOCs/TiO2. The figure (A) was taken from ref. 35.
These results were further simulated by the density functional theory (DFT) calculations [7]. In the DFT-optimized structure for a model Fe2O3 cluster-adsorbed TiO2 system, plural Fe–O–Ti interfacial bonds were observed. The PEDOS (projected electronic density of states) plots showed that states from the adsorbed Fe2O3 clusters lie above the VB of TiO2, that is, the iron oxide-derived states make it to the top of the VB. This changes the nature of the VB edge that moves the top of the VB to higher energy. The offsets between the TiO2 VB edge and the iron oxide states around the VB are ~0.3 eV for Fe2O3-modified TiO2, which is comparable with the experimental value. The effective mixing between the surface Fe2O3 levels and O 2p through the Tis–O–Fe interfacial bond is considered as yielding a d-band overlapping the VB of TiO2. Thus, the excitation of Fe2O3/TiO2 by the visible light with wavelength below 500 nm can induce the interfacial electron transfer from the surface d-band to the CB of TiO2.
Conversely, the information about empty levels can be obtained by photoluminescence spectroscopy. TiO2(ST-01) has a broad emission band centered at 538 nm (E1) [22]. The E1 signal intensity remarkably weakens with heating ST-01 at 773 K for 1 h in air. This PL band is assignable to the emission from the surface oxygen vacancy levels of anatase TiO2 [33]. On modifying ST-01 with the Fe oxocomplexes, the intensity further decreases to disappear at Γ > 0.044 ions nm−2, while a new emission appears at 423 nm (E2). The E2 signal can be attributed to the emissions from extrinsic levels. These findings strongly suggest that the excited electrons in the CB of TiO2 are transferred to the empty surface Fe oxocomplex levels with the energy distributed around 0.27 V below the CB of TiO2.
5.3. Electrocatalytic activity for oxygen reduction reaction
As stated above, the ORR is frequently the key process in the TiO2-photocatalyzed reactions as well as low-temperature polymer electrolyte membrane fuel cells (PEMFCs) [34,35]. Figure 7 shows dark current (I)–potential (E) curves of the mp-TiO2 film-coated F-doped tin oxide (FTO) electrodes (mp-TiO2/FTO) with and without the surface modification by Fe oxocomplexes. In the absence of O2, a small current due to water reduction is observed regardless of the surface modification. In the presence of O2, the current for ORR markedly increases with the surface modification (Fe2O3/mp-TiO2/FTO), whereas it remains weak without O2. In this manner, the surface Fe oxocomplex has an electrocatalytic activity for the ORR, and a similar ORR-promoting effect is also observed for the NiO/TiO2 [30] and Co2O3/TiO2 [29] systems. This is also the unique feature of the MOC/TiO2 systems.
Figure 7.
(A) Dark current (I)–potential (E) curves for the Fe2O3/mp-TiO2/FTO electrodes. (B) Comparison of the electrocatalytic activity of the MOC/mp-TiO2/FTO electrodes for the ORR.
6. Photocatalytic activity
Acetaldehyde is a toxic volatile organic compound (VOC), while 2-naphthol is widely used as the starting material of azo dyes. Both of them are optically transparent in the visible region, and then, acetaldehyde and 2-naphthol were used as model air and water pollutants, respectively. The relative photocatalytic activities of various MOCs/TiO2 were evaluated with respect to that of highly active commercial TiO2 particles with a crystal form of anatase (ST-01, Ishihara Sangyo Co.). The photocatalytic degradation of 2-naphthol and acetaldehyde apparently follows the first-order rate law, and the rate constants for irradiation of UV light (330 < λ < 400 nm, kUV) and visible light (λ > 400 nm, kvis) were used as the indicators for the photocatalytic activities. Figure 8 shows the kvis and kUV of Fe2O3/TiO2 for the degradations of 2-naphthol (A) and acetaldehyde (B) as a function of Γ. Surprisingly, the surface modification of TiO2 by the Fe-oxocomplex gives rise to a high level of visible-light activity and a concomitant increase in the UV-light activity of anatase TiO2 [24]. Each plot exhibits a volcano-shaped curve, which is a general feature in the activity-Γ plots for the MOC/TiO2 systems. By using an atomic layer deposition technique, Libera et al. have recently prepared Fe(III) oxospecies–surface-modified TiO2 showing a reactivity for the decoloration of methylene blue under visible-light irradiation [18].
Figure 8.
(A) UV-light activity (kUV, blue) and visible-light activity (kvis, red) of Fe2O3/TiO2(ST-01) for the liquid-phase decomposition of 2-NAP as a function of Γ. (B) UV-light activity (kUV, blue) and visible-light activity (kvis, red) of Fe2O3/TiO2(ST-01) for the gas-phase decomposition of CH3CHO as a function of Γ.
Figure 9.
TiO2 NTA parepared by a two-step anodization of Ti plate (first anodization 40 V, 0.5 h/second anodization 40 V-1 h/heating temperature, Tc = 773 K). The figure was taken from Ref. 35.
Particulate systems have high photocatalytic activity due to the large surface area, but needs the troublesome separation of the particles from purified water. Oppositely, in supported films, the photocatalytic activity is generally much lower due to the smaller surface area, while the separation process is unnecessary. TiO2 nanotube array (NTA) has the advantages of the particulate and film systems is promising. Figure 9 shows TEM image for TiO2 NTA prepared by two-step anodization. The application of the CCC technique to the TiO2 NTA led to a high visible-light activity for 2-naphthol degradation comparable with that of the particulate system [36].
Figure 10 compares the relative visible-light activity (kvis) and UV-light activity (kUV) of 3d MOCs/TiO2(ST-01) with respect to the activities of unmodified TiO2(ST-01) (kvis0 and kUV0) for the 2-naphthol degradation under the same conditions. Each Γ shows the optimum value for visible-light activity in each MOC/TiO2 system. Among MOCs, the surface modification by Fe2O3 [24], Co2O3 [25], and NiO [30] is effective in the visible-light activation. Particularly, the Co2O3/TiO2 system exhibits a very high level of visible-light activity [29]. The activity is on the order of Co2O3 > Fe2O3 > NiO > CuO > V2O5 ≈ Mn2O3 > SnO2 ≈ unmodified TiO2. However, the surface modification with Fe2O3, NiO, and Co2O3 by the CCC technique can endow anatase TiO2 with high levels of visible-light activity, with the high UV-light activity further increased (Fe2O3) or maintained (Co2O3, NiO). Although the effect of the surface modification by SnO2 was small for anatase, a significant increase in the UV-light activity was induced for rutile [37]. Interestingly, Boppana and Lobo have recently reported that loading of SnOx clusters on ZnGa2O4 by the impregnation method causes visible-light activity for the decomposition of p-cresol [38]. Besides metal oxides, the surface modification of TiO2 with halogeno complexes of rhodium(III) and platinum(IV) on the TiO2 surface is known to induce visible-light activity [39,40].
Figure 10.
Comparison of the visible-light activities (kvis) and UV-light activities (kUV) of MOCs/TiO2(ST-01) with respect to those of unmodified TiO2 for the 2-naphthol degradation under the same conditions.
The degradation of formic acid was further carried out in the aqueous phase with Co2O3/TiO2 at 298 K under visible-light irradiation. The Co2O3 surface modification greatly enhanced the decomposition of formic acid to CO2. The visible-light activity reached a maximum at Γ = 0.17 with the conversion to CO2 reaching ~100% within 5 h [29] (Eq. 3).
HCOOH+1/2O2→hν(λ>400nm)CO2O3/TiO2CO2+H2OE3
Also, prolonging irradiation decomposed 2-naphthol to CO2, but the conversion was only ~6% at 96 h. The decomposition of 2-naphthol to CO2 would proceed stepwise via oxidative cleavage of the naphthalene ring.
On the basis of the energy band diagram, the action mechanism of MOCs in the TiO2 photocatalysis can be explained. In the nanoscale Fe2O3–TiO2 coupling system, Fe2O3 NP with a band gap of 2.2 eV is excited by the visible-light irradiation. However, the potential of the CB electrons is more positive than the TiO2 CB minimum of TiO2 (−0.48 V) and the standard redox potential of O2 (E0(O2/O2−) = −0.284 V). Thus, the electron transfer from the CB electrons of Fe2O3 to neither TiO2 nor O2 can occur. Consequently, nano-coupling does not show visible-light activity [41].
Sheme 3.
Surface modification effects of the Fe oxocomplex on the TiO2-photocatalyzed decomposition of organic pollutants. The levels around −0.2 V show the vacant Fe oxocomplex.
Scheme 3 illustrates the surface modification effects of the Fe oxocomplex on the TiO2 photocatalytic decomposition of organic pollutants. In this case, the surface modification raises the VB maximum with the CB minimum unchanged, due to the effective electronic coupling through the Fe–O–Ti interfacial bonds (Effect 1). The resulting decrease in the band gap shifts the light absorption to the visible region (Effect 2). The visible-light absorption triggers electronic excitation from the highest-energy oxocomplex-derived VB states to the empty CB of TiO2 in order to generate charge carriers. This surface-to-bulk interfacial electron transfer enhances charge separation (Effect 3). The surface modification permits the electron transfer from the CB of TiO2 to shallow vacant surface oxocomplex levels, which distribute around ca. −0.2 V [22]. The formation of O2− radicals was confirmed by chemiluminescence photometry in the Cu2+-grafted TiO2 system under visible-light irradiation [42]. In this cathodic process, the electrons efficiently reduce adsorbed O2 with the aid of the electrocatalytic activity of the surface-adsorbed oxocomplex (Effect 4). This effect should also contribute to the increase in the UV-light activity. In the anodic process, the holes generated in the VB could take part in the oxidation process without diffusion (Effect 5) [15]. Consequently, Fe2O3/TiO2 as well as NiO/TiO2 and Co2O3/TiO2 satisfy the three requirements of the “solar environmental catalyst.”
7. Conclusions and future prospect
The surface of TiO2 can be modified by oxocomplexes of the first transition metals (MOCs/TiO2) with the loading amount precisely controlled by using the CCC technique. Among the MOCs/TiO2, Fe2O3-, Co2O3- and NiO-surface-modified TiO2 possess unique physicochemical properties such as strong visible-light absorption and the excellent reduction ability of O2. Spectroscopic experiments and first-principles DFT simulation have revealed that the surface modification with the MOCs raises the VB maximum of TiO2 due to the formation of plural metal–O–Ti interfacial bonds. Surface-to-bulk and/or bulk-to-surface interfacial electron transfer induced by visible-light absorption enhances charge separation. This novel coupling system consisting of MOCs and TiO2 would be promising as the “solar environmental catalyst.”
The standard potentials of multiple-electron ORRs (E0(O2/H2O2) = +0.695 V and E0(O2/H2O) = +1.229 V versus SHE) are much more positive than that of one-electron ORR. Therefore, the hybridization of appropriate electrocatalysts for the multiple-electron ORR can impart visible-light activity to many metal oxide semiconductors with Eg < 3 eV. The effectiveness of this approach has recently been verified in the Pt NP-WO3 (Eg = 2.7 eV) [43] and Cu(acac)2-BiVO4 (Eg = 2.4 eV) hybrid systems [44], where Pt NP and O2-bridged Cu complex work as excellent electrocatalysts for multiple ORRs, respectively.
As a future subject, we further suggest the importance of the effective use of the infrared ray occupying 52% of the solar energy for the catalytic reactions (Figure 1). For example, Co2O3/TiO2 exhibits high levels of photocatalytic and thermocatalytic activities [29], whereas Mn2O3/TiO2 exhibits a high thermocatalytic activity for the oxidation of organic compounds [45]. Further, MOCs/TiO2 with the VB maximum level (or the oxidizing ability of the VB holes) fine-tuned by the loading amount may open up the application of MOCs/TiO2 to “green” and selective chemical transformations [46–48].
Acknowledgments
A series of studies on metal oxocomplex–surface-modified TiO2 have been performed in collaboration with Dr. Michael Nolan and Dr. Anna Iwaszuk (Tyndall National Institute, University College Cork). The authors are sincerely grateful for their very useful DFT simulations. Also, the authors acknowledge Dr. M. Fujishima (Kinki University) for a helpful discussion, and T. Hattori, S. Okuoka, and Y. Sumida (Nippon Shokubai Co.) for EXAFS measurements and a valuable discussion. Ishihara Sangyo Co. gifted us with ST-01, and K. Fujiwara aided us in the collection and arrangement of the materials. H.T. acknowledges the support from the Ministry of Education, Science, Sport, and Culture, Japan, through a Grant-in-Aid for Scientific Research (C) No. 24550239, No. 15K05654, MEXT-Supported Program for the Strategic Research Foundation at Private Universities, and Nippon Sheet Glass Foundation for Materials Science and Engineering, and by Sumitomo Foundation.
\n',keywords:"Visible-light photocatalyst, Titanium(IV) oxide, Surface modification, Metal oxide cluster, Metal oxocomplex, Band energy turning, Solar environmental purification",chapterPDFUrl:"https://cdn.intechopen.com/pdfs/49611.pdf",chapterXML:"https://mts.intechopen.com/source/xml/49611.xml",downloadPdfUrl:"/chapter/pdf-download/49611",previewPdfUrl:"/chapter/pdf-preview/49611",totalDownloads:1596,totalViews:308,totalCrossrefCites:0,totalDimensionsCites:1,totalAltmetricsMentions:0,impactScore:0,impactScorePercentile:12,impactScoreQuartile:1,hasAltmetrics:0,dateSubmitted:"April 20th 2015",dateReviewed:"November 18th 2015",datePrePublished:null,datePublished:"February 3rd 2016",dateFinished:"November 26th 2015",readingETA:"0",abstract:"The ongoing global energy and environmental issues warrant the development of environmental catalysts for decomposing pollutants in water and air by utilizing solar energy named as “solar environmental catalysts.” This chapter describes the recent studies on a novel class of solar environmental catalysts consisting of TiO2 and molecular-scale first-row transition metal oxide clusters (or metal oxocomplexes) on the surface (MOs/TiO2). The TiO2 surface modification with the oxocomplexes by the chemisorption–calcination cycle (CCC) technique presents a novel band engineering for fine-tuning the band energy. The unique physicochemical and electronic properties of MOs/TiO2 give rise to the outstanding photocatalytic activity for the decomposition of organic pollutants. The combination with the rapidly growing technique for preparation of TiO2 nanostructures allows us to expect further improvement of the performances and the wide application to the solar chemical transformation for producing useful substances.",reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/49611",risUrl:"/chapter/ris/49611",book:{id:"5072",slug:"advanced-catalytic-materials-photocatalysis-and-other-current-trends"},signatures:"Hiroaki Tada and Qiliang Jin",authors:[{id:"167854",title:"Prof.",name:"Hiroaki",middleName:null,surname:"Tada",fullName:"Hiroaki Tada",slug:"hiroaki-tada",email:"h-tada@apch.kindai.ac.jp",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institution:{name:"National Institute of Radiological Sciences",institutionURL:null,country:{name:"Japan"}}}],sections:[{id:"sec_1",title:"1. Introduction",level:"1"},{id:"sec_2",title:"2. Design for solar environmental catalysts",level:"1"},{id:"sec_3",title:"3. Catalyst preparation",level:"1"},{id:"sec_3_2",title:"3.1. Chemisorption–calcination cycle technique",level:"2"},{id:"sec_4_2",title:"3.2. Control of loading amount",level:"2"},{id:"sec_6",title:"4. Structure of surface metal oxocomplexes",level:"1"},{id:"sec_7",title:"5. Characteristics of metal oxocomplex–surface-modified TiO2",level:"1"},{id:"sec_7_2",title:"5.1. Optical property",level:"2"},{id:"sec_8_2",title:"5.2. Fine-tuning of band energy",level:"2"},{id:"sec_9_2",title:"5.3. Electrocatalytic activity for oxygen reduction reaction",level:"2"},{id:"sec_11",title:"6. Photocatalytic activity",level:"1"},{id:"sec_12",title:"7. Conclusions and future prospect",level:"1"},{id:"sec_13",title:"Acknowledgments",level:"1"}],chapterReferences:[{id:"B1",body:'Fujishima A, Zhang X, Tryk D A: TiO2 photocatalysis and related surface phenomena. Surf. Sci. Rep. 2008; 63: 515–582. DOI: j.surfrep.2008.10.001'},{id:"B2",body:'Hashimoto K, Irie H, Fujishima A: TiO2 photocatalysis: A historical overview and future prospects. Jpn. J. Appl. Phys. 2005; 44: 8269–8285.'},{id:"B3",body:'Hoffmann M R, Martin S T, Choi W, Bahnemann D W: Environmental applications of semiconductor photocatalysis. Chem. Rev. 1995; 95: 69–96. DOI: 10.1021/cr00033a004'},{id:"B4",body:'A. Y. Ahmed, T. A. Kandiel, T. Oekermann, D. Bahnemann: Photocatalytic activities of different well-defined single crystal TiO2 surfaces: Anatase versus rutile. J. Phys. Chem. Lett. 2011; 2: 2461–2465. DOI: 10.1021/jz201156b'},{id:"B5",body:'Kawahara T, Konishi Y, Tada H, Tohge N, Nishii J, Ito S: A patterned TiO2(anatase)/TiO2(rutile) bilayer-type photocatalyst: Effect of the anatase/rutile junction on the photocatalytic activity. Angew. Chem. Int. Ed. 2002; 41: 2811–2813. DOI: 10.1002/1521-3757(20020802)114:15<2935:: AID-ANGE2935>3.0.CO;2-6'},{id:"B6",body:'Kisch H: Semiconductor photocatalysis–mechanistic and synthetic aspects. Angew. Chem. Int. Ed. 2013; 52: 812–847. DOI: 10.1002/anie.201201200'},{id:"B7",body:'Nolan M, Iwaszuk A, Tada H: Molecular metal oxide cluster-surface modified titanium(IV) dioxide photocatalysts. Aust. J. Chem. 2012; 65: 624–632.'},{id:"B8",body:'Asahi R, Morikawa T, Ohwaki T, Aoki K, Taga Y: Visible-light photocatalysis in nitrogen-doped titanium oxides. Science 2001; 293: 269–271. DOI: 10.1126/science.1061051'},{id:"B9",body:'Khan S U M, Al-Shahry M, Ingler Jr. W B: Efficient photochemical water splitting by a chemically modified n-TiO2. Science 2002; 297: 2243–2245. DOI: 10.1126/science.1075035'},{id:"B10",body:'Serpone N: Is the band gap of pristine TiO2 narrowed by anion- and cation-doping of titanium dioxide in second-generation photocatalysts? J. Phys. Chem. B 2006; 110: 24287–24293. DOI: 10.1021/jp065659r'},{id:"B11",body:'Zhang H, Chen G, Bahnemann D W: Photoelectrocatalytic materials for environmental applications. J. Mater. Chem. 2009; 19: 5089–5121. DOI: 10.1039/B821991E'},{id:"B12",body:'Anpo M, Takeuchi M: The design and development of highly reactive titanium oxide photocatalysts operating under visible light irradiation. J. Catal. 2003; 216: 505–516. DOI: 10.1016/S0021-9517(02)00104-5'},{id:"B13",body:'Kitano M, Funatsu K, Matsuoka M, Ueshima M, Anpo M: Preparation of nitrogen-substituted TiO2 thin film photocatalysts by the radio frequency magnetron sputtering deposition method and their photocatalytic reactivity under visible light irradiation. J. Phys. Chem. B 2006; 110: 25266–25272. DOI: 10.1021/jp064893e'},{id:"B14",body:'Liu G, Wang L, Yang H G, Cheng H-M, Lu G Q: Titania-based photocatalysts-crystal growth, doping and heterostructuring. J. Mater. Chem. 2010; 20: 831–843. DOI: 10.1039/B909930A'},{id:"B15",body:'Irie H, Shibanuma T, Kamiya K, Miura S, Yokoyama T, Hashimoto K: Characterization of Cr(III)-grafted TiO2 for photocatalytic reaction under visible light. Appl. Catal. B. 2010; 96: 142–148. DOI: 10.1016/j.apcatb.2010.02.011'},{id:"B16",body:'Murakami N, Chiyoya T, Tsubota T, Ohno T: Switching redox site of photocatalytic reaction on titanium(IV) oxide particles modified with transition-metal ion controlled by irradiation wavelength. Appl. Catal. A. 2008; 348: 148–152. DOI: 10.1016/j.apcata.2008.06.040'},{id:"B17",body:'Yu H, Irie H, Shimodaira Y, Hosogi Y, Kuroda Y, Miyauchi M, Hashimoto K: J. Phys. Chem. C 2010; 114: 16481–16487. DOI: 10.1021/jp1071956'},{id:"B18",body:'Libera J A, Elam J W, Sather N F, Rajh T M, Dimitrijevic N M: Iron(III)-oxo centers on TiO2 for visible-light photocatalysis. Chem. Mater. 2010; 22: 409–413. DOI: 10.1021/cm902825c'},{id:"B19",body:'Irie H, Miura S, Kamiya K, Hashimoto K: Efficient visible light-sensitive photocatalysts: Grafting Cu(II) ions onto TiO2 and WO3 photocatalysts. Chem. Phys. Lett. 2008; 457: 202–205. DOI: 10.1016/j.cplett.2008.04.006'},{id:"B20",body:'Tada H: Encyclopedia of Surface and Colloid Science. Ed. Hubbard A T, New York: Marcel Dekker, 2002. ISBN: 0-8247-0633-1'},{id:"B21",body:'Wang C-M, Heller A, Gerischer H: Palladium catalysis of O2 reduction by electrons accumulated on TiO2 particles during photoassisted oxidation of organic compounds. J. Am. Chem. Soc. 1992; 114: 5230–5234. DOI: 10.1021/ja00039a039'},{id:"B22",body:'Jin Q, Fujishima M, Tada H: Visible-light-active iron oxide-modified anatase titanium(IV) dioxide. J. Phys. Chem C 2011; 115: 6478–6483. DOI: 10.1021/jp201131t'},{id:"B23",body:'Fujishima M, Jin Q, Yamamoto H, Tada H, Nolan M: Tin oxide-surface modified anatase titanium(IV) dioxide with enhanced UV-light photocatalytic activity. Phys. Chem. Chem. Phys. 2012; 14: 705–711. DOI: 10.1039/C1CP22708D'},{id:"B24",body:'Tada H, Jin Q, Nishijima H, Yamamoto H, Fujishima M, Okuoka S-i, Hattori T, Sumida Y, Kobayashi H: Titanium(IV) dioxide surface-modified with iron oxide as a visible light photocatalyst. Angew. Chem. Int. Ed. 2011; 50: 3501–3505. DOI: 10.1002/anie.201007869'},{id:"B25",body:'Nosaka Y, Nosaka A. Nyumon: Hikarisyokubai (Introduction to Photocatalyst). Tokyo: Tokyo-Tosho; 2004, 68 p. ISBN: 4-489-00684-5 C3043'},{id:"B26",body:'Navio J A, Colon G, Litter M I, Bianco G N: Synthesis, characterization and photocatalytic properties of iron-doped titania semiconductors prepared from TiO2 and iron(III) acetylacetonate. J. Mol. Catal. A: Chem. 1996; 106: 267–276. DOI: 10.1016/1381-1169(95)00264-2'},{id:"B27",body:'Wang C-Y, Bahnemann D W, Dohrmann J K: A novel preparation of iron-doped TiO2 nanoparticles with enhanced photocatalytic activity. Chem. Commun. 2000; 1539–1540. DOI: 10.1039/B002988M'},{id:"B28",body:'Serpone N, Lawless D, Disdier J, Hermann J-M: Spectroscopic, photoconductivity, and photocatalytic studies of TiO2 colloids: Naked and with the lattice doped with Cr3+, Fe3+, and V5+ cations. Langmuir 1994; 10: 643–652. DOI: 10.1021/la00015a010'},{id:"B29",body:'Jin Q, Yamamoto H, Yamamoto K, Fujishima M, Tada H: Simultaneous induction of high level thermal and visible-light catalytic activities to titanium(IV) oxide by surface modification with cobalt(III) oxide clusters. Phys. Chem. Chem. Phys. 2013; 15: 20313–20319. DOI: 10.1039/C3CP54304H'},{id:"B30",body:'Jin Q, Ikeda T, Fujishima M, Tada H: Nickel(II) oxide surface-modified titanium(IV) dioxide as a visible-light-active photocatalyst. Chem. Commun. 2011; 47: 8814–8816. DOI: 10.1039/C1CC13096J'},{id:"B31",body:'Iwaszuk A, Nolan M, Jin Q, Fujishima M, Tada H: Origin of the visible-light response of nickel(II) oxide cluster surface modified titanium(IV) dioxide. J. Phys. Chem. C 2013; 117: 2709–2718. DOI: 10.1021/jp306793r'},{id:"B32",body:'Jin Q, Fujishima M, Iwaszuk A, Nolan M, Tada H: Loading effect in copper(II) oxide cluster-surface-modified titanium(IV) oxide on visible- and UV-light activities. J. Phys. Chem. C 2013; 117: 23848–23857. DOI: 10.1021/jp4085525'},{id:"B33",body:'Shi J, Chen J, Feng Z, Chen T, Lian Y, Wang X, Li C: Photoluminescence characteristics of TiO2 and their relationship to the photoassisted reaction of water/methanol mixture. J. Phys. Chem. 2007; 111: 693–699. DOI: 10.1021/jp065744z'},{id:"B34",body:'Gewirth A A, Thorum M S: Electroreduction of dioxygen for fuel-cell applications: Materials and challenges. Inorg. Chem. 2010; 49: 3557–3566. DOI: 10.1021/ic9022486'},{id:"B35",body:'Fermández J L, Walsh D A, Bard A J: Thermodynamic guidelines for the design of bimetallic catalysts for oxygen electroreduction and rapid screening by scanning electrochemical microscopy. M-co (M: Pd, Ag, Au). J. Am. Chem. Soc. 2005; 127: 357–365. DOI: 10.1021/ja0449729'},{id:"B36",body:'Muramatsu Y, Jin Q, Fujishima M, Tada H: Visible-light-activation of TiO2 nanotube array by the molecular iron oxide surface modification. Appl. Catal. B: Environ. 2012; 119–120: 74–80. DOI: 10.1016/j.apcatb.2012.02.012'},{id:"B37",body:'Jin Q, Fujishima M, Nolan M, Iwaszuk A, Tada H: Photocatalytic activities of tin(IV) oxide surface-modified titanium(IV) dioxide show a strong sensitivity to the TiO2 crystal form. J. Phys. Chem. C 2012; 116: 12621–12626. DOI: 10.1021/jp302493f'},{id:"B38",body:'Boppana V B R, Lobo R F: SnOx-ZnGa2O4 photocatalysts with enhanced visible light activity. ACS Catal. 2011; 1: 923–928. DOI: 10.1021/cs200137h'},{id:"B39",body:'Kisch H: Semiconductor photocatalysis-mechanistic and synthetic aspects. Angew. Chem. Int. Ed. 2013; 52: 812–847. DOI: 10.1002/anie.201201200'},{id:"B40",body:'Kitano S, Murakami N, Ohno T, Mitani Y, Nosaka Y, Asakura H, Teramura K, Tanakia T,'},{id:"B41",body:'Tada H, Hashimoto K, Kominami H: Bifunctionality of Rh3+ modifier on TiO2 and working mechanism of Rh3+/TiO2 photocatalyst under irradiation of visible light. J. Phys. Chem. C 2013; 117: 11008–11016. DOI: 10.1021/jp311801e'},{id:"B42",body:'Lin X, Li D-Z, Wu Q-P, Fu X-Z, Wang X-X: Chem. Photocatalytic activity and mechanism of heterojunction thin films. J. Chin. Univ. 2005; 26: 727–730.'},{id:"B43",body:'Nosaka Y, Takahashi S, Sakamoto H, Nosaka A: Reaction mechanism of Cu(II)-grafted visible-light responsive TiO2 and WO3 photocatalysts studied by means of ESR spectroscopy and chemiluminescence photometry. J. Phys. Chem. C 2011; 115: 21283–21290. DOI: 10.1021/jp2070634'},{id:"B44",body:'Abe R, Takami H, Murakami N, Ohtani B: Pristine simple oxides as visible light driven photocatalysts: Highly efficient decomposition of organic compounds over platinum-loaded tungsten oxide. J. Am. Chem. Soc. 2008; 130: 7780–7781. DOI: 10.1021/ja800835q'},{id:"B45",body:'Naya S, Niwa T, Negishi R, Kobayashi H, Tada H: Multi-electron oxygen reduction by a hybrid visible-light-photocatalyst consisting of metal-oxide semiconductor and self-assembled biomimetic complex. Angew. Chem. Int. Ed. 2014; 53: 13894–13897. DOI: 10.1002/anie.201408352'},{id:"B46",body:'Jin Q, Arimoto H, Fujishima M, Tada H: Manganese oxide-surface modified titanium(IV) dioxide as environmental catalyst. Catalysts 2013; 3: 444–454. DOI: 10.3390/catal3020444'},{id:"B47",body:'Ide Y, Hattori H, Ogo S, Sadakane M, Sano T: Highly efficient and selective sunlight-induced photocatalytic oxidation of cyclohexane on an eco-catalyst under a CO2 atmosphere. Green Chem. 2012; 14: 1264–1267. DOI: 10.1039/C2GC16594E'},{id:"B48",body:'Higasihmoto S, Shirai R, Osano Y, Azuma M, Ohue H, Sakata Y, Kobayashi H: Influence of metal ions on the photocatalytic activity: Selective oxidation of benzyl alcohol on iron (III) ion-modified TiO2 using visible light. J. Catal. 2014; 311: 137–143. DOI: 10.1016/j.jca.2013.11.013'},{id:"B49",body:'Tang J, Grampp G, Liu Y, Wang, B-X, Tao F-F, Wang L-J, Liang X-Z, Xiao H-Q, Shen, Y-M: Visible light mediated cyclization of tertiary anilines with maleimides using nickel(II) oxide surface-modified titanium dioxide catalyst. J. Org. Chem. 2015; 80: 2724–2732. DOI: 10.1021/jo502901h'}],footnotes:[],contributors:[{corresp:"yes",contributorFullName:"Hiroaki Tada",address:"h-tada@apch.kindai.ac.jp",affiliation:'
Department of Applied Chemistry, School of Science and Engineering, Kinki University, Kowakae, Higashi-Osaka, Osaka, Japan
R&D Placement Business Division, WORLD INTEC CO., Sakae, Naka-ku, Nagoya, Aichi, Japan
'}],corrections:null},book:{id:"5072",type:"book",title:"Advanced Catalytic Materials",subtitle:"Photocatalysis and Other Current Trends",fullTitle:"Advanced Catalytic Materials - Photocatalysis and Other Current Trends",slug:"advanced-catalytic-materials-photocatalysis-and-other-current-trends",publishedDate:"February 3rd 2016",bookSignature:"Luis Enrique Norena and Jin-An Wang",coverURL:"https://cdn.intechopen.com/books/images_new/5072.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",isbn:null,printIsbn:"978-953-51-2244-9",pdfIsbn:"978-953-51-5062-6",reviewType:"peer-reviewed",numberOfWosCitations:52,isAvailableForWebshopOrdering:!0,editors:[{id:"15562",title:"Dr.",name:"Noreña",middleName:null,surname:"Luis",slug:"norena-luis",fullName:"Noreña Luis"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"511"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"49683",type:"chapter",title:"X-Ray Spectroscopy — The Driving Force to Understand and Develop Catalysis",slug:"x-ray-spectroscopy-the-driving-force-to-understand-and-develop-catalysis",totalDownloads:1924,totalCrossrefCites:1,signatures:"Jakub Szlachetko and Jacinto Sá",reviewType:"peer-reviewed",authors:[{id:"176327",title:"Prof.",name:"Jacinto",middleName:null,surname:"Sa",fullName:"Jacinto Sa",slug:"jacinto-sa"},{id:"176328",title:"Dr.",name:"Jakub",middleName:null,surname:"Szlachetko",fullName:"Jakub Szlachetko",slug:"jakub-szlachetko"}]},{id:"49674",type:"chapter",title:"Iron-based Nanomaterials in the Catalysis",slug:"iron-based-nanomaterials-in-the-catalysis",totalDownloads:4389,totalCrossrefCites:6,signatures:"Boris I. Kharisov, Oxana V. Kharissova, H.V. Rasika Dias, Ubaldo Ortiz\nMéndez, Idalia Gómez de la Fuente, Yolanda Peña and Alejandro\nVázquez Dimas",reviewType:"peer-reviewed",authors:[{id:"13939",title:"Dr.",name:"Boris",middleName:null,surname:"Kharisov",fullName:"Boris Kharisov",slug:"boris-kharisov"},{id:"13941",title:"Dr.",name:"Oxana V.",middleName:null,surname:"Kharissova",fullName:"Oxana V. Kharissova",slug:"oxana-v.-kharissova"},{id:"13942",title:"Dr.",name:"Ubaldo",middleName:null,surname:"Ortiz Mendez",fullName:"Ubaldo Ortiz Mendez",slug:"ubaldo-ortiz-mendez"},{id:"176321",title:"Prof.",name:"H.V. Rasika",middleName:null,surname:"Dias",fullName:"H.V. Rasika Dias",slug:"h.v.-rasika-dias"},{id:"179552",title:"Dr.",name:"Idalia",middleName:null,surname:"Gomez De La Fuente",fullName:"Idalia Gomez De La Fuente",slug:"idalia-gomez-de-la-fuente"},{id:"179553",title:"Dr.",name:"Alejandro",middleName:null,surname:"Vazques Dimas",fullName:"Alejandro Vazques Dimas",slug:"alejandro-vazques-dimas"},{id:"179554",title:"Dr.",name:"Yolanda",middleName:null,surname:"Peña Mendez",fullName:"Yolanda Peña Mendez",slug:"yolanda-pena-mendez"}]},{id:"49671",type:"chapter",title:"New Catalytic Systems for Fixation of Carbon Dioxide into Valuable Poly(Alkylene Carbonates)",slug:"new-catalytic-systems-for-fixation-of-carbon-dioxide-into-valuable-poly-alkylene-carbonates-",totalDownloads:4053,totalCrossrefCites:0,signatures:"Bahareh Bahramian and Fariba Dehghani",reviewType:"peer-reviewed",authors:[{id:"176380",title:"Prof.",name:"Fariba",middleName:null,surname:"Dehghani",fullName:"Fariba Dehghani",slug:"fariba-dehghani"},{id:"176429",title:"Mrs.",name:"Bahareh",middleName:null,surname:"Bahramian",fullName:"Bahareh Bahramian",slug:"bahareh-bahramian"}]},{id:"49601",type:"chapter",title:"Catalytic Applications of Metal-Organic Frameworks",slug:"catalytic-applications-of-metal-organic-frameworks",totalDownloads:3841,totalCrossrefCites:3,signatures:"Sandra Loera-Serna and Elba Ortiz",reviewType:"peer-reviewed",authors:[{id:"176856",title:"Dr.",name:"Sandra",middleName:null,surname:"Loera-Serna",fullName:"Sandra Loera-Serna",slug:"sandra-loera-serna"},{id:"176863",title:"Dr.",name:"Elba",middleName:null,surname:"Ortiz",fullName:"Elba Ortiz",slug:"elba-ortiz"}]},{id:"49657",type:"chapter",title:"Studies on Obtaining Diglycidyl Ether from Allyl-Glycidyl Ether over the Mesoporous Ti-SBA-15 Catalyst",slug:"studies-on-obtaining-diglycidyl-ether-from-allyl-glycidyl-ether-over-the-mesoporous-ti-sba-15-cataly",totalDownloads:1355,totalCrossrefCites:1,signatures:"Agnieszka Wróblewska, Edyta Makuch and Ewelina Mójta",reviewType:"peer-reviewed",authors:[{id:"176317",title:"Associate Prof.",name:"Agnieszka",middleName:null,surname:"Wróblewska",fullName:"Agnieszka Wróblewska",slug:"agnieszka-wroblewska"},{id:"177280",title:"MSc.",name:"Edyta",middleName:null,surname:"Makuch",fullName:"Edyta Makuch",slug:"edyta-makuch"},{id:"177872",title:"MSc.",name:"Ewelina",middleName:null,surname:"Mójta",fullName:"Ewelina Mójta",slug:"ewelina-mojta"}]},{id:"49758",type:"chapter",title:"Practical Design of Green Catalysts for PET Recycling and Energy Conversion",slug:"practical-design-of-green-catalysts-for-pet-recycling-and-energy-conversion",totalDownloads:2556,totalCrossrefCites:1,signatures:"Arvin Sangalang, Seunghwan Seok and Do Hyun Kim",reviewType:"peer-reviewed",authors:[{id:"97132",title:"Prof.",name:"Do Hyun",middleName:null,surname:"Kim",fullName:"Do Hyun Kim",slug:"do-hyun-kim"},{id:"177578",title:"MSc.",name:"Arvin",middleName:null,surname:"Sangalang",fullName:"Arvin Sangalang",slug:"arvin-sangalang"},{id:"177579",title:"MSc.",name:"Seunghwan",middleName:null,surname:"Seok",fullName:"Seunghwan Seok",slug:"seunghwan-seok"}]},{id:"49829",type:"chapter",title:"Advanced Nanomatericals for Solar Photocatalysis",slug:"advanced-nanomatericals-for-solar-photocatalysis",totalDownloads:3283,totalCrossrefCites:6,signatures:"Le Li and Minqiang Wang",reviewType:"peer-reviewed",authors:[{id:"176453",title:"Dr.",name:"Le",middleName:null,surname:"Li",fullName:"Le Li",slug:"le-li"},{id:"176454",title:"Prof.",name:"Minqiang",middleName:null,surname:"Wang",fullName:"Minqiang Wang",slug:"minqiang-wang"}]},{id:"49631",type:"chapter",title:"ZnO/Sepiolite Catalysts – Characterization and Photoactivity Measurements",slug:"zno-sepiolite-catalysts-characterization-and-photoactivity-measurements",totalDownloads:1948,totalCrossrefCites:0,signatures:"A. Neren Ökte",reviewType:"peer-reviewed",authors:[{id:"176470",title:"Prof.",name:"A.Neren",middleName:null,surname:"Ökte",fullName:"A.Neren Ökte",slug:"a.neren-okte"}]},{id:"49809",type:"chapter",title:"Preparation of Functionalized Graphene and Gold Nanocomposites – Self-assembly and Catalytic Properties",slug:"preparation-of-functionalized-graphene-and-gold-nanocomposites-self-assembly-and-catalytic-propertie",totalDownloads:1883,totalCrossrefCites:0,signatures:"Jingxin Zhou, Tifeng Jiao, Qingrui Zhang and Jie Hu",reviewType:"peer-reviewed",authors:[{id:"63887",title:"Prof.",name:"Tifeng",middleName:null,surname:"Jiao",fullName:"Tifeng Jiao",slug:"tifeng-jiao"},{id:"176236",title:"Dr.",name:"Jie",middleName:null,surname:"Hu",fullName:"Jie Hu",slug:"jie-hu"},{id:"176237",title:"Dr.",name:"Qingrui",middleName:null,surname:"Zhang",fullName:"Qingrui Zhang",slug:"qingrui-zhang"}]},{id:"49692",type:"chapter",title:"Photochemical Decomposition of Hydrogen Sulfide",slug:"photochemical-decomposition-of-hydrogen-sulfide",totalDownloads:2745,totalCrossrefCites:2,signatures:"Shan Yu and Ying Zhou",reviewType:"peer-reviewed",authors:[{id:"176372",title:"Dr.",name:"Ying",middleName:null,surname:"Zhou",fullName:"Ying Zhou",slug:"ying-zhou"},{id:"176791",title:"Dr.",name:"Shan",middleName:null,surname:"Yu",fullName:"Shan Yu",slug:"shan-yu"}]},{id:"49640",type:"chapter",title:"Metal/Semiconductor Hybrid Nanocrystals and Synergistic Photocatalysis Applications",slug:"metal-semiconductor-hybrid-nanocrystals-and-synergistic-photocatalysis-applications",totalDownloads:2969,totalCrossrefCites:3,signatures:"Jiatao Zhang, Muwei Ji, Jiajia Liu and Meng Xu",reviewType:"peer-reviewed",authors:[{id:"176158",title:"Prof.",name:"Jiatao",middleName:null,surname:"Zhang",fullName:"Jiatao Zhang",slug:"jiatao-zhang"},{id:"177574",title:"Mr.",name:"Muwei",middleName:null,surname:"Ji",fullName:"Muwei Ji",slug:"muwei-ji"},{id:"177575",title:"Dr.",name:"Jiajia",middleName:null,surname:"Liu",fullName:"Jiajia Liu",slug:"jiajia-liu"},{id:"177576",title:"Dr.",name:"Meng",middleName:null,surname:"Xu",fullName:"Meng Xu",slug:"meng-xu"},{id:"177577",title:"Prof.",name:"Hesun",middleName:null,surname:"Zhu",fullName:"Hesun Zhu",slug:"hesun-zhu"}]},{id:"49599",type:"chapter",title:"Recent Advances in Visible-Light Driven Photocatalysis",slug:"recent-advances-in-visible-light-driven-photocatalysis",totalDownloads:2744,totalCrossrefCites:0,signatures:"Yuhua Wangab, Xinlong Ma, Hao Li, Bin Liu, Huihui Li, Shu Yin and\nTsugio Sato",reviewType:"peer-reviewed",authors:[{id:"19332",title:"Dr.",name:"Yuhua",middleName:null,surname:"Wang",fullName:"Yuhua Wang",slug:"yuhua-wang"},{id:"177843",title:"Dr.",name:"Xinlong",middleName:null,surname:"Ma",fullName:"Xinlong Ma",slug:"xinlong-ma"},{id:"177844",title:"Dr.",name:"Hao",middleName:null,surname:"Li",fullName:"Hao Li",slug:"hao-li"},{id:"177845",title:"Dr.",name:"Bin",middleName:null,surname:"Liu",fullName:"Bin Liu",slug:"bin-liu"},{id:"177846",title:"Dr.",name:"Huihui",middleName:null,surname:"Li",fullName:"Huihui Li",slug:"huihui-li"},{id:"177847",title:"Dr.",name:"Shu",middleName:null,surname:"Yin",fullName:"Shu Yin",slug:"shu-yin"},{id:"177848",title:"Dr.",name:"Tsugio",middleName:null,surname:"Sato",fullName:"Tsugio Sato",slug:"tsugio-sato"}]},{id:"49611",type:"chapter",title:"First-Transition Metal Oxocomplex–Surface-Modified Titanium(IV) Oxide for Solar Environmental Purification",slug:"first-transition-metal-oxocomplex-surface-modified-titanium-iv-oxide-for-solar-environmental-purific",totalDownloads:1596,totalCrossrefCites:0,signatures:"Hiroaki Tada and Qiliang Jin",reviewType:"peer-reviewed",authors:[{id:"167854",title:"Prof.",name:"Hiroaki",middleName:null,surname:"Tada",fullName:"Hiroaki Tada",slug:"hiroaki-tada"}]},{id:"49588",type:"chapter",title:"Electrocatalytic Applications of Graphene–Metal Oxide Nanohybrid Materials",slug:"electrocatalytic-applications-of-graphene-metal-oxide-nanohybrid-materials",totalDownloads:3779,totalCrossrefCites:10,signatures:"Arnab Halder, Minwei Zhang and Qijin Chi",reviewType:"peer-reviewed",authors:[{id:"176168",title:"Prof.",name:"Qijin",middleName:null,surname:"Chi",fullName:"Qijin Chi",slug:"qijin-chi"},{id:"177663",title:"Dr.",name:"Arnab",middleName:null,surname:"Halder",fullName:"Arnab Halder",slug:"arnab-halder"},{id:"177664",title:"Dr.",name:"Minwei",middleName:null,surname:"Zhang",fullName:"Minwei Zhang",slug:"minwei-zhang"}]},{id:"49748",type:"chapter",title:"Ag–Cu Nanoalloy Electrocatalysts for Oxygen Reduction in Alkaline Media for Advanced Energy Conversion and Storage",slug:"ag-cu-nanoalloy-electrocatalysts-for-oxygen-reduction-in-alkaline-media-for-advanced-energy-conversi",totalDownloads:2407,totalCrossrefCites:1,signatures:"Adnan Qaseem, Fuyi Chen and Nan Zhang",reviewType:"peer-reviewed",authors:[{id:"151028",title:"Dr.",name:"Fuyi",middleName:null,surname:"Chen",fullName:"Fuyi Chen",slug:"fuyi-chen"},{id:"176457",title:"Mr.",name:"Adnan",middleName:null,surname:"Qaseem",fullName:"Adnan Qaseem",slug:"adnan-qaseem"},{id:"176460",title:"Ms.",name:"Nan",middleName:null,surname:"Zhang",fullName:"Nan Zhang",slug:"nan-zhang"}]},{id:"49804",type:"chapter",title:"Native and Synthetic G-quartet-based DNAzyme Systems – Artificial Enzymes for Biotechnological Applications",slug:"native-and-synthetic-g-quartet-based-dnazyme-systems-artificial-enzymes-for-biotechnological-applica",totalDownloads:1767,totalCrossrefCites:1,signatures:"Stefan Loic",reviewType:"peer-reviewed",authors:[{id:"176415",title:"Dr.",name:"Stefan",middleName:null,surname:"Loic",fullName:"Stefan Loic",slug:"stefan-loic"}]}]},relatedBooks:[{type:"book",id:"1772",title:"Neutron Diffraction",subtitle:null,isOpenForSubmission:!1,hash:"56eee3a81abfd89c555eeec99bdc4227",slug:"neutron-diffraction",bookSignature:"Irisali Khidirov",coverURL:"https://cdn.intechopen.com/books/images_new/1772.jpg",editedByType:"Edited by",editors:[{id:"113446",title:"Prof.",name:"Irisali",surname:"Khidirov",slug:"irisali-khidirov",fullName:"Irisali Khidirov"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"32362",title:"Hydrides of Cu and Mg Intermetallic Systems: Characterization and Catalytic Function",slug:"hydrides-of-cu-and-mg-intermetallic-systems-characterization-and-catalytic-function",signatures:"M. Helena Braga, Michael J. Wolverton, Maria H. de Sá and Jorge A. Ferreira",authors:[{id:"111737",title:"Prof.",name:"Maria Helena",middleName:null,surname:"Braga",fullName:"Maria Helena Braga",slug:"maria-helena-braga"},{id:"112816",title:"MSc.",name:"Michael J.",middleName:null,surname:"Wolverton",fullName:"Michael J. Wolverton",slug:"michael-j.-wolverton"},{id:"112817",title:"Dr.",name:"Maria",middleName:null,surname:"Sa",fullName:"Maria Sa",slug:"maria-sa"},{id:"112818",title:"MSc.",name:"Jorge",middleName:null,surname:"Ferreira",fullName:"Jorge Ferreira",slug:"jorge-ferreira"}]},{id:"32363",title:"Neutron Diffraction Measurements for Residual Stresses in AL-6XN Stainless Steel Welded Beams",slug:"neutron-diffraction-measurements-for-residual-stresses-in-al-6xn-stainless-steel-welded-beams",signatures:"Xiaohua Cheng, Henry J. Prask, Thomas Gnaeupel-Herold, Vladimir Luzin and John W. Fisher",authors:[{id:"113155",title:"Dr.",name:"Xiaohua",middleName:null,surname:"Cheng",fullName:"Xiaohua Cheng",slug:"xiaohua-cheng"}]},{id:"32364",title:"Modelling Residual Stress and Phase Transformations in Steel Welds",slug:"modelling-residual-stress-and-phase-transformations-in-steel-welds",signatures:"Hui Dai",authors:[{id:"106776",title:"Dr.",name:"Hui",middleName:null,surname:"Dai",fullName:"Hui Dai",slug:"hui-dai"}]},{id:"32365",title:"Data Processing Steps in Neutron Diffraction: From the Raw Data to the Differential Cross Section",slug:"data-processing-steps-in-neutron-diffraction-from-the-raw-data-to-the-differential-cross-section",signatures:"J. Dawidowski, G.J. Cuello and L.A. Rodríguez Palomino",authors:[{id:"104197",title:"Dr.",name:"Gabriel",middleName:null,surname:"Cuello",fullName:"Gabriel Cuello",slug:"gabriel-cuello"},{id:"113448",title:"Dr",name:"Javier",middleName:null,surname:"Dawidowski",fullName:"Javier Dawidowski",slug:"javier-dawidowski"},{id:"138941",title:"Dr.",name:"Luis Alberto",middleName:null,surname:"Rodríguez Palomino",fullName:"Luis Alberto Rodríguez Palomino",slug:"luis-alberto-rodriguez-palomino"}]},{id:"32366",title:"Neutron Diffraction Studies of the Magnetic Oxide Materials",slug:"neutron-diffraction-studies-of-the-magnetic-oxide-materials",signatures:"J.B. Yang, Q. Cai, H.L. Du, X.D. Zhou, W.B. Yelon and W.J. James",authors:[{id:"109912",title:"Dr",name:"Honglin",middleName:null,surname:"Du",fullName:"Honglin Du",slug:"honglin-du"},{id:"111204",title:"Dr.",name:"Jinbo",middleName:null,surname:"Yang",fullName:"Jinbo Yang",slug:"jinbo-yang"},{id:"113487",title:"Prof.",name:"William",middleName:null,surname:"James",fullName:"William James",slug:"william-james"},{id:"113493",title:"Prof.",name:"William B.",middleName:null,surname:"Yelon",fullName:"William B. Yelon",slug:"william-b.-yelon"},{id:"145975",title:"Dr.",name:"Qingsheng",middleName:null,surname:"Cai",fullName:"Qingsheng Cai",slug:"qingsheng-cai"},{id:"145976",title:"Prof.",name:"Xiaodong",middleName:null,surname:"Zhou",fullName:"Xiaodong Zhou",slug:"xiaodong-zhou"}]},{id:"32367",title:"Introduction of Neutron Diffractometers for Mechanical Behavior Studies of Structural Materials",slug:"introduction-of-neutron-diffractometers-for-mechanical-behavior-studies-of-structural-materials",signatures:"E-Wen Huang, Wanchuck Woo and Ji-Jung Kai",authors:[{id:"110141",title:"Prof.",name:"E-Wen",middleName:null,surname:"Huang",fullName:"E-Wen Huang",slug:"e-wen-huang"},{id:"111180",title:"Dr.",name:"Wanchuck",middleName:null,surname:"Woo",fullName:"Wanchuck Woo",slug:"wanchuck-woo"},{id:"138522",title:"Prof.",name:"Ji-Jung",middleName:null,surname:"Kai",fullName:"Ji-Jung Kai",slug:"ji-jung-kai"}]},{id:"32368",title:"The Molecular Conformations and Intermolecular Correlations in Positional Isomers 1- and 2- Propanols in Liquid State Through Neutron Diffraction",slug:"the-molecular-conformations-and-intermolecular-correlations-in-positional-isomers-1-and-2-propanols-",signatures:"R.N. Joarder",authors:[{id:"112963",title:"Dr.",name:"Ramendra",middleName:"Nath",surname:"Joarder",fullName:"Ramendra Joarder",slug:"ramendra-joarder"}]},{id:"32369",title:"Neutron Diffraction Study of Hydrogen Thermoemission Phenomenon from Powder Crystals",slug:"neutron-diffraction-study-of-hydrogen-thermoemission-phenomenon-from-powder-crystals",signatures:"I. Khidirov",authors:[{id:"113446",title:"Prof.",name:"Irisali",middleName:null,surname:"Khidirov",fullName:"Irisali Khidirov",slug:"irisali-khidirov"}]},{id:"32370",title:"Three-Dimensional Magnetically-Oriented Microcrystal Array: A Large Sample for Neutron Diffraction Analysis",slug:"three-dimensional-magnetically-oriented-microcrystal-array-a-large-sample-for-neutron-diffraction-an",signatures:"T. Kimura, F. Kimura, K. Matsumoto and N. Metoki",authors:[{id:"103789",title:"Prof.",name:"Tsunehisa",middleName:null,surname:"Kimura",fullName:"Tsunehisa Kimura",slug:"tsunehisa-kimura"},{id:"103798",title:"Dr.",name:"Fumiko",middleName:null,surname:"Kimura",fullName:"Fumiko Kimura",slug:"fumiko-kimura"},{id:"103803",title:"Mr.",name:"Kenji",middleName:null,surname:"Matsumoto",fullName:"Kenji Matsumoto",slug:"kenji-matsumoto"},{id:"104124",title:"Dr.",name:"Metoki",middleName:null,surname:"Naoto",fullName:"Metoki Naoto",slug:"metoki-naoto"}]},{id:"32371",title:"Temperature Evolution of the Double Umbrella Magnetic Structure in Terbium Iron Garnet",slug:"temperature-evolution-of-the-double-umbrella-magnetic-structure-in-terbium-iron-garnet",signatures:"Mahieddine Lahoubi",authors:[{id:"107844",title:"Prof.",name:"Mahieddine",middleName:null,surname:"Lahoubi",fullName:"Mahieddine Lahoubi",slug:"mahieddine-lahoubi"}]},{id:"32372",title:"Superspace Group Approach to the Crystal Structure of Thermoelectric Higher Manganese Silicides MnSi",slug:"superspace-group-approach-to-the-crystal-structure-of-thermoelectric-higher-manganese-silicides-mnsi",signatures:"Yuzuru Miyazaki",authors:[{id:"109291",title:"Prof.",name:"Yuzuru",middleName:null,surname:"Miyazaki",fullName:"Yuzuru Miyazaki",slug:"yuzuru-miyazaki"}]},{id:"32373",title:"The pH Dependence of Protonation States of Polar Amino Acid Residues Determined by Neutron Diffraction",slug:"the-ph-dependence-of-protonation-states-of-polar-amino-acid-residues-determined-by-neutron-diffracti",signatures:"Nobuo Niimura",authors:[{id:"106653",title:"Dr.",name:"Nobuo",middleName:null,surname:"Niimura",fullName:"Nobuo Niimura",slug:"nobuo-niimura"}]},{id:"32374",title:"Determination of Internal Stresses in Lightweight Metal Matrix Composites",slug:"determination-of-internal-stresses-in-lightweight-metal-matrix-composites",signatures:"Guillermo Requena, Gerardo Garcés, Ricardo Fernández and Michael Schöbel",authors:[{id:"21296",title:"Dr.",name:"Ricardo",middleName:null,surname:"Fernández",fullName:"Ricardo Fernández",slug:"ricardo-fernandez"},{id:"108256",title:"Prof.",name:"Guillermo",middleName:null,surname:"Requena",fullName:"Guillermo Requena",slug:"guillermo-requena"},{id:"114233",title:"Dr.",name:"Gerardo",middleName:null,surname:"Garcés",fullName:"Gerardo Garcés",slug:"gerardo-garces"},{id:"114235",title:"Dr.",name:"Michael",middleName:null,surname:"Schöbel",fullName:"Michael Schöbel",slug:"michael-schobel"}]}]}],publishedBooks:[{type:"book",id:"7486",title:"Advanced Sorption Process Applications",subtitle:null,isOpenForSubmission:!1,hash:"bc77a8d4e58d7c7eb4d2137adb0f0f34",slug:"advanced-sorption-process-applications",bookSignature:"Serpil Edebali",coverURL:"https://cdn.intechopen.com/books/images_new/7486.jpg",editedByType:"Edited by",editors:[{id:"223744",title:"Dr.",name:"Serpil",surname:"Edebali",slug:"serpil-edebali",fullName:"Serpil Edebali"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8012",title:"Sorption in 2020s",subtitle:null,isOpenForSubmission:!1,hash:"a89bf0c99155aa01dc2f2ba46cbdbb8b",slug:"sorption-in-2020s",bookSignature:"George Kyzas and Nikolaos Lazaridis",coverURL:"https://cdn.intechopen.com/books/images_new/8012.jpg",editedByType:"Edited by",editors:[{id:"152296",title:"Prof.",name:"George",surname:"Kyzas",slug:"george-kyzas",fullName:"George Kyzas"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9199",title:"Sonochemical Reactions",subtitle:null,isOpenForSubmission:!1,hash:"72f3010437d022fd2a932421ff4a9200",slug:"sonochemical-reactions",bookSignature:"Selcan Karakuş",coverURL:"https://cdn.intechopen.com/books/images_new/9199.jpg",editedByType:"Edited by",editors:[{id:"206110",title:"Dr.",name:"Selcan",surname:"Karakuş",slug:"selcan-karakus",fullName:"Selcan Karakuş"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],publishedBooksByAuthor:[]},onlineFirst:{chapter:{type:"chapter",id:"74121",title:"Reactive Oxygen Species and Metabolic Re-Wiring in Acute Leukemias",doi:"10.5772/intechopen.94829",slug:"reactive-oxygen-species-and-metabolic-re-wiring-in-acute-leukemias",body:'
1. Introduction
To maintain hemostasis, new blood cells must be constantly generated to replace those lost through injury, disease, or age. Hematopoiesis, is the process where hematopoietic stem cells (HSC) differentiate into mature blood cells and is tightly regulated by the bone marrow (BM) micro-environment (or stem cell niche; reviewed in [1]), signal transduction pathways (reviewed in [2]), cytokines (reviewed in [3]), transcription factors (reviewed in [4]), epigenetics, (reviewed in [5]) and metabolic pathways (reviewed in [6]). HSCs are rare, constituting only 0.001% of peripheral blood (PB) and 0.05% of BM cells, but are responsible for producing a lifetime supply of blood cells. HSCs are cells that able to durably self-renew whilst also being multipotent. This differentiation is generally considered to occur via several intermediate progenitor cells, ultimately terminating in the specific mature blood cell through a process termed fate restriction or lineage commitment.
The compartmentalization of HSC, their progenitors and terminally differentiated blood cells, into different stages of differentiation, is traditionally based on the expression of cell surface proteins (Figure 1). The recent emergence of single cell technologies such as fluorescent in situ hybridization, high-throughput single-cell quantitative PCR, single cell mass spectrometry and mass cytometry however, have led to re-analysis of these models of hematopoietic differentiation [7]. Discrete progenitor cell populations, as determined by cell surface markers, have been shown to consist of heterogenous populations with different fates [8]. Recently, a study by Velten et al., 2017, using a combination of single cell technologies and xenotransplantation as functional validation, proposed that early hematopoiesis consists of, a cellular continuum of low-primed undifferentiated (CLOUD) hematopoietic stem progenitor cells (HSPC), with simultaneous lineage gene expression for multiple fates [9]. This study suggested that early discrete stable progenitors do not exist, with any lineage determination occurring further downstream than originally presumed.
Figure 1.
Human hematopoiesis. Schematic diagram showing classical model of hematopoietic lineage commitment, with phenotypical cell surface markers (red), transcription factors determining differentiation (green box) and growth factors involved in myelopoiesis (blue). Hematopoietic stem cell (HSC), cluster of differentiation (CD), hematopoietic progenitor cell (HPC), common myeloid progenitor (CMP), common lymphoid progenitor (CLP), interleukin (IL), granulocyte macrophage (GM) colony-stimulating-factor (CSF), stem cell factor (SCF), thrombopoietin (TPO), erythropoietin (EPO), granulocyte myeloid progenitor (GMP), runt-related transcription factor 1 (RUNX1), transcription factor stem cell leukemia (SCL), ccaat enhancer binding proteins (C/EBP), friend of GATA protein 1 (FOG-1).
Regardless of provenance, leukemogenesis is characterized by a block in differentiation and an accumulation of immature white blood cell blasts with a rapid increase in these blasts, characteristic of the acute leukemias. Acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) are heterogenous diseases with a block in lymphoid or myeloid differentiation, respectively. They occur due to one or more genetic insults. Whilst ALL is predominantly a disease of children (80%), with a greater than 90% 5 y survival rate [10], in adults long term survival stands at only 30–40% [11]. AML in contrast is primarily a disease of the elderly, and like adult ALL it’s 5 y survival rate is around 30%, however this falls in the over 60’s to a particularly bleak 10% [12]. In ALL, recent advances for example in the use of tyrosine kinase inhibitors and CAR-T cell therapy, have started to suggest improvements to overall survival [10]. However, in patients fit enough to tolerate chemotherapy, the standard treatment for AML since 1973 has been a seven-day continuous intravenous infusion of cytarabine (Ara-C) (100–200 mg/m2) and 3 daily doses of daunorubicin (45–90 mg/m2), sometimes followed by allogeneic or autologous stem cell transplantation, and despite some recent advances (reviewed in [13, 14]), current treatments appear to have reached their efficacious limits and new therapies are required.
One potential therapeutic opportunity involves exploiting the metabolic differences that exist between malignant and non-malignant cells [15]. Differences that, in AML at least, appear exacerbated by cellular levels of reactive oxygen species (ROS) [16].
2. Reactive oxygen species
ROS is the collective term for several oxygen containing free radicals and other reactive molecules, such as hydrogen peroxide (H2O2). Physiologically, ROS are initially generated via the univalent reduction of molecular oxygen which generates superoxide (O2•−). Superoxide (t1/2 = 1 μs) subsequently dismutates to H2O2 (t1/2 = 1 ms) [17], either spontaneously or via the catalytic action of the enzyme superoxide dismutase (SOD), or reacts with other ROS molecules, forming a variety of other ROS (Figure 2). Functionally, ROS is important in innate immunity, protein folding in the endoplasmic reticulum and as a cell signalling molecule involved in cellular proliferation, survival, differentiation and gene expression [18].
Figure 2.
Formation of reactive oxygen species (ROS). Diatomic oxygen (O2) is univalently reduced by peroxisomes (PO), xanthine oxidase (XO), the electron transport chain (ETC), or NADPH oxidase (NOX) to generate superoxide (O2•−). PO may also reduce O2 directly to form H2O2. O2•− may then dismutate to H2O2 either spontaneously or through the enzymatic action of superoxide dismutase (SOD). Hydroxyl radicals (OH•) may then be formed from H2O2 via the formation of hypochlorous radical (HOCl) in the PO, or via Fenton chemistry. Reactive nitrogen species (RNS) may also be formed through the reaction of nitric oxide radical (NO•) with O2•−.
There are several sources of cellular ROS, including the mitochondria, the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase family of enzymes (NOX), the cytochrome P450 enzymes, peroxisomes and the metabolic enzyme xanthine oxidase (XO).
2.1 Sources of ROS: electron transport chain
Generation of ROS by the mitochondria is primarily a function of ‘electron leakage’ from the electron transport chain (ETC), however, mitochondrial ROS may also be generated as a result of numerous enzymes including monoamine oxidase, cytochrome b5 reductase, glycerol-3-phosphate dehydrogenase, aconitase, pyruvate dehydrogenase and α-ketoglutarate dehydrogenase (reviewed in [19]). Mitochondrial ROS production resulting from the ETC generates O2•−, and is thought to occur as result of one of three mechanisms. The first mechanism is a consequence of a high NADH/NAD+ ratio, and results from oxygen interacting with fully reduced FMN. Mitochondrial ROS generated by this mechanism has been observed due to mitochondrial mutation, physiological damage such as ischemia or aging, and only small amounts of ROS are thought to be generated via these mechanisms in normally respiring cells [20]. The second mechanism occurs when there is a high level of reduced co-enzyme Q (CoQH2) in complex II, which in the presence of a high proton motive force generated by the proton pump, force electrons back into complex I in a process known as reverse electron transport (RET). Whilst RET generated ROS has also been implicated in diseases such as ischemia, it is now also thought to be involved as a cell signalling molecule in metabolic adaptation, myeloid differentiation and response to bacterial infection [21]. The third mechanism of ROS generation by the ETC occurs at complex III and has also been implicated in ROS signalling. The formation of O2•− occurs at the ubiquinol oxidation centre (Qo) site of the cytochrome bc1 complex, in which fully oxidized CoQ supports formation of O2•−, through the transfer of electrons from reduced heme b1 to molecular oxygen [22]. Generation of O2•− by complex I and II occurs exclusively in the mitochondrial matrix, whereas O2•− generated by complex III also occurs in the intermembrane space. O2•− generated in the mitochondrial matrix is rapidly converted to H2O2 by mitochondrial SOD (Mn-SOD), whereas O2•− generated in the intermembrane space travels through the outer mitochondrial membrane prior to conversion to H2O2 by cytosolic SOD (Cu/Zn-SOD).
2.2 Sources of ROS: nicotinamide adenine dinucleotide phosphate (NADPH) oxidase family of enzymes (NOX)
Whilst mitochondrial oxidative phosphorylation is a major source of intracellular ROS, the main source of extracellular ROS involves the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase family of enzymes (NOX). The NOX family of enzymes comprise of seven members, NOX1–5 and dual oxidase (DUOX) 1 and 2. NOX enzymes are transmembrane proteins that transfer electrons from NADPH to molecular oxygen, generating O2•− (or H2O2), which can then be converted to other forms of ROS. Different NOX isoforms share conserved structural features comprising of six helical transmembrane domains (TM) (with helix III and helix V containing two heme-binding histidines), and a C-terminus cytosolic domain (DH), which allows binding of FAD and NADPH (Figure 3). Difficulties in obtaining suitable levels of NOX proteins mean that to date relatively little crystal structure data is available. However, a recently published report [23], has elucidated the structure of the TM and DH domains (common to all NOX isoforms) of Cylindrospermum stagnale NOX5 in complex with FAD. In this structure, the six transmembrane helices of TM domain form a pyramidal shape with the base on the cytosolic side, a N-terminus α-helix runs parallel to the cytosolic side of the membrane and the heme groups sit in cavities formed by helices II–V, so that one is positioned near the cytosolic side of the membrane (heme 1) and the other on the outer side (heme 2). The DH domain, located on the cytosolic side, contains two pockets, one for FAD binding and one for NADPH binding. The FAD is positioned so that the flavin is in direct contact with heme 1 of the TM, to promote interdomain electron transfer. The proposed mechanism of electron transfer then involves NADPH donating its electron to FAD, which in turn donates an electron to heme 1 and then to heme 2 via Trp378 (equating to Phe 215 in human NOX2, Phe 200 in human NOX4 and Val 362 in human NOX5) of the loop between helix II and III of the TM, before reduction of molecular oxygen, via a final electron transfer step generates O2•− (Figure 3).
Figure 3.
Generation of superoxide (O2•−) by NADPH Oxidase (NOX). Schematic diagram showing the major structural features of NOX2, it’s activation by phosphorylation (P) of p67phoxand p47phox and the assembly of the major subunits of the NOX complex, and the generation of superoxide via electron transfer from NADPH to flavin adenine dinucleotide (FAD) to heme groups to diatomic oxygen. Guanosine triphosphate (GTP), guanosine diphosphate (GDP), homology domain (DH), RAS-related C3 botulinum toxin substrate 2 (Rac2).
From a metabolic perspective, one source of NOX2 activation results when cells experience intermittent hypoxia. Under this condition activation of the metabolic enzyme XO, an enzyme important in the catabolism of purines and a major source of cellular ROS, occurs [24]. XO activation leads to increased ROS, which induces Ca2+ activation of protein kinase C, an enzyme important in cell signalling, migration of p47phox and p67phox to the cell membrane, resulting in activation of the NOX2 complex (Figure 3). Finally it is important to note, from a cell signalling perspective, that extracellular H2O2 (which is rapidly formed from O2•−) is readily transported across the cell membrane via the transmembrane water permeable channel protein family of aquaporins [25, 26].
3. Role of ROS on normal hematopoiesis
ROS has been implicated in both HSC quiescence and hematopoietic differentiation. HSC reside in the bone marrow and their quiescence is known to be negatively regulated by ROS. Forkhead box O (FOXO) transcription factors are involved in cell-cycle arrest and apoptosis and are activated in response to oxidative stress whereupon they translocate to the nucleus [27]. Translocation of FOXO4 to the nucleus has been shown to be a function of redox signalling, where oxidation of cys-239 by ROS mediates the formation of disulphide bonds with nuclear import receptor transportin-1, which in turn allows nuclear localization [28]. FOXO deactivation occurs as a result of phosphorylation in response to activation of the regulatory cell cycle PI3K/AKT/mTOR pathway, resulting in their export from the nucleus and subsequent degradation in the cytoplasm [29]. Studies in murine HSC have shown that deletion of FOXO3a, which upregulates transcription of Mn-SOD [30], results in decreased HSC renewal [31] which is mediated by the tumor suppressor protein ataxia-telangiectasia mutated (ATM) and is accompanied by elevated ROS levels and myeloid lineage expansion [32]. Deletion of ATM in mice resulted in BM failure which was restored following treatment with antioxidants [33]. In a different study, isolation of murine HSC into ROS high and ROS low populations showed that the ROS low population maintained self-renewal capacity following serial transplantations, whilst the self-renewal capacity of the ROS high population was exhausted following the third serial transplantation. Treatment of the ROS high HSC with the antioxidant N-acetyl cysteine (NAC), the p38 inhibitor SB203508 or rapamycin (a mTOR inhibitor), restored self-renewal activity [34]. Interestingly, the ROS high population in this study also exhibited a decreased ability to adhere to cells containing calcium sensing receptors, whilst NOX generated ROS has additionally been implicated in osteoclast differentiation in human mesenchymal cells, further emphasizing a potential regulatory role of ROS, in the BM niche [35].
Whilst these increased ROS levels are associated with HSC losing quiescence, it has also been shown, in the human megakaryocytic cell line MO7e, that hematopoietic cytokines, such as granulocyte macrophage-colony stimulating factor, interleukin-3, stem cell factor and thrombopoietin all increase ROS levels [36]. In megakaryopoiesis, ROS has been shown to increase platelet production and maturation in the chronic myeloid leukemia (CML) cell line MEG-01 and primary human megakaryocytes [37], which in murine models is mediated by the transcription factor NF-E2 [38]. Following lineage commitment, megakaryocyte progenitors undergo endomitosis (chromosomal replication in the absence of cell division), which in murine cells is potentially mediated by NOX1-derived ROS [39]. In human HSC, NOX-derived ROS has also been shown to be crucial for megakaryocyte differentiation via activation of ERK, AKT and JAK2 signalling pathways [40], whilst another study revealed the importance of cytochrome P450 2E1-generated ROS in megakaryocyte differentiation in human HSC [41]. As noted above, increased ROS in HSC has been associated with expanded myelopoiesis. Interestingly, a recent study using murine CMP, showed that higher levels of ROS impeded megakaryopoiesis, instead directing differentiation of CMP into GMP [42]. Finally, ROS has also been shown to induce differentiation of the promonocytic cell line, U937, into macrophages [43], and the differentiation of primary human monocytes into dendritic cells [44].
4. Role of ROS on solid tumors and leukemia development
One of the first studies implicating ROS in carcinogenesis was performed in mice subcutaneously injected with C3H mouse fibroblasts, that had been previously cultured in vitro with neutrophils stimulated with 12-O-tetradecanoylphorbol-13-acetate (TPA) stimulated or unstimulated or with the ROS generating enzyme XO and hypoxanthine. In this study approximately 20% of mice treated with these cells developed tumors within 13–22 weeks compared to none of the control mice [45]. In 1991, analysis of H2O2 production in human melanoma, colon, pancreatic, neuroblastoma, breast and ovarian cancer cell lines, revealed constitutively active H2O2 production over a 4 h period, generating H2O2 levels similar to those observed in TPA stimulated neutrophils, suggesting increased ROS production may be a feature of transformation [46]. Later, studies in patients with liver disease suggested ROS plays a part in hepatocarcinogenesis [47], and levels of Cu/Zn-SOD are significantly lower in hepatoma tissue than normal human liver tissue [48]. Further, homozygous deletion of Cu/Zn-SOD in mice results in decreased lifespan, with 70% developing hepatocarcinoma or benign nodular hyperplasia [49], whilst homozygous deletion of Mn-SOD in mice is lethal within two weeks of birth [50]. In the same study, heterozygous deletion of Mn-SOD resulted in increased incidence of hemangioma and adenocarcinoma and significant increases in the incidence of lymphoma. Currently, elevated ROS levels have been reported in many solid tumors and the role they play in tumorigenesis is complex and multifaceted (reviewed in [51]).
In leukemia, a study which collected blood samples from ALL and CML patients samples and compared them with normal blood samples showed elevated levels of ROS in both ALL and CML patients [52], whilst elevated levels of NOX generated ROS, are observed, alongside increased proliferation in both AML models and AML patient samples when compared with healthy controls [53]. Reactions of ROS with DNA can generate numerous oxidised bases, including 8-hydroxy-2-deoxyguanosine (8-OHdG) which causes G:C to T:A DNA transversions (reviewed in [54]). Increased levels of 8-OHdG have been observed in patients with breast cancer [55], gastric carcinomas [56], lung cancer [57] and colorectal cancer [58]. In leukemia, a study of 116 Chinese children with either ALL or AML revealed significantly elevated levels of 8-OHdG, whilst 8-OHdG levels were also significantly elevated in relapsed AML adult patients [59].
As a signalling molecule, ROS can lead to hyperactivation of the PI3K pathway, a common feature of many cancers, resulting in increased cell survival, VEGF production, secretion of MMP (reviewed in [60]) and inactivation of FOXO [32]. In AML, constitutive activation of the PI3K/AKT pathway is frequently observed [61, 62], however the role of FOXO is less clear. A recent study revealed that FOXO1 expression in osteoblasts mediated β-catenin initiated AML [63], whilst a study of AML patient samples showed that 40% exhibited FOXO activation, that upon inhibition resulted in myeloid differentiation and AML cell death [64]. Additionally, in both CML and AML the BCR-ABL fusion protein and FMS-like tyrosine kinase receptor 3 internal tandem duplications (FLT3-ITD) have been shown to lead to phosphorylation of AKT resulting in increased activation of NOX, and increased ROS production (reviewed in [65]), which may in turn reinforce PI3K/AKT activation.
5. Metabolism and cancer
Broadly defined, cellular metabolism involves a series of catabolic or anabolic chemical reactions which generate or use energy as part of this process. In chemotrophs this energy is obtained through the oxidation of nutrients, with the energy typically stored in the form of ATP. Whilst in higher organisms a plethora of enzymatically catalyzed metabolic reactions occur, which are all part of different interconnecting metabolic pathways with multitudinous feedback mechanisms. These pathways are evolutionarily highly conserved with the citric acid cycle, for example, essentially a feature in all terrestrial life. There are three main classes of molecules involved in metabolism; carbohydrates, proteins and lipids that are either catabolized to generate energy or energy stores or used by anabolic pathways in the synthesis of, for example, nucleotides and structural molecules such as cell membranes. In mammals, a triumvirate of glycolysis, citric acid cycle and the ETC are central to the generation of ATP, with glycolysis and the citric acid cycle contributing 2 ATP molecules each and the ETC generating up to 34 ATP molecules in a process collectively termed aerobic respiration (reviewed in [66]).
Given the skew towards ATP production in the ETC, Otto Warburg’s observation in 1956 that aerobic glycolysis was a hallmark feature of cancer cells [15], was initially attributed to being the result of defective mitochondria in malignant cells, and initially raised little interest. However, this hypothesis is now known in most cases to be incorrect (reviewed in [67]) and instead, it has been shown that mitochondrial respiration is often necessary in tumorigenesis [68]. However, given its ubiquity and despite its inefficiency when compared with ETC, it is clear that the phenomenon of increased aerobic glycolysis (eponymously titled ‘The Warburg Effect’), must offer cancer cells some competitive advantage, although its exact ontology remains unclear. One hypothesis contends that whilst inefficient, aerobic glycolysis generates ATP at a rate 10–100 times faster than oxidative phosphorylation, therefore supplying cancer cells with energy at a faster rate. This increased glycolytic flux could then, potentially generate more nucleotides, amino acids and lipids for biosynthesis as well as generating the reducing agent NADPH, to deal with the increased levels of ROS common in many cancer cells [69]. Alternatively, increases in excreted lactate as a result of aerobic glycolysis would likely generate a more acidic microenvironment, breaking down stromal membrane structures and potentially increasing cancer cell motility and metastasis [70].
5.1 NADPH: a link between ROS and metabolism in cancer
It has been shown that activation of the tumor suppressor protein ATM by ROS promotes glucose-6-phosphate dehydrogenase (G-6-PD) activity, the first step of the pentose phosphate pathway (PPP), which in turn generates NADPH [71]. Given that major cellular antioxidant systems, ultimately rely on NADPH to provide their reducing power, it is perhaps not surprising that ROS in both normal and aberrant cellular processes is inextricably linked with metabolism. In the cytosol, NADPH is primarily generated through the PPP, whilst a number of mechanisms exist for mitochondrial NADPH generation [72], which include the serine synthesis pathway (SSP) (via the folate cycle) [73] and the action of the citric acid cycle enzyme isocitrate dehydrogenase (IDH). IDH1 and IDH2 are commonly mutated in AML [74], although in this context NADPH is consumed, and the D-2-hydroxyglutarate generated leads to stabilization of the hypoxia regulator, hypoxia inducible factor alpha (HIF-1α) [75].
HIF-1α as a target of ROS is controversial [76], however it is overexpressed in many cancers where it induces expression of numerous glycolytic genes. The ROS regulated transcription factor nuclear-related factor 2 (NRF2) has also been shown to modulate metabolism in lung cancer cell lines, through the upregulation of enzymes involved in the NADPH production, notably G-6-PD, IDH1 and malic enzyme 1 [77] and high NRF2 levels have previously been reported in AML [78]. Furthermore, the tumor suppressor protein TP53 is also important in regulating metabolism. Homozygous deletion of TP53 in mice results in decreased oxygen consumption arising from decreased mitochondrial respiration [79]. TP53 expression has been shown to inhibit, both glucose transporter (GLUT) 1 and 4 and the glycolytic enzyme phosphoglycerate mutase (PGAM) (reviewed in [80]) leading to decreased glycolysis and potentially increased metabolism via the PPP and SSP. Finally, TP53 also upregulates the apoptosis regulator (TIGAR) an enzyme which has an active domain similar to 6-Phosphofructo-2-kinase/fructoste-2,6-bisphosphatase (PFKFB). TIGAR catalyzes the reaction of fructose-2,6-bisphosphate (F-2,6-BP) to fructose-6-phosphate (F-6-P), which inhibits glycolysis, redirects metabolites into the PPP, generating NADPH [81].
5.2 ROS regulation of metabolic pathways
Changes of cellular ROS levels in both normal signalling as well cell signalling following cellular transformation result in changes in numerous signalling pathways controlling multiple cellular functions including growth, proliferation and differentiation. A number of these signalling pathways, exercise regulatory control over various metabolic pathways, which in turn modulate ROS levels via several feedback mechanisms (Figure 4). In leukemia, mutations in the RAS gene are present in about 15% of hematological malignancies [82]. RAS activates the PI3K/AKT/mTOR pathway which promotes nucleotide biosynthesis and lipid synthesis (reviewed in [83]) as well as HIF-1α, which upregulate glycolysis via the activation of numerous glycolytic genes. In addition to HIF-1α, other ROS activated transcription factors are important in metabolic regulation such as STAT3, which has been shown to promote glycolysis in hepatocellular carcinoma cell lines [84], FOXO3A, which inhibits glycolysis via activation of tuberous sclerosis 1 protein [85] and NF-κB which was shown to upregulate GLUT3 in mouse embryonic fibroblasts [86].
Figure 4.
Regulation of metabolic pathways. Schematic illustration outlining some of the regulatory mechanism involved in glycolysis and other key metabolic pathways. Transcription factors are in pink and signalling pathways in blue. Reactive oxygen species (ROS), forkhead box O (FOXO), pyruvate kinase muscle 2 (PKM2), signal transducer and activator of transcription (STAT), nuclear factor kappa-light-chain-enhancer of activated B-cells (NF-κB), glucose transporter (GLUT) hypoxia inducible factor-1 alpha (HIF-1α), tumour suppressor protein 53 (TP53), glycogen synthase kinase 3β (GSK-3β), isocitrate dehydrogenase (IDH), succinate dehydrogenase (SDH), fumarate hydratase (FH), protein kinase B (AKT), mammalian target of rapamycin (mTOR), phosphoinositide 3-kinase (PI3K), synthesis of cytochrome c oxidase 2 (SCO2) and prolyl-hydroxylase domain (PHD).
Nuclear localization of the glycolytic enzyme pyruvate kinase muscle 2 (PKM2) is also ROS mediated, where it acts as a co-factor in the activation of the transcription factor, c-MYC. RAS also activates c-MYC which is overexpressed in greater than 50% of human cancers and c-MYC has been shown to activate glycolysis via the upregulation of GLUT, the glycolytic enzymes hexokinase (HK), phosphoglucose isomerase (PGI), phosphofructokinase (PFK), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), phosphoglycerate kinase (PGK), PKM2, as well as lactate dehydrogenase A (LDHA), pyruvate dehydrogenase kinase 1 (PDK1) and PFKFB3 (reviewed in [87]). Increased glutaminolysis is also a target of c-MYC, which upregulates the glutamine transporter ASCT2 and a key enzyme glutaminase. Additionally, c-MYC was shown to upregulate both phosphoglycerate dehydrogenase (PHGDH) which catalyzes the first step of the SSP, serine hydroxymethyltransferase, part of the folate cycle as well as several genes involved in fatty acid metabolism and the citric acid cycle (reviewed in [67]). In contrast TP53 is known to inhibit glycolysis through inhibition of GLUT1, GLUT4 and PGAM and through activation of TIGAR and synthesis of cytochrome c oxidase 2 (SCO2). Inhibition of glycolysis also occurs due to the regulatory role of miRNA. For example, miR-195-5p inhibits GLUT3, miR-143 inhibits HK2 and miR-155 inhibits HIF-1α. Furthermore, TP53 induces miR-34a which suppresses HK1, HK2, GPI and PDK1, as well as sirtuin 1, which activates FOXO1, NF-κB and in a positive feedback loop TP53 (reviewed in [80]).
5.3 Metabolism and leukemia
Given the role that ROS plays in regulating metabolism, it is not surprising that expression of nearly all enzymes associated with glycolysis have been shown to be altered in solid tumors, a pattern also observed in leukemia. In ALL, micro-array analysis showed significant upregulation of PFK as well as the glucose transporters GLUT1 and GLUT4 in pediatric B-ALL samples [88], whilst deletion of GLUT1 in primary human B-ALL cells suppressed leukemic progression in vivo [89]. In AML, upregulation of GLUT1 mRNA [90] and the fructose transporter GLUT5 [91] have also been reported to be associated with poor outcome in AML patients. Furthermore, NOX generated ROS has previously been reported to modulate cellular glucose uptake through increased GLUT1 activity, in leukemic cell lines [92]. In Philadelphia+ ALL (Ph+ALL) GLUT5 has been found to be upregulated at both the mRNA and protein level [93]. Song et al have identified HK2 overexpression as a feature of AML patients who failed to show remission [90], whilst decreased proliferation in the AML cell line, KG-1, was observed upon knock-down of PGI with shRNA [94]. The HK inhibitors 2-deoxy-D-glucose and 3-bromopyruvate have both been shown to be cytotoxic in AML patient samples harboring a FLT3-ITD mutation both alone and in combination with sorafenib [90, 95]. In chronic lymphocytic leukemia (CLL), a study by Ryland et al., 2013 showed increased expression of glyceraldehyde phosphate dehydrogenase (GAPDH) in CLL patients compared to healthy controls [96]. Proteomic studies revealed elevated levels of aldolase A (ALDO(A)), ALDO(C) and enolase 1 (ENO1) in the chemoresistant leukemia cell line K562/A02 when compared with parental K562 cells and in the case of ENO1 this was confirmed by western blot [97]. Elevated levels of ENO2 have also been reported in patients with ALL where it is associated with lower overall survival [98], whilst PGAM is upregulated in both AML and CML patient samples [99]. LDH is a tetramer which exists as five isoforms, comprising of two subunits LDHA and LDHB in different combinations and encoded by the LDHA and LDHB genes [100], with LDHA strongly catalyzing pyruvate to lactate and LDHB preferentially catalyzing the reverse reaction. In B-ALL, mRNA expression levels of LDHB were shown to be decreased [88], suggesting increased lactate production, whilst more recently increased serum levels of LDH were found in patients with B-ALL in conjunction with increased levels of total oxidant status and decreased total anti-oxidant status [101]. Another recent study involving 204 patients with acute leukemia’s also reported that LDH plasma levels were significantly elevated compared to healthy controls and were also increased in relapse patients compared to those in complete remission [102]. Recently, it was shown that ROS dependent proliferative increases observed in hematopoietic models [103] were also accompanied by increased glucose uptake and expression of the regulatory glycolytic enzyme PFKFB3 [53], whilst downregulation of this enzyme suppressed growth both in vivo and in vitro [16]. This study also reported that metabolomic analysis comparing AML patient samples with high/low levels of ROS, which showed significantly elevated levels of glucose, glucose-6-phosphate (G-6-P) and F-6-P in the ROS high patients. Another metabolomic study involving serum from 400 AML patients compared with 446 healthy controls, identified elevated levels of the glycolytic intermediates 3-phosphoglycerate (3-PG), pyruvate and lactate as conferring a poor prognosis for survival [104]. Interestingly, a recent study showed that the bromodomain and extra-terminal protein inhibitor JQ1, which has shown promise in ALL by targeting c-myc, downregulates expression of HK2, PKM2 and LDHA both at the transcriptional and protein level [105].
The citric acid cycle is a series of metabolic reactions involving oxidation/reduction reactions, which generate nicotinamide adenine dinucleotide (NAD)H and flavin adenine dinucleotide (FAD)H via the transfer of hydride ions, thus providing electrons for the ETC which is a major source of cellular ROS (reviewed in [106]). Mutations of IDH, which catalyzes the decarboxylation of isocitrate to alpha-ketoglutarate are frequently reported in AML (reviewed in [107]). Characterization of the inhibitor AG-221, which has been shown to inhibit mutant IDH2 in AML cells in vitro and in vivo and is currently undergoing phase I/II clinical trials [108], as is the IDH1 inhibitor, AG-120 [109]. A metabolomic study which examined a cohort of 183 patients with de novo AML matched with 232 healthy controls showed significant differences in citrate levels between AML patients and controls [110]. In pediatric ALL a recent metabolomic study revealed increased metabolites of glycolysis, the citric acid cycle and the PPP in patients testing positive for measurable residual disease compared to those testing negative [111]. Interestingly use of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors on ALL cell lines and patient samples showed cytotoxicity in vitro. NAMPT is a key enzyme in the synthesis of the oxidizing agent NAD+, in both glycolysis and the citric acid cycle.
The SSP branches from the glycolytic pathway at the glycolytic intermediate 3-PG, where it is converted into 3-phosphohydroxypyruvate by the enzyme PHGDH, followed by conversion to phosphoserine by phosphoserine aminotransferase 1 and finally to serine by the action of the enzyme phosphoserine phosphatase (reviewed in [73]). Regulation of the SSP is achieved through 2-phosphoglycerate (2-PG) which activates PHGDH whilst serine activates the tetrameric form of PKM2 leading to increased glycolysis and decreased levels of 2-PG. Importantly serine can enter the folate cycle, which provides another route for the generation of NADPH, which has been shown to contribute to tumor growth in vivo [112]. Whilst overexpression of PHGDH has been reported in melanomas, colorectal and breast cancers, little has been published from a leukemia perspective. Knock-down of PHGDH has been shown to inhibit the growth of the leukemia cell line, HL-60 [113], and in multiple myeloma increased expression of PHGDH led to increased SSP activity and antioxidant capacity in cells resistant to treatment with the proteasome inhibitor bortezomib [114].
The PPP generate nucleotides for biosynthesis and is a major source of cellular NADPH, an important cellular antioxidant. The first step involves the dehydrogenation of G-6-P to 6-phosphogluconolactone (6-PG) catalyzed by G-6-PD and the conversion of NADP+ to [115]. Gluconolactonase catalyzes the hydrolysis of 6-PG to 6-phosphogluconate, which is then catalyzed by 6-phosphogluconate dehydrogenase (6-PGD) to ribulose-5-phosphate (Ru-5-P) alongside the generation of a second NADPH. Ru-5-P can then be converted into ribose-5-phosphate (R-5-P) by the enzymatic action of ribulose-5-phosphate isomerase. R-5-P can then be used in the synthesis of nucleotides. Alternatively, where redox homeostasis and not nucleotide synthesis is the major requirement of the cell Ru-5-P can be catalyzed by ribulose-5-phosphate epimerase, into xyulose-5-phosphate (X-5-P) and via a series of further metabolic reactions back into the glycolytic intermediates F-6-P and glyceraldehyde-3-phosphate. G-6-PD is the rate limiting step of the PPP and is regulated by the NADP+/NADPH ratio, RAS/PI3K signalling and phosphorylation by Src, whilst 6-PGD is inhibited by 3-PG [99]. In cancer, aberrant RAS signalling or activation of Src can promote activation of the PPP. In AML, a recent study showed upregulation of G-6-PD mRNA in approximately 60% of patients, although it was not correlated with overall survival or relapse [116]. Targeting of xenograft mice injected with the leukemic cell line K562, with the antimalarial drug dihydroartemisinin and the 6-PGD inhibitor Physicon resulted in decreased tumor growth, whilst primary leukemia cells isolated from the PB of AML patients showed significantly decreased viability, with no toxicity observed in hematopoietic cells isolated from healthy individuals [117]. A metabolomic study comparing primary AML samples with either high or low levels of ROS, have also shown increased levels of the PPP metabolites sedoheptulose-7-phosphate and Ru-5-P in the samples with higher ROS levels [16]. Another study, using both AML cell lines and patient material, showed increased glucose metabolism and increased flux through the PPP, alongside increased G-6-PD mRNA expression [118]. Importantly, this study showed that use of the G-6-PD inhibitor 6-aminonictoinamide (6-AN) in AML cell lines induced both in vitro and in vivo cytotoxicity, and induced apoptosis in primary AML cells but not normal HPCs. In B-ALL, redirection of carbon from the glycolytic pathway to the PPP by the serine/threonine-protein phosphatase 2A (PP2A), has been shown to occur to combat cellular oxidative stress. Synergistic inhibition of G-6-PD by 6-AN and PP2A inhibitor LB100 induced cell death in patient derived Ph+ALL [119].
Lipid metabolism has also been shown to be dysregulated in both solid tumors and hematological malignancies (reviewed in [120]). Increased fatty acid oxidation (FAO) allows cancer cells to overcome metabolic and oxidative stress through the generation of ATP and NADPH. Significant changes to lipid metabolite levels are seen in AML patient samples with either high levels or low levels of ROS [16], whilst suppression of NOX2 has also been shown to increase FAO [121]. Furthermore, inhibition of the FAO using Avocatin B results in decreased NADPH levels and ROS dependent cell death in primary human AML samples but not normal mononuclear cells [122]. In ALL, use of L-asparaginase has been shown to increase FAO activity as a metabolic escape mechanism, however use of the FAO inhibitor etomoxir in combination with L-asparaginase has been shown to increase sensitivity of both leukemic cell lines and patient samples [123].
6. Conclusions
In the last twenty years, it has become increasingly clear that ROS play a significant role in cellular signalling, particularly pathways associated with growth, differentiation and survival, whilst its roles in HSC quiescence and normal hematopoiesis have started to be delineated. In many cancers including hematological malignancies, ROS levels have been shown to be elevated, leading to aberrant signalling in these pathways. Previously, arguments for both the use of anti-oxidant and pro-oxidant treatments in leukemia have been made (reviewed in [124]). Despite the transformation of survival rates in patients with acute promyelocytic leukemia using arsenic trioxide [125] cancer cells often upregulate the production of antioxidants, and downregulate pro-apoptotic pathways such as TP53, as a response to high ROS, allowing them to escape apoptosis. In addition, it has been shown that both cancer stem cells [126, 127] and leukemic stem cells [128] exhibit low ROS levels, suggesting that even if treatment with pro-oxidants eliminates the bulk of cancer cells, cancer/leukemic stem cells may survive and relapse occur. Conversely, studies involving the use of antioxidants in treatment and epidemiological studies of antioxidant use, have shown mixed results (reviewed in [129, 130]). Increasingly it is becoming apparent that increased levels of ROS are leading to changes in signalling pathways directly or indirectly controlling metabolism, as a mechanism for managing oxidative stress. Whilst, it has long been known that cancer cells exhibit greatly altered metabolism, only recently have the purposes behind this altered metabolism, started to be elucidated. Consequently, synergistic treatments involving the use of metabolic inhibitors, alongside classical treatments for leukemias are being explored. Future work, elucidating the intricate mechanisms governing the interplay between ROS and metabolism, alongside new and more specific metabolic inhibitors provide much promise for the future treatment of leukemia.
Acknowledgments
We are grateful to Blood Cancer UK for programmatic funding and to Tenovus Cancer Care for funding Andrew Robinson. We are grateful to Wellcome ISSF for funding aspects of ROS research. We are grateful for support from the NCRI AML trials cell bank and the AML patients for providing primary samples used in several of our studies.
\n',keywords:"NADPH, NOX, ROS, hematopoiesis, HSC, AML",chapterPDFUrl:"https://cdn.intechopen.com/pdfs/74121.pdf",chapterXML:"https://mts.intechopen.com/source/xml/74121.xml",downloadPdfUrl:"/chapter/pdf-download/74121",previewPdfUrl:"/chapter/pdf-preview/74121",totalDownloads:526,totalViews:0,totalCrossrefCites:0,dateSubmitted:"June 22nd 2020",dateReviewed:"October 28th 2020",datePrePublished:"February 5th 2021",datePublished:"March 24th 2021",dateFinished:"November 19th 2020",readingETA:"0",abstract:"Reactive oxygen species (ROS) is the collective term for several oxygen containing free radicals, such as hydrogen peroxide. ROS is important in innate immunity, protein folding in the endoplasmic reticulum and as a cell signalling molecule involved in cellular proliferation, survival, differentiation, and gene expression. ROS has been implicated in both hematopoietic stem cell quiescence and hematopoietic differentiation. Consequently, ROS is of considerable interest as a therapeutic target, with both pro-oxidant and anti-oxidant cellular modulation being explored. Recently, it has been established that increased ROS production in acute myeloid leukemia (AML) leads to increased glycolysis and metabolic reprogramming. It is often stated as a key tenet of the Warburg effect, that transformed cells, including AML, show increased aerobic glycolysis accompanied by increased cellular glucose uptake and lactate secretion. This review will summarize ROS state of the art in acute leukemia and how these reactive molecules re-wire metabolism in cancer cells. The review will focus on what are ROS? What are the sources of ROS in hematopoietic cells and their function and how this relates to the Warburg effect and regulation of metabolic pathways in acute leukemias.",reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/74121",risUrl:"/chapter/ris/74121",signatures:"Andrew J. Robinson, Richard L. Darley and Alex Tonks",book:{id:"9508",type:"book",title:"Acute Leukemias",subtitle:null,fullTitle:"Acute Leukemias",slug:"acute-leukemias",publishedDate:"March 24th 2021",bookSignature:"Pier Paolo Piccaluga",coverURL:"https://cdn.intechopen.com/books/images_new/9508.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",isbn:"978-1-83881-169-3",printIsbn:"978-1-83881-168-6",pdfIsbn:"978-1-83881-173-0",isAvailableForWebshopOrdering:!0,editors:[{id:"76041",title:"Prof.",name:"Pier Paolo",middleName:null,surname:"Piccaluga",slug:"pier-paolo-piccaluga",fullName:"Pier Paolo Piccaluga"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"325197",title:"Prof.",name:"Alex",middleName:null,surname:"Tonks",fullName:"Alex Tonks",slug:"alex-tonks",email:"tonksa@cardiff.ac.uk",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institution:null},{id:"325199",title:"Dr.",name:"Andrew",middleName:null,surname:"Robinson",fullName:"Andrew Robinson",slug:"andrew-robinson",email:"robinsona22@cf.ac.uk",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institution:{name:"Cardiff University",institutionURL:null,country:{name:"United Kingdom"}}},{id:"325201",title:"Prof.",name:"Richard",middleName:null,surname:"Darley",fullName:"Richard Darley",slug:"richard-darley",email:"darley@cf.ac.uk",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",institution:{name:"Cardiff University",institutionURL:null,country:{name:"United Kingdom"}}}],sections:[{id:"sec_1",title:"1. Introduction",level:"1"},{id:"sec_2",title:"2. Reactive oxygen species",level:"1"},{id:"sec_2_2",title:"2.1 Sources of ROS: electron transport chain",level:"2"},{id:"sec_3_2",title:"2.2 Sources of ROS: nicotinamide adenine dinucleotide phosphate (NADPH) oxidase family of enzymes (NOX)",level:"2"},{id:"sec_5",title:"3. Role of ROS on normal hematopoiesis",level:"1"},{id:"sec_6",title:"4. Role of ROS on solid tumors and leukemia development",level:"1"},{id:"sec_7",title:"5. Metabolism and cancer",level:"1"},{id:"sec_7_2",title:"5.1 NADPH: a link between ROS and metabolism in cancer",level:"2"},{id:"sec_8_2",title:"5.2 ROS regulation of metabolic pathways",level:"2"},{id:"sec_9_2",title:"5.3 Metabolism and leukemia",level:"2"},{id:"sec_11",title:"6. Conclusions",level:"1"},{id:"sec_12",title:"Acknowledgments",level:"1"}],chapterReferences:[{id:"B1",body:'Ho MS, Medcalf RL, Livesey SA, Traianedes K. The dynamics of adult haematopoiesis in the bone and bone marrow environment. British Journal of Haematology. 2015;170:472-486'},{id:"B2",body:'Luis TC, Killmann NM, Staal FJ. Signal transduction pathways regulating hematopoietic stem cell biology: introduction to a series of Spotlight Reviews. Leukemia. 2012;26:86-90'},{id:"B3",body:'Tarasova A, Haylock D, Winkler D. Principal signalling complexes in haematopoiesis: structural aspects and mimetic discovery. Cytokine & Growth Factor Reviews. 2011;22:231-253'},{id:"B4",body:'Wolff L, Humeniuk R. Concise review: erythroid versus myeloid lineage commitment: regulating the master regulators. Stem Cells. 2013;31:1237-1244'},{id:"B5",body:'Alvarez-Errico D, Vento-Tormo R, Sieweke M, Ballestar E. Epigenetic control of myeloid cell differentiation, identity and function. Nature Reviews. Immunology. 2015;15:7-17'},{id:"B6",body:'Oburoglu L, Romano M, Taylor N, Kinet S. Metabolic regulation of hematopoietic stem cell commitment and erythroid differentiation. Current Opinion in Hematology. 2016;23:198-205'},{id:"B7",body:'Ye F, Huang W, Guo G. Studying hematopoiesis using single-cell technologies. Journal of Hematology & Oncology. 2017;10:27'},{id:"B8",body:'Cvejic A. Mechanisms of fate decision and lineage commitment during haematopoiesis. Immunology and Cell Biology. 2016;94:230-235'},{id:"B9",body:'Velten L, Haas SF, Raffel S, Blaszkiewicz S, Islam S, Hennig BP, et al. Human haematopoietic stem cell lineage commitment is a continuous process. Nature Cell Biology. 2017;19:271-281'},{id:"B10",body:'Samra B, Jabbour E, Ravandi F, Kantarjian H, Short NJ. Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions. Journal of Hematology & Oncology. 2020;13:70'},{id:"B11",body:'Terwilliger T, Abdul-Hay M. Acute lymphoblastic leukemia: a comprehensive review and 2017 update. Blood Cancer Journal. 2017;7:e577'},{id:"B12",body:'Estey E, Gale RP. Acute myeloid leukemia therapy and the chosen people. Leukemia. 2017;31:269-271'},{id:"B13",body:'Tamamyan G, Kadia T, Ravandi F, Borthakur G, Cortes J, Jabbour E, et al. Frontline treatment of acute myeloid leukemia in adults. Critical Reviews in Oncology/Hematology. 2017;110:20-34'},{id:"B14",body:'Winer ES, Stone RM. Novel therapy in Acute myeloid leukemia (AML): moving toward targeted approaches. Ther Adv Hematol. 2019;10:2040620719860645'},{id:"B15",body:'Warburg O. On the origin of cancer cells. Science. 1956;123:309-314'},{id:"B16",body:'Robinson AJ, Hopkins GL, Rastogi N, Hodges M, Doyle M, Davies S, et al. Reactive Oxygen Species Drive Proliferation in Acute Myeloid Leukemia via the Glycolytic Regulator PFKFB3. Cancer Research. 2020;80:937-949'},{id:"B17",body:'Bienert GP, Schjoerring JK, Jahn TP. Membrane transport of hydrogen peroxide. Biochimica et Biophysica Acta. 1758;2006:994-1003'},{id:"B18",body:'Corcoran A, Cotter TG. Redox regulation of protein kinases. The FEBS Journal. 2013;280:1944-1965'},{id:"B19",body:'Angelova PR, Abramov AY. Functional role of mitochondrial reactive oxygen species in physiology. Free Radical Biology & Medicine. 2016;100:81-85'},{id:"B20",body:'Murphy MP. How mitochondria produce reactive oxygen species. The Biochemical Journal. 2009;417:1-13'},{id:"B21",body:'Scialo F, Fernandez-Ayala DJ, Sanz A. Role of Mitochondrial Reverse Electron Transport in ROS Signaling: Potential Roles in Health and Disease. Frontiers in Physiology. 2017;8:428'},{id:"B22",body:'Drose S, Brandt U. The mechanism of mitochondrial superoxide production by the cytochrome bc1 complex. The Journal of Biological Chemistry. 2008;283:21649-21654'},{id:"B23",body:'Magnani F, Nenci S, Millana FE, Ceccon M, Romero E, Fraaije MW, et al. Crystal structures and atomic model of NADPH oxidase. Proceedings of the National Academy of Sciences of the United States of America. 2017;114:6764-6769'},{id:"B24",body:'Nanduri J, Vaddi DR, Khan SA, Wang N, Makerenko V, Prabhakar NR. Xanthine oxidase mediates hypoxia-inducible factor-2alpha degradation by intermittent hypoxia. PLoS One. 2013;8:e75838'},{id:"B25",body:'Bertolotti M, Bestetti S, Garcia-Manteiga JM, Medrano-Fernandez I, Dal MA, Malosio ML, et al. Tyrosine kinase signal modulation: a matter of H2O2 membrane permeability? Antioxidants & Redox Signaling. 2013;19:1447-1451'},{id:"B26",body:'Miller EW, Dickinson BC, Chang CJ. Aquaporin-3 mediates hydrogen peroxide uptake to regulate downstream intracellular signaling. Proceedings of the National Academy of Sciences of the United States of America. 2010;107:15681-15686'},{id:"B27",body:'Essers MA, Weijzen S, de Vries-Smits AM, Saarloos I, de Ruiter ND, Bos JL, et al. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. The EMBO Journal. 2004;23:4802-4812'},{id:"B28",body:'Putker M, Madl T, Vos HR, de RH, Visscher M, van den Berg MC, et al. Redox-dependent control of FOXO/DAF-16 by transportin-1. Molecular Cell 2013;49:730-42'},{id:"B29",body:'Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 1999;96:857-868'},{id:"B30",body:'Kops GJ, Dansen TB, Polderman PE, Saarloos I, Wirtz KW, Coffer PJ, et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature. 2002;419:316-321'},{id:"B31",body:'Miyamoto K, Araki KY, Naka K, Arai F, Takubo K, Yamazaki S, et al. Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell. 2007;1:101-112'},{id:"B32",body:'Tothova Z, Kollipara R, Huntly BJ, Lee BH, Castrillon DH, Cullen DE, et al. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell. 2007;128:325-339'},{id:"B33",body:'Ito K, Hirao A, Arai F, Matsuoka S, Takubo K, Hamaguchi I, et al. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature. 2004;431:997-1002'},{id:"B34",body:'Jang YY, Sharkis SJ. A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood. 2007;110:3056-3063'},{id:"B35",body:'Huang H, Kim HJ, Chang EJ, Lee ZH, Hwang SJ, Kim HM, et al. IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling. Cell Death and Differentiation. 2009;16:1332-1343'},{id:"B36",body:'Sattler M, Winkler T, Verma S, Byrne CH, Shrikhande G, Salgia R, et al. Hematopoietic growth factors signal through the formation of reactive oxygen species. Blood. 1999;93:2928-2935'},{id:"B37",body:'O\'Brien JJ, Spinelli SL, Tober J, Blumberg N, Francis CW, Taubman MB, et al. 15-deoxy-delta12,14-PGJ2 enhances platelet production from megakaryocytes. Blood. 2008;112:4051-4060'},{id:"B38",body:'Motohashi H, Kimura M, Fujita R, Inoue A, Pan X, Takayama M, et al. NF-E2 domination over Nrf2 promotes ROS accumulation and megakaryocytic maturation. Blood. 2010;115:677-686'},{id:"B39",body:'McCrann DJ, Eliades A, Makitalo M, Matsuno K, Ravid K. Differential expression of NADPH oxidases in megakaryocytes and their role in polyploidy. Blood. 2009;114:1243-1249'},{id:"B40",body:'Sardina JL, Lopez-Ruano G, Sanchez-Abarca LI, Perez-Simon JA, Gaztelumendi A, Trigueros C, et al. p22phox-dependent NADPH oxidase activity is required for megakaryocytic differentiation. Cell Death and Differentiation. 2010;17:1842-1854'},{id:"B41",body:'Tang Y, Zhang G, Baird M, Racke F, Zhao W. A novel role of CYP2E1 in human megakaryocyte development. In Vivo. 2014;28:1077-1084'},{id:"B42",body:'Shinohara A, Imai Y, Nakagawa M, Takahashi T, Ichikawa M, Kurokawa M. Intracellular reactive oxygen species mark and influence the megakaryocyte-erythrocyte progenitor fate of common myeloid progenitors. Stem Cells. 2014;32:548-557'},{id:"B43",body:'Yamamoto T, Sakaguchi N, Hachiya M, Nakayama F, Yamakawa M, Akashi M. Role of catalase in monocytic differentiation of U937 cells by TPA: hydrogen peroxide as a second messenger. Leukemia. 2009;23:761-769'},{id:"B44",body:'Del Prete A, Zaccagnino P, Di PM, Saltarella M, Oliveros CC, Nico B, et al. Role of mitochondria and reactive oxygen species in dendritic cell differentiation and functions. Free Radical Biology & Medicine. 2008;44:1443-1451'},{id:"B45",body:'Weitzman SA, Weitberg AB, Clark EP, Stossel TP. Phagocytes as carcinogens: malignant transformation produced by human neutrophils. Science. 1985;227:1231-1233'},{id:"B46",body:'Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Research. 1991;51:794-798'},{id:"B47",body:'Valgimigli M, Valgimigli L, Trere D, Gaiani S, Pedulli GF, Gramantieri L, et al. Oxidative stress EPR measurement in human liver by radical-probe technique. Correlation with etiology, histology and cell proliferation. Free Radical Research. 2002;36:939-948'},{id:"B48",body:'Liaw KY, Lee PH, Wu FC, Tsai JS, Lin-Shiau SY. Zinc, copper, and superoxide dismutase in hepatocellular carcinoma. The American Journal of Gastroenterology. 1997;92:2260-2263'},{id:"B49",body:'Elchuri S, Oberley TD, Qi W, Eisenstein RS, Jackson RL, Van RH, et al. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life. Oncogene. 2005;24:367-380'},{id:"B50",body:'Van Remmen H, Ikeno Y, Hamilton M, Pahlavani M, Wolf N, Thorpe SR, et al. Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiological Genomics. 2003;16:29-37'},{id:"B51",body:'Galadari S, Rahman A, Pallichankandy S, Thayyullathil F. Reactive oxygen species and cancer paradox: To promote or to suppress? Free Radical Biology & Medicine. 2017;104:144-164'},{id:"B52",body:'Devi GS, Prasad MH, Saraswathi I, Raghu D, Rao DN, Reddy PP. Free radicals antioxidant enzymes and lipid peroxidation in different types of leukemias. Clinica Chimica Acta. 2000;293:53-62'},{id:"B53",body:'Hole PS, Zabkiewicz J, Munje C, Newton Z, Pearn L, White P, et al. Overproduction of NOX-derived ROS in AML promotes proliferation and is associated with defective oxidative stress signaling. Blood. 2013;122:3322-3330'},{id:"B54",body:'Cooke MS, Evans MD, Dizdaroglu M, Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. The FASEB Journal. 2003;17:1195-1214'},{id:"B55",body:'Matsui A, Ikeda T, Enomoto K, Hosoda K, Nakashima H, Omae K, et al. Increased formation of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, in human breast cancer tissue and its relationship to GSTP1 and COMT genotypes. Cancer Letters. 2000;151:87-95'},{id:"B56",body:'Borrego S, Vazquez A, Dasi F, Cerda C, Iradi A, Tormos C, et al. Oxidative Stress and DNA Damage in Human Gastric Carcinoma: 8-Oxo-7′8-dihydro-2′-deoxyguanosine (8-oxo-dG) as a Possible Tumor Marker. International Journal of Molecular Sciences. 2013;14:3467-3486'},{id:"B57",body:'Gackowski D, Kowalewski J, Siomek A, Olinski R. Oxidative DNA damage and antioxidant vitamin level: comparison among lung cancer patients, healthy smokers and nonsmokers. International Journal of Cancer. 2005;114:153-156'},{id:"B58",body:'Obtulowicz T, Swoboda M, Speina E, Gackowski D, Rozalski R, Siomek A, et al. Oxidative stress and 8-oxoguanine repair are enhanced in colon adenoma and carcinoma patients. Mutagenesis. 2010;25:463-471'},{id:"B59",body:'Zhou FL, Zhang WG, Wei YC, Meng S, Bai GG, Wang BY, et al. Involvement of oxidative stress in the relapse of acute myeloid leukemia. The Journal of Biological Chemistry. 2010;285:15010-15015'},{id:"B60",body:'Gao X, Schottker B. Reduction-oxidation pathways involved in cancer development: a systematic review of literature reviews. Oncotarget. 2017;8:51888-51906'},{id:"B61",body:'Altomare DA, Testa JR. Perturbations of the AKT signaling pathway in human cancer. Oncogene. 2005;24:7455-7464'},{id:"B62",body:'Xu Q , Simpson SE, Scialla TJ, Bagg A, Carroll M. Survival of acute myeloid leukemia cells requires PI3 kinase activation. Blood. 2003;102:972-980'},{id:"B63",body:'Kode A, Mosialou I, Manavalan SJ, Rathinam CV, Friedman RA, Teruya-Feldstein J, et al. FoxO1-dependent induction of acute myeloid leukemia by osteoblasts in mice. Leukemia. 2016;30:1-13'},{id:"B64",body:'Sykes SM, Lane SW, Bullinger L, Kalaitzidis D, Yusuf R, Saez B, et al. AKT/FOXO signaling enforces reversible differentiation blockade in myeloid leukemias. Cell. 2011;146:697-708'},{id:"B65",body:'Jayavelu AK, Moloney JN, Bohmer FD, Cotter TG. NOX-driven ROS formation in cell transformation of FLT3-ITD-positive AML. Experimental Hematology. 2016;44:1113-1122'},{id:"B66",body:'Mikawa T, LLeonart ME, Takaori-Kondo A, Inagaki N, Yokode M, Kondoh H. Dysregulated glycolysis as an oncogenic event. Cellular and Molecular Life Sciences. 2015;72:1881-1892'},{id:"B67",body:'DeBerardinis RJ, Chandel NS. Fundamentals of cancer metabolism. Science Advances. 2016;2:e1600200'},{id:"B68",body:'Weinberg F, Hamanaka R, Wheaton WW, Weinberg S, Joseph J, Lopez M, et al. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proceedings of the National Academy of Sciences of the United States of America. 2010;107:8788-8793'},{id:"B69",body:'Liberti MV, Locasale JW. The Warburg Effect: How Does it Benefit Cancer Cells? Trends in Biochemical Sciences. 2016;41:211-218'},{id:"B70",body:'Han T, Kang D, Ji D, Wang X, Zhan W, Fu M, et al. How does cancer cell metabolism affect tumor migration and invasion? Cell Adhesion & Migration. 2013;7:395-403'},{id:"B71",body:'Cosentino C, Grieco D, Costanzo V. ATM activates the pentose phosphate pathway promoting anti-oxidant defence and DNA repair. The EMBO Journal. 2011;30:546-555'},{id:"B72",body:'Ciccarese F, Ciminale V. Escaping Death: Mitochondrial Redox Homeostasis in Cancer Cells. Frontiers in Oncology. 2017;7:117'},{id:"B73",body:'Yang M, Vousden KH. Serine and one-carbon metabolism in cancer. Nature Reviews. Cancer. 2016;16:650-662'},{id:"B74",body:'Dang L, Jin S, Su SM. IDH mutations in glioma and acute myeloid leukemia. Trends in Molecular Medicine. 2010;16:387-397'},{id:"B75",body:'Zhao S, Lin Y, Xu W, Jiang W, Zha Z, Wang P, et al. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science. 2009;324:261-265'},{id:"B76",body:'Hagen T. Oxygen versus Reactive Oxygen in the Regulation of HIF-1alpha: The Balance Tips. Biochemistry Research International. 2012;2012:436981'},{id:"B77",body:'Mitsuishi Y, Taguchi K, Kawatani Y, Shibata T, Nukiwa T, Aburatani H, et al. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell. 2012;22:66-79'},{id:"B78",body:'Rushworth SA, MacEwan DJ. HO-1 underlies resistance of AML cells to TNF-induced apoptosis. Blood. 2008;111:3793-3801'},{id:"B79",body:'Matoba S, Kang JG, Patino WD, Wragg A, Boehm M, Gavrilova O, et al. p53 regulates mitochondrial respiration. Science. 2006;312:1650-1653'},{id:"B80",body:'Zhao L, Mao Y, Zhao Y, Cao Y, Chen X. Role of multifaceted regulators in cancer glucose metabolism and their clinical significance. Oncotarget. 2016;7:31572-31585'},{id:"B81",body:'Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, et al. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell. 2006;126:107-120'},{id:"B82",body:'Prior IA, Lewis PD, Mattos C. A comprehensive survey of Ras mutations in cancer. Cancer Research. 2012;72:2457-2467'},{id:"B83",body:'Efeyan A, Zoncu R, Sabatini DM. Amino acids and mTORC1: from lysosomes to disease. Trends in Molecular Medicine. 2012;18:524-533'},{id:"B84",body:'Li M, Jin R, Wang W, Zhang T, Sang J, Li N, et al. STAT3 regulates glycolysis via targeting hexokinase 2 in hepatocellular carcinoma cells. Oncotarget. 2017;8:24777-24784'},{id:"B85",body:'Khatri S, Yepiskoposyan H, Gallo CA, Tandon P, Plas DR. FOXO3a regulates glycolysis via transcriptional control of tumor suppressor TSC1. The Journal of Biological Chemistry. 2010;285:15960-15965'},{id:"B86",body:'Kawauchi K, Araki K, Tobiume K, Tanaka N. p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation. Nature Cell Biology. 2008;10:611-618'},{id:"B87",body:'Hsieh AL, Walton ZE, Altman BJ, Stine ZE, Dang CV. MYC and metabolism on the path to cancer. Seminars in Cell & Developmental Biology. 2015;43:11-21'},{id:"B88",body:'Boag JM, Beesley AH, Firth MJ, Freitas JR, Ford J, Hoffmann K, et al. Altered glucose metabolism in childhood pre-B acute lymphoblastic leukaemia. Leukemia. 2006;20:1731-1737'},{id:"B89",body:'Liu T, Kishton RJ, Macintyre AN, Gerriets VA, Xiang H, Liu X, et al. Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis. Cell Death & Disease. 2014;5:e1470'},{id:"B90",body:'Song K, Li M, Xu X, Xuan LI, Huang G, Liu Q . Resistance to chemotherapy is associated with altered glucose metabolism in acute myeloid leukemia. Oncology Letters. 2016;12:334-342'},{id:"B91",body:'Chen WL, Wang YY, Zhao A, Xia L, Xie G, Su M, et al. Enhanced Fructose Utilization Mediated by SLC2A5 Is a Unique Metabolic Feature of Acute Myeloid Leukemia with Therapeutic Potential. Cancer Cell. 2016;30:779-791'},{id:"B92",body:'Prata C, Maraldi T, Fiorentini D, Zambonin L, Hakim G, Landi L. Nox-generated ROS modulate glucose uptake in a leukaemic cell line. Free Radical Research. 2008;42:405-414'},{id:"B93",body:'Zhao P, Huang J, Zhang D, Zhang D, Wang F, Qu Y, et al. SLC2A5 overexpression in childhood philadelphia chromosome-positive acute lymphoblastic leukaemia. British Journal of Haematology. 2018;183:242-250'},{id:"B94",body:'You ZM, Zhao L, Xia J, Wei Q , Liu YM, Liu XY, et al. Down-regulation of phosphoglucose isomerase/autocrine motility factor enhances gensenoside Rh2 pharmacological action on leukemia KG1alpha cells. Asian Pacific Journal of Cancer Prevention. 2014;15:1099-1104'},{id:"B95",body:'Ju HQ , Zhan G, Huang A, Sun Y, Wen S, Yang J, et al. ITD mutation in FLT3 tyrosine kinase promotes Warburg effect and renders therapeutic sensitivity to glycolytic inhibition. Leukemia. 2017;31:2143-2150'},{id:"B96",body:'Ryland LK, Doshi UA, Shanmugavelandy SS, Fox TE, Aliaga C, Broeg K, et al. C6-ceramide nanoliposomes target the Warburg effect in chronic lymphocytic leukemia. PLoS One. 2013;8:e84648'},{id:"B97",body:'Shi SY, Lu SY, Sivasubramaniyam T, Revelo XS, Cai EP, Luk CT, et al. DJ-1 links muscle ROS production with metabolic reprogramming and systemic energy homeostasis in mice. Nature Communications. 2015;6:7415'},{id:"B98",body:'Liu CC, Wang H, Wang JH, Wang L, Geng QR, Chen XQ , et al. Serum neuron-specific enolase levels are upregulated in patients with acute lymphoblastic leukemia and are predictive of prognosis. Oncotarget. 2016;7:55181-55190'},{id:"B99",body:'Hitosugi T, Zhou L, Elf S, Fan J, Kang HB, Seo JH, et al. Phosphoglycerate mutase 1 coordinates glycolysis and biosynthesis to promote tumor growth. Cancer Cell. 2012;22:585-600'},{id:"B100",body:'McCleland ML, Adler AS, Deming L, Cosino E, Lee L, Blackwood EM, et al. Lactate dehydrogenase B is required for the growth of KRAS-dependent lung adenocarcinomas. Clinical Cancer Research. 2013;19:773-784'},{id:"B101",body:'Tahir IM, Iqbal T, Jamil A, Saqib M. Association of BCL-2 with oxidative stress and total antioxidant status in pediatric acute lymphoblastic leukemia. Journal of Biological Regulators and Homeostatic Agents. 2017;31:1023-1027'},{id:"B102",body:'Hu W, Wang X, Yang R. Evaluation of D-dimer and lactate dehydrogenase plasma levels in patients with relapsed acute leukemia. Oncology Letters. 2016;12:591-596'},{id:"B103",body:'Hole PS, Pearn L, Tonks AJ, James PE, Burnett AK, Darley RL, et al. Ras-induced reactive oxygen species promote growth factor-independent proliferation in human CD34+ hematopoietic progenitor cells. Blood. 2010;115:1238-1246'},{id:"B104",body:'Chen WL, Wang JH, Zhao AH, Xu X, Wang YH, Chen TL, et al. A distinct glucose metabolism signature of acute myeloid leukemia with prognostic value. Blood. 2014;124:1645-1654'},{id:"B105",body:'Zhang MY, Liu SL, Huang WL, Tang DB, Zheng WW, Zhou N, et al. Bromodomains and Extra-Terminal (BET) Inhibitor JQ1 Suppresses Proliferation of Acute Lymphocytic Leukemia by Inhibiting c-Myc-Mediated Glycolysis. Medical Science Monitor. 2020;26:e923411'},{id:"B106",body:'Wallace DC. Mitochondria and cancer. Nature Reviews. Cancer. 2012;12:685-698'},{id:"B107",body:'Naoe T, Kiyoi H. Gene mutations of acute myeloid leukemia in the genome era. International Journal of Hematology. 2013;97:165-174'},{id:"B108",body:'Yen K, Travins J, Wang F, David MD, Artin E, Straley K, et al. AG-221, a First-in-Class Therapy Targeting Acute Myeloid Leukemia Harboring Oncogenic IDH2 Mutations. Cancer Discovery. 2017;7:478-493'},{id:"B109",body:'DiNardo C, Botton S, Pollyea D, Stein E, Fathi A, Roboz G, et al. Molecular Profiling and Relationship with Clinical Response in Patients with IDH1 Mutation-Positive Hematologic Malignancies Receiving AG-120, a First-in-Class Potent Inhibitor of Mutant IDH1, in Addition to Data from the Completed Dose Escalation Portion of the Phase 1 Study. Blood. 2015;126:1306'},{id:"B110",body:'Wang Y, Zhang L, Chen WL, Wang JH, Li N, Li JM, et al. Rapid diagnosis and prognosis of de novo acute myeloid leukemia by serum metabonomic analysis. Journal of Proteome Research. 2013;12:4393-4401'},{id:"B111",body:'Schraw JM, Junco JJ, Brown AL, Scheurer ME, Rabin KR, Lupo PJ. Metabolomic profiling identifies pathways associated with minimal residual disease in childhood acute lymphoblastic leukaemia. eBioMedicine. 2019;48:49-57'},{id:"B112",body:'Ye J, Fan J, Venneti S, Wan YW, Pawel BR, Zhang J, et al. Serine catabolism regulates mitochondrial redox control during hypoxia. Cancer Discovery. 2014;4:1406-1417'},{id:"B113",body:'Polet F, Corbet C, Pinto A, Rubio LI, Martherus R, Bol V, et al. Reducing the serine availability complements the inhibition of the glutamine metabolism to block leukemia cell growth. Oncotarget. 2016;7:1765-1776'},{id:"B114",body:'Zaal EA, Wu W, Jansen G, Zweegman S, Cloos J, Berkers CR. Bortezomib resistance in multiple myeloma is associated with increased serine synthesis. Cancer Metab. 2017;5:7'},{id:"B115",body:'Patra KC, Hay N. The pentose phosphate pathway and cancer. Trends in Biochemical Sciences. 2014;39:347-354'},{id:"B116",body:'Chen Y, Xu Q , Ji D, Wei Y, Chen H, Li T, et al. Inhibition of pentose phosphate pathway suppresses acute myelogenous leukemia. Tumour Biology. 2016;37:6027-6034'},{id:"B117",body:'Elf S, Lin R, Xia S, Pan Y, Shan C, Wu S, et al. Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin. Oncogene. 2017;36:254-262'},{id:"B118",body:'Poulain L, Sujobert P, Zylbersztejn F, Barreau S, Stuani L, Lambert M, et al. High mTORC1 activity drives glycolysis addiction and sensitivity to G6PD inhibition in acute myeloid leukemia cells. Leukemia. 2017;31:2326-2335'},{id:"B119",body:'Xiao G, Chan LN, Klemm L, Braas D, Chen Z, Geng H, et al. B-Cell-Specific Diversion of Glucose Carbon Utilization Reveals a Unique Vulnerability in B Cell Malignancies. Cell. 2018;173:470-484'},{id:"B120",body:'Starkova J, Hermanova I, Hlozkova K, Hararova A, Trka J. Altered Metabolism of Leukemic Cells: New Therapeutic Opportunity. International Review of Cell and Molecular Biology. 2018;336:93-147'},{id:"B121",body:'Adane B, Ye H, Khan N, Pei S, Minhajuddin M, Stevens BM, et al. The Hematopoietic Oxidase NOX2 Regulates Self-Renewal of Leukemic Stem Cells. Cell Reports. 2019;27:238-254'},{id:"B122",body:'Lee EA, Angka L, Rota SG, Hanlon T, Mitchell A, Hurren R, et al. Targeting Mitochondria with Avocatin B Induces Selective Leukemia Cell Death. Cancer Research. 2015;75:2478-2488'},{id:"B123",body:'Hermanova I, Arruabarrena-Aristorena A, Valis K, Nuskova H, Alberich-Jorda M, Fiser K, et al. Pharmacological inhibition of fatty-acid oxidation synergistically enhances the effect of l-asparaginase in childhood ALL cells. Leukemia. 2016;30:209-218'},{id:"B124",body:'Hole PS, Darley RL, Tonks A.Do reactive oxygen species play a role in myeloid leukemias? Blood. 2011;117:5816-5826'},{id:"B125",body:'McCulloch D, Brown C, Iland H. Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives. Oncotargets and Therapy. 2017;10:1585-1601'},{id:"B126",body:'Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 2009;458:780-783'},{id:"B127",body:'Kim HM, Haraguchi N, Ishii H, Ohkuma M, Okano M, Mimori K, et al. Increased CD13 expression reduces reactive oxygen species, promoting survival of liver cancer stem cells via an epithelial-mesenchymal transition-like phenomenon. Annals of Surgical Oncology. 2012;19(Suppl 3):S539-S548'},{id:"B128",body:'Lagadinou ED, Sach A, Callahan K, Rossi RM, Neering SJ, Minhajuddin M, et al. BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells. Cell Stem Cell. 2013;12:329-341'},{id:"B129",body:'Poprac P, Jomova K, Simunkova M, Kollar V, Rhodes CJ, Valko M. Targeting Free Radicals in Oxidative Stress-Related Human Diseases. Trends in Pharmacological Sciences. 2017;38:592-607'},{id:"B130",body:'Yasueda A, Urushima H, Ito T. Efficacy and Interaction of Antioxidant Supplements as Adjuvant Therapy in Cancer Treatment: A Systematic Review. Integrative Cancer Therapies. 2016;15:17-39'}],footnotes:[],contributors:[{corresp:null,contributorFullName:"Andrew J. Robinson",address:null,affiliation:'
Department of Haematology, Division of Cancer and Genetics, Cardiff University, Cardiff, UK
'},{corresp:null,contributorFullName:"Richard L. Darley",address:null,affiliation:'
Department of Haematology, Division of Cancer and Genetics, Cardiff University, Cardiff, UK
Department of Haematology, Division of Cancer and Genetics, Cardiff University, Cardiff, UK
'}],corrections:null},book:{id:"9508",type:"book",title:"Acute Leukemias",subtitle:null,fullTitle:"Acute Leukemias",slug:"acute-leukemias",publishedDate:"March 24th 2021",bookSignature:"Pier Paolo Piccaluga",coverURL:"https://cdn.intechopen.com/books/images_new/9508.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",isbn:"978-1-83881-169-3",printIsbn:"978-1-83881-168-6",pdfIsbn:"978-1-83881-173-0",isAvailableForWebshopOrdering:!0,editors:[{id:"76041",title:"Prof.",name:"Pier Paolo",middleName:null,surname:"Piccaluga",slug:"pier-paolo-piccaluga",fullName:"Pier Paolo Piccaluga"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},profile:{item:{id:"68189",title:"Dr.",name:"Moslem",middleName:null,surname:"Najafi",email:"najafim@tbzmed.ac.ir",fullName:"Moslem Najafi",slug:"moslem-najafi",position:null,biography:null,institutionString:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",totalCites:0,totalChapterViews:"0",outsideEditionCount:0,totalAuthoredChapters:"1",totalEditedBooks:"0",personalWebsiteURL:null,twitterURL:null,linkedinURL:null,institution:{name:"Tabriz University of Medical Sciences",institutionURL:null,country:{name:"Iran"}}},booksEdited:[],chaptersAuthored:[{id:"34338",title:"Metabolic Modulators to Treat Cardiac Arrhythmias Induced by Ischemia and Reperfusion",slug:"metabolic-modulators-to-treat-cardiac-arrhythmias-induced-by-ischemia-and-reperfusion",abstract:null,signatures:"Moslem Najafi and Tahereh Eteraf-Oskouei",authors:[{id:"68189",title:"Dr.",name:"Moslem",surname:"Najafi",fullName:"Moslem Najafi",slug:"moslem-najafi",email:"najafim@tbzmed.ac.ir"},{id:"71207",title:"Dr.",name:"Tahereh",surname:"Eteraf-Oskouei",fullName:"Tahereh Eteraf-Oskouei",slug:"tahereh-eteraf-oskouei",email:"eteraf_t@yahoo.com"}],book:{id:"997",title:"Tachycardia",slug:"tachycardia",productType:{id:"1",title:"Edited Volume"}}}],collaborators:[{id:"21955",title:"Dr.",name:"Jesus",surname:"Ruiz",slug:"jesus-ruiz",fullName:"Jesus Ruiz",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of the Basque Country",institutionURL:null,country:{name:"Spain"}}},{id:"51500",title:"Dr.",name:"Sofia",surname:"Ruiz De Gauna",slug:"sofia-ruiz-de-gauna",fullName:"Sofia Ruiz De Gauna",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of the Basque Country",institutionURL:null,country:{name:"Spain"}}},{id:"57451",title:"Dr.",name:"Unai",surname:"Irusta",slug:"unai-irusta",fullName:"Unai Irusta",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"University of the Basque Country",institutionURL:null,country:{name:"Spain"}}},{id:"57452",title:"Dr.",name:"Elisabete",surname:"Aramendi",slug:"elisabete-aramendi",fullName:"Elisabete Aramendi",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"64296",title:"Dr.",name:"Anand",surname:"Deshmukh",slug:"anand-deshmukh",fullName:"Anand Deshmukh",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"64594",title:"Dr.",name:"Ana",surname:"Gomez",slug:"ana-gomez",fullName:"Ana Gomez",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Inserm",institutionURL:null,country:{name:"France"}}},{id:"71604",title:"Dr.",name:"Maria",surname:"Fernandez-Velasco",slug:"maria-fernandez-velasco",fullName:"Maria Fernandez-Velasco",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Spanish National Research Council",institutionURL:null,country:{name:"Spain"}}},{id:"71606",title:"Dr.",name:"Jean-Pierre",surname:"Benitah",slug:"jean-pierre-benitah",fullName:"Jean-Pierre Benitah",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Inserm",institutionURL:null,country:{name:"France"}}},{id:"72184",title:"Prof.",name:"Ad",surname:"Bogers",slug:"ad-bogers",fullName:"Ad Bogers",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Erasmus University Medical Center",institutionURL:null,country:{name:"Netherlands"}}},{id:"72190",title:"Mr.",name:"Charles",surname:"Kik",slug:"charles-kik",fullName:"Charles Kik",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Erasmus University Medical Center",institutionURL:null,country:{name:"Netherlands"}}}]},generic:{page:{slug:"open-access-funding",title:"Open Access Funding",intro:"
IntechOpen’s Academic Editors and Authors have received funding for their work through many well-known funders, including: the European Commission, Bill and Melinda Gates Foundation, Wellcome Trust, Chinese Academy of Sciences, Natural Science Foundation of China (NSFC), CGIAR Consortium of International Agricultural Research Centers, National Institute of Health (NIH), National Science Foundation (NSF), National Aeronautics and Space Administration (NASA), National Institute of Standards and Technology (NIST), German Research Foundation (DFG), Research Councils United Kingdom (RCUK), Oswaldo Cruz Foundation, Austrian Science Fund (FWF), Foundation for Science and Technology (FCT), Australian Research Council (ARC).
Open Access publication costs can often be designated directly in the grants or in specific budgets allocated for that purpose. Many of the most important funding organisations encourage, and even request, that the projects they fund are made available at no cost to the wider public. IntechOpen strives to maintain excellent relationships with these funders and ensures compliance with mandates.
\\n\\n
In order to help Authors identify appropriate funding agencies and institutions, we have created a list, based on extensive research on various OA resources (including ROARMAP and SHERPA/JULIET) of organizations that have funds available. Before consulting our list we encourage you to petition your own institution or organization for Open Access funds or check the specifications of your grant with your funder to ascertain if publication costs are included. Where you are in receipt of a grant you should clarify:
\\n\\n
\\n\\t
Does your institution already have a budget for covering Open Access publication costs?
\\n\\t
Does your grant list Open Access publication fees as legitimate direct/indirect costs?
\\n
\\n\\n
If you are associated with any of the institutions in our list below, you can apply to receive OA publication funds by following the instructions provided in the links. Please consult the Open Access policies or grant Terms and Conditions of any institution with which you are linked to explore ways to cover your publication costs (also accessible by clicking on the link in their title).
\\n\\n
Please note that this list is not a definitive one and is updated regularly. To suggest possible modifications or the inclusion of your institution/funder, please contact us at funders@intechopen.com
\\n\\n
Please be aware that you must be a member, or grantee, of the institutions/funders listed in order to apply for their Open Access publication funds.
Open Access publication costs can often be designated directly in the grants or in specific budgets allocated for that purpose. Many of the most important funding organisations encourage, and even request, that the projects they fund are made available at no cost to the wider public. IntechOpen strives to maintain excellent relationships with these funders and ensures compliance with mandates.
\n\n
In order to help Authors identify appropriate funding agencies and institutions, we have created a list, based on extensive research on various OA resources (including ROARMAP and SHERPA/JULIET) of organizations that have funds available. Before consulting our list we encourage you to petition your own institution or organization for Open Access funds or check the specifications of your grant with your funder to ascertain if publication costs are included. Where you are in receipt of a grant you should clarify:
\n\n
\n\t
Does your institution already have a budget for covering Open Access publication costs?
\n\t
Does your grant list Open Access publication fees as legitimate direct/indirect costs?
\n
\n\n
If you are associated with any of the institutions in our list below, you can apply to receive OA publication funds by following the instructions provided in the links. Please consult the Open Access policies or grant Terms and Conditions of any institution with which you are linked to explore ways to cover your publication costs (also accessible by clicking on the link in their title).
\n\n
Please note that this list is not a definitive one and is updated regularly. To suggest possible modifications or the inclusion of your institution/funder, please contact us at funders@intechopen.com
\n\n
Please be aware that you must be a member, or grantee, of the institutions/funders listed in order to apply for their Open Access publication funds.
\n'}]},successStories:{items:[]},authorsAndEditors:{filterParams:{},profiles:[{id:"6700",title:"Dr.",name:"Abbass A.",middleName:null,surname:"Hashim",slug:"abbass-a.-hashim",fullName:"Abbass A. Hashim",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/6700/images/1864_n.jpg",biography:"Currently I am carrying out research in several areas of interest, mainly covering work on chemical and bio-sensors, semiconductor thin film device fabrication and characterisation.\nAt the moment I have very strong interest in radiation environmental pollution and bacteriology treatment. The teams of researchers are working very hard to bring novel results in this field. I am also a member of the team in charge for the supervision of Ph.D. students in the fields of development of silicon based planar waveguide sensor devices, study of inelastic electron tunnelling in planar tunnelling nanostructures for sensing applications and development of organotellurium(IV) compounds for semiconductor applications. I am a specialist in data analysis techniques and nanosurface structure. I have served as the editor for many books, been a member of the editorial board in science journals, have published many papers and hold many patents.",institutionString:null,institution:{name:"Sheffield Hallam University",country:{name:"United Kingdom"}}},{id:"54525",title:"Prof.",name:"Abdul Latif",middleName:null,surname:"Ahmad",slug:"abdul-latif-ahmad",fullName:"Abdul Latif Ahmad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"20567",title:"Prof.",name:"Ado",middleName:null,surname:"Jorio",slug:"ado-jorio",fullName:"Ado Jorio",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidade Federal de Minas Gerais",country:{name:"Brazil"}}},{id:"47940",title:"Dr.",name:"Alberto",middleName:null,surname:"Mantovani",slug:"alberto-mantovani",fullName:"Alberto Mantovani",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"12392",title:"Mr.",name:"Alex",middleName:null,surname:"Lazinica",slug:"alex-lazinica",fullName:"Alex Lazinica",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/12392/images/7282_n.png",biography:"Alex Lazinica is the founder and CEO of IntechOpen. After obtaining a Master's degree in Mechanical Engineering, he continued his PhD studies in Robotics at the Vienna University of Technology. Here he worked as a robotic researcher with the university's Intelligent Manufacturing Systems Group as well as a guest researcher at various European universities, including the Swiss Federal Institute of Technology Lausanne (EPFL). During this time he published more than 20 scientific papers, gave presentations, served as a reviewer for major robotic journals and conferences and most importantly he co-founded and built the International Journal of Advanced Robotic Systems- world's first Open Access journal in the field of robotics. Starting this journal was a pivotal point in his career, since it was a pathway to founding IntechOpen - Open Access publisher focused on addressing academic researchers needs. Alex is a personification of IntechOpen key values being trusted, open and entrepreneurial. Today his focus is on defining the growth and development strategy for the company.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"19816",title:"Prof.",name:"Alexander",middleName:null,surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/19816/images/1607_n.jpg",biography:"Alexander I. Kokorin: born: 1947, Moscow; DSc., PhD; Principal Research Fellow (Research Professor) of Department of Kinetics and Catalysis, N. Semenov Institute of Chemical Physics, Russian Academy of Sciences, Moscow.\r\nArea of research interests: physical chemistry of complex-organized molecular and nanosized systems, including polymer-metal complexes; the surface of doped oxide semiconductors. He is an expert in structural, absorptive, catalytic and photocatalytic properties, in structural organization and dynamic features of ionic liquids, in magnetic interactions between paramagnetic centers. The author or co-author of 3 books, over 200 articles and reviews in scientific journals and books. He is an actual member of the International EPR/ESR Society, European Society on Quantum Solar Energy Conversion, Moscow House of Scientists, of the Board of Moscow Physical Society.",institutionString:null,institution:{name:"Semenov Institute of Chemical Physics",country:{name:"Russia"}}},{id:"62389",title:"PhD.",name:"Ali Demir",middleName:null,surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/62389/images/3413_n.jpg",biography:"Dr. Ali Demir Sezer has a Ph.D. from Pharmaceutical Biotechnology at the Faculty of Pharmacy, University of Marmara (Turkey). He is the member of many Pharmaceutical Associations and acts as a reviewer of scientific journals and European projects under different research areas such as: drug delivery systems, nanotechnology and pharmaceutical biotechnology. Dr. Sezer is the author of many scientific publications in peer-reviewed journals and poster communications. Focus of his research activity is drug delivery, physico-chemical characterization and biological evaluation of biopolymers micro and nanoparticles as modified drug delivery system, and colloidal drug carriers (liposomes, nanoparticles etc.).",institutionString:null,institution:{name:"Marmara University",country:{name:"Turkey"}}},{id:"61051",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"100762",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"St David's Medical Center",country:{name:"United States of America"}}},{id:"107416",title:"Dr.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Texas Cardiac Arrhythmia",country:{name:"United States of America"}}},{id:"64434",title:"Dr.",name:"Angkoon",middleName:null,surname:"Phinyomark",slug:"angkoon-phinyomark",fullName:"Angkoon Phinyomark",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/64434/images/2619_n.jpg",biography:"My name is Angkoon Phinyomark. I received a B.Eng. degree in Computer Engineering with First Class Honors in 2008 from Prince of Songkla University, Songkhla, Thailand, where I received a Ph.D. degree in Electrical Engineering. My research interests are primarily in the area of biomedical signal processing and classification notably EMG (electromyography signal), EOG (electrooculography signal), and EEG (electroencephalography signal), image analysis notably breast cancer analysis and optical coherence tomography, and rehabilitation engineering. I became a student member of IEEE in 2008. During October 2011-March 2012, I had worked at School of Computer Science and Electronic Engineering, University of Essex, Colchester, Essex, United Kingdom. In addition, during a B.Eng. I had been a visiting research student at Faculty of Computer Science, University of Murcia, Murcia, Spain for three months.\n\nI have published over 40 papers during 5 years in refereed journals, books, and conference proceedings in the areas of electro-physiological signals processing and classification, notably EMG and EOG signals, fractal analysis, wavelet analysis, texture analysis, feature extraction and machine learning algorithms, and assistive and rehabilitative devices. I have several computer programming language certificates, i.e. Sun Certified Programmer for the Java 2 Platform 1.4 (SCJP), Microsoft Certified Professional Developer, Web Developer (MCPD), Microsoft Certified Technology Specialist, .NET Framework 2.0 Web (MCTS). I am a Reviewer for several refereed journals and international conferences, such as IEEE Transactions on Biomedical Engineering, IEEE Transactions on Industrial Electronics, Optic Letters, Measurement Science Review, and also a member of the International Advisory Committee for 2012 IEEE Business Engineering and Industrial Applications and 2012 IEEE Symposium on Business, Engineering and Industrial Applications.",institutionString:null,institution:{name:"Joseph Fourier University",country:{name:"France"}}},{id:"55578",title:"Dr.",name:"Antonio",middleName:null,surname:"Jurado-Navas",slug:"antonio-jurado-navas",fullName:"Antonio Jurado-Navas",position:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRisIQAS/Profile_Picture_1626166543950",biography:"Antonio Jurado-Navas received the M.S. degree (2002) and the Ph.D. degree (2009) in Telecommunication Engineering, both from the University of Málaga (Spain). He first worked as a consultant at Vodafone-Spain. From 2004 to 2011, he was a Research Assistant with the Communications Engineering Department at the University of Málaga. In 2011, he became an Assistant Professor in the same department. From 2012 to 2015, he was with Ericsson Spain, where he was working on geo-location\ntools for third generation mobile networks. Since 2015, he is a Marie-Curie fellow at the Denmark Technical University. His current research interests include the areas of mobile communication systems and channel modeling in addition to atmospheric optical communications, adaptive optics and statistics",institutionString:null,institution:{name:"University of Malaga",country:{name:"Spain"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:6597},{group:"region",caption:"Middle and South America",value:2,count:5902},{group:"region",caption:"Africa",value:3,count:2400},{group:"region",caption:"Asia",value:4,count:12537},{group:"region",caption:"Australia and Oceania",value:5,count:1006},{group:"region",caption:"Europe",value:6,count:17560}],offset:12,limit:12,total:132761},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{hasNoEditors:"1",sort:"dateEndThirdStepPublish",topicId:"7,10,15,24,5,6,8,9,11,23,14,16,17,12,18,19,20,21,22,13,25"},books:[{type:"book",id:"11254",title:"Optical Coherence Tomography",subtitle:null,isOpenForSubmission:!0,hash:"a958c09ceaab1fc44c1dd0a817f48c92",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11254.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11472",title:"21st Century Slavery",subtitle:null,isOpenForSubmission:!0,hash:"b341f3fc3411ced881e43ce007a892b8",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11472.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11473",title:"Social Inequality",subtitle:null,isOpenForSubmission:!0,hash:"20307129f7fb39aa443d5449acb6a784",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11473.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11546",title:"Smart and Sustainable Transportation",subtitle:null,isOpenForSubmission:!0,hash:"e8ea27a1ff85cde00efcb6f6968c20f8",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11546.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11554",title:"Information Systems Management",subtitle:null,isOpenForSubmission:!0,hash:"3134452ff2fdec020663f241c7a9a748",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11554.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11436",title:"Beauty",subtitle:null,isOpenForSubmission:!0,hash:"0e15ba86bab1a64f950318f3ab2584ed",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11436.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11438",title:"Fake News in the Era of Pandemics",subtitle:null,isOpenForSubmission:!0,hash:"bc9e4cab86c76f35cd70b39086d9b69e",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11438.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11588",title:"Autism",subtitle:null,isOpenForSubmission:!0,hash:"0c5043c6174db167599cb3f762e8bba8",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11588.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11605",title:"Bamboo",subtitle:null,isOpenForSubmission:!0,hash:"378d957561b27c86b750a9c7841a5d18",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11605.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11612",title:"Landraces",subtitle:null,isOpenForSubmission:!0,hash:"06316c41a6f6317ad2bee244dc98c6a4",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11612.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11616",title:"Foraging",subtitle:null,isOpenForSubmission:!0,hash:"955b60bb658c8d1a09dd4efc9bf6674b",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11616.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"11632",title:"Updated Research on Bacteriophages",subtitle:null,isOpenForSubmission:!0,hash:"d34dfa0d5d10511184f97ddaeef9936b",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/11632.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:43},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:12},{group:"topic",caption:"Business, Management and Economics",value:7,count:8},{group:"topic",caption:"Chemistry",value:8,count:19},{group:"topic",caption:"Computer and Information Science",value:9,count:18},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:18},{group:"topic",caption:"Engineering",value:11,count:47},{group:"topic",caption:"Environmental Sciences",value:12,count:7},{group:"topic",caption:"Immunology and Microbiology",value:13,count:12},{group:"topic",caption:"Materials Science",value:14,count:15},{group:"topic",caption:"Mathematics",value:15,count:7},{group:"topic",caption:"Medicine",value:16,count:109},{group:"topic",caption:"Nanotechnology and Nanomaterials",value:17,count:2},{group:"topic",caption:"Neuroscience",value:18,count:7},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:11},{group:"topic",caption:"Physics",value:20,count:5},{group:"topic",caption:"Psychology",value:21,count:8},{group:"topic",caption:"Robotics",value:22,count:2},{group:"topic",caption:"Social Sciences",value:23,count:32},{group:"topic",caption:"Technology",value:24,count:1},{group:"topic",caption:"Veterinary Medicine and Science",value:25,count:2}],offset:12,limit:12,total:385},popularBooks:{featuredBooks:[],offset:0,limit:12,total:null},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[],latestBooks:[]},subject:{topic:{id:"167",title:"Bioethics",slug:"medicine-bioethics",parent:{id:"16",title:"Medicine",slug:"medicine"},numberOfBooks:8,numberOfSeries:0,numberOfAuthorsAndEditors:159,numberOfWosCitations:61,numberOfCrossrefCitations:38,numberOfDimensionsCitations:79,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicId:"167",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"9566",title:"Bioethics in Medicine and Society",subtitle:null,isOpenForSubmission:!1,hash:"16f1f01dc302bf4f0042445f11965fa1",slug:"bioethics-in-medicine-and-society",bookSignature:"Thomas F. Heston and Sujoy Ray",coverURL:"https://cdn.intechopen.com/books/images_new/9566.jpg",editedByType:"Edited by",editors:[{id:"217926",title:"Dr.",name:"Thomas F.",middleName:null,surname:"Heston",slug:"thomas-f.-heston",fullName:"Thomas F. Heston"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"7798",title:"Neuroethics in Principle and Praxis",subtitle:"Conceptual Foundations",isOpenForSubmission:!1,hash:"c331b07083fed290d6be2ccf32f1118f",slug:"neuroethics-in-principle-and-praxis-conceptual-foundations",bookSignature:"Denis Larrivee",coverURL:"https://cdn.intechopen.com/books/images_new/7798.jpg",editedByType:"Edited by",editors:[{id:"206412",title:"Prof.",name:"Denis",middleName:null,surname:"Larrivee",slug:"denis-larrivee",fullName:"Denis Larrivee"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6615",title:"Nursing",subtitle:null,isOpenForSubmission:!1,hash:"ec518aff724f10de937340ca865b5e94",slug:"nursing",bookSignature:"Nilgun Ulutasdemir",coverURL:"https://cdn.intechopen.com/books/images_new/6615.jpg",editedByType:"Edited by",editors:[{id:"191796",title:"Associate Prof.",name:"Nilgun",middleName:null,surname:"Ulutasdemir",slug:"nilgun-ulutasdemir",fullName:"Nilgun Ulutasdemir"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6568",title:"Reflections on Bioethics",subtitle:null,isOpenForSubmission:!1,hash:"8da3f5e7819e769f07a77dc3f0f357c2",slug:"reflections-on-bioethics",bookSignature:"José Antonio Morales-González and María Eugenia Aguilar Nájera",coverURL:"https://cdn.intechopen.com/books/images_new/6568.jpg",editedByType:"Edited by",editors:[{id:"109774",title:"Dr.",name:"Jose Antonio",middleName:null,surname:"Morales-Gonzalez",slug:"jose-antonio-morales-gonzalez",fullName:"Jose Antonio Morales-Gonzalez"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1743",title:"Contemporary Issues in Bioethics",subtitle:null,isOpenForSubmission:!1,hash:"978cee44b901ff59a20a088f7dcfdbc5",slug:"contemporary-issues-in-bioethics",bookSignature:"Peter A. Clark",coverURL:"https://cdn.intechopen.com/books/images_new/1743.jpg",editedByType:"Edited by",editors:[{id:"58889",title:"Dr.",name:"Peter A.",middleName:null,surname:"Clark",slug:"peter-a.-clark",fullName:"Peter A. Clark"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"250",title:"Bioethics in the 21st Century",subtitle:null,isOpenForSubmission:!1,hash:"08402b34b7f530af1fee59d8ad1b976e",slug:"bioethics-in-the-21st-century",bookSignature:"Abraham Rudnick",coverURL:"https://cdn.intechopen.com/books/images_new/250.jpg",editedByType:"Edited by",editors:[{id:"34793",title:"Dr.",name:"Abraham",middleName:null,surname:"Rudnick",slug:"abraham-rudnick",fullName:"Abraham Rudnick"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"498",title:"Global Bioethics",subtitle:"Perspective for Human Survival",isOpenForSubmission:!1,hash:"7b97154fc118995c01d4a14e0f1d1cda",slug:"global-bioethics-perspective-for-human-survival",bookSignature:"Brunetto Chiarelli",coverURL:"https://cdn.intechopen.com/books/images_new/498.jpg",editedByType:"Edited by",editors:[{id:"39651",title:"Prof.",name:"Brunetto",middleName:null,surname:"Chiarelli",slug:"brunetto-chiarelli",fullName:"Brunetto Chiarelli"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"242",title:"Euthanasia",subtitle:'The "Good Death" Controversy in Humans and Animals',isOpenForSubmission:!1,hash:"438ac92607fefc3261b3a36c835fdf04",slug:"euthanasia-the-good-death-controversy-in-humans-and-animals",bookSignature:"Josef Kuře",coverURL:"https://cdn.intechopen.com/books/images_new/242.jpg",editedByType:"Edited by",editors:[{id:"30926",title:"Prof.",name:"Josef",middleName:null,surname:"Kuře",slug:"josef-kure",fullName:"Josef Kuře"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:8,seriesByTopicCollection:[],seriesByTopicTotal:0,mostCitedChapters:[{id:"59779",doi:"10.5772/intechopen.74995",title:"Effective Communication in Nursing",slug:"effective-communication-in-nursing",totalDownloads:9348,totalCrossrefCites:5,totalDimensionsCites:9,abstract:"Nurses are critical in the delivery of essential health services and are core in strengthening the health system. They bring people-centred care closer to the communities where they are needed most, thereby helping improve health outcomes and the overall cost-effectiveness of services. Nurses usually act as first responders to complex humanitarian crises and disasters; protectors and advocates for the community and communicators and co-ordinators within teams. Communication is a core component of sound relationships, collaboration and co-operation, which in turn are essential aspects of professional practice. The quality of communication in interactions between nurses and patients has a major influence on patient outcomes. Increases in nursing communication can lessen medical errors and make a difference in positive patient outcomes. This chapter explores how effective communication and interpersonal skills can enhance professional nursing practice and nursing relationships with various stakeholders. It explains principles of communication, communication process, purpose of communication, types of communication, barriers to effective communication, models of communication and strategies of improving communication and guidelines for successful therapeutic interactions.",book:{id:"6615",slug:"nursing",title:"Nursing",fullTitle:"Nursing"},signatures:"Maureen Nokuthula Sibiya",authors:[{id:"73330",title:"Dr.",name:"Nokuthula",middleName:null,surname:"Sibiya",slug:"nokuthula-sibiya",fullName:"Nokuthula Sibiya"}]},{id:"24279",doi:"10.5772/19684",title:"Speculative Ethics: Valid Enterprise or Tragic Cul-De-Sac?",slug:"speculative-ethics-valid-enterprise-or-tragic-cul-de-sac-",totalDownloads:2511,totalCrossrefCites:8,totalDimensionsCites:9,abstract:null,book:{id:"250",slug:"bioethics-in-the-21st-century",title:"Bioethics in the 21st Century",fullTitle:"Bioethics in the 21st Century"},signatures:"Gareth Jones, Maja Whitaker and Michael King",authors:[{id:"35851",title:"Prof.",name:"Gareth",middleName:null,surname:"Jones",slug:"gareth-jones",fullName:"Gareth Jones"},{id:"47645",title:"Dr",name:"Michael",middleName:"Robert",surname:"King",slug:"michael-king",fullName:"Michael King"},{id:"47646",title:"Mrs.",name:"Maja",middleName:null,surname:"Whitaker",slug:"maja-whitaker",fullName:"Maja Whitaker"}]},{id:"31743",doi:"10.5772/35001",title:"Neuroenhancement - A Controversial Topic in Contemporary Medical Ethics",slug:"neuroenhancement-a-controversial-topic-in-medical-ethics",totalDownloads:3895,totalCrossrefCites:3,totalDimensionsCites:6,abstract:null,book:{id:"1743",slug:"contemporary-issues-in-bioethics",title:"Contemporary Issues in Bioethics",fullTitle:"Contemporary Issues in Bioethics"},signatures:"Kirsten Brukamp and Dominik Gross",authors:[{id:"102555",title:"Dr.",name:"Kirsten",middleName:null,surname:"Brukamp",slug:"kirsten-brukamp",fullName:"Kirsten Brukamp"},{id:"105119",title:"Prof.",name:"Dominik",middleName:null,surname:"Groß",slug:"dominik-gross",fullName:"Dominik Groß"}]},{id:"19610",doi:"10.5772/20184",title:"Euthanasia: A Confounding and Intricate Issue",slug:"euthanasia-a-confounding-and-intricate-issue",totalDownloads:2802,totalCrossrefCites:4,totalDimensionsCites:6,abstract:null,book:{id:"242",slug:"euthanasia-the-good-death-controversy-in-humans-and-animals",title:"Euthanasia",fullTitle:'Euthanasia - The "Good Death" Controversy in Humans and Animals'},signatures:"Isabelle Marcoux",authors:[{id:"37725",title:"Prof.",name:"Isabelle",middleName:null,surname:"Marcoux",slug:"isabelle-marcoux",fullName:"Isabelle Marcoux"}]},{id:"31748",doi:"10.5772/33900",title:"Medical Ethics in Undergraduate Medical Education in Pakistan: Towards a Curricular Change",slug:"medical-ethics-in-undergraduate-medical-education-in-pakistan-towards-a-curricular-change-",totalDownloads:2735,totalCrossrefCites:0,totalDimensionsCites:5,abstract:null,book:{id:"1743",slug:"contemporary-issues-in-bioethics",title:"Contemporary Issues in Bioethics",fullTitle:"Contemporary Issues in Bioethics"},signatures:"Ayesha Shaikh and Naheed Humayun",authors:[{id:"97665",title:"Prof.",name:"Ayesha",middleName:null,surname:"Humayun",slug:"ayesha-humayun",fullName:"Ayesha Humayun"},{id:"104368",title:"Prof.",name:"Naheed",middleName:null,surname:"Humayun",slug:"naheed-humayun",fullName:"Naheed Humayun"}]}],mostDownloadedChaptersLast30Days:[{id:"59779",title:"Effective Communication in Nursing",slug:"effective-communication-in-nursing",totalDownloads:9376,totalCrossrefCites:5,totalDimensionsCites:9,abstract:"Nurses are critical in the delivery of essential health services and are core in strengthening the health system. They bring people-centred care closer to the communities where they are needed most, thereby helping improve health outcomes and the overall cost-effectiveness of services. Nurses usually act as first responders to complex humanitarian crises and disasters; protectors and advocates for the community and communicators and co-ordinators within teams. Communication is a core component of sound relationships, collaboration and co-operation, which in turn are essential aspects of professional practice. The quality of communication in interactions between nurses and patients has a major influence on patient outcomes. Increases in nursing communication can lessen medical errors and make a difference in positive patient outcomes. This chapter explores how effective communication and interpersonal skills can enhance professional nursing practice and nursing relationships with various stakeholders. It explains principles of communication, communication process, purpose of communication, types of communication, barriers to effective communication, models of communication and strategies of improving communication and guidelines for successful therapeutic interactions.",book:{id:"6615",slug:"nursing",title:"Nursing",fullTitle:"Nursing"},signatures:"Maureen Nokuthula Sibiya",authors:[{id:"73330",title:"Dr.",name:"Nokuthula",middleName:null,surname:"Sibiya",slug:"nokuthula-sibiya",fullName:"Nokuthula Sibiya"}]},{id:"19615",title:"Everything Under Control: How and When to Die - A Critical Analysis of the Arguments for Euthanasia",slug:"everything-under-control-how-and-when-to-die-a-critical-analysis-of-the-arguments-for-euthanasia",totalDownloads:6532,totalCrossrefCites:0,totalDimensionsCites:0,abstract:null,book:{id:"242",slug:"euthanasia-the-good-death-controversy-in-humans-and-animals",title:"Euthanasia",fullTitle:'Euthanasia - The "Good Death" Controversy in Humans and Animals'},signatures:"Josef Kuře",authors:[{id:"30926",title:"Prof.",name:"Josef",middleName:null,surname:"Kuře",slug:"josef-kure",fullName:"Josef Kuře"}]},{id:"19620",title:"Debate For and Against Euthanasia in the Control of Dog Populations",slug:"debate-for-and-against-euthanasia-in-the-control-of-dog-populations",totalDownloads:12530,totalCrossrefCites:0,totalDimensionsCites:2,abstract:null,book:{id:"242",slug:"euthanasia-the-good-death-controversy-in-humans-and-animals",title:"Euthanasia",fullTitle:'Euthanasia - The "Good Death" Controversy in Humans and Animals'},signatures:"Antonio Ortega-Pacheco and Matilde Jiménez-Coello",authors:[{id:"30340",title:"Dr.",name:"Matilde",middleName:null,surname:"Jimenez-Coello",slug:"matilde-jimenez-coello",fullName:"Matilde Jimenez-Coello"},{id:"30393",title:"Dr.",name:"Antonio",middleName:null,surname:"Ortega-Pacheco",slug:"antonio-ortega-pacheco",fullName:"Antonio Ortega-Pacheco"}]},{id:"61494",title:"Transcultural Nursing",slug:"transcultural-nursing",totalDownloads:2646,totalCrossrefCites:3,totalDimensionsCites:3,abstract:"Culture is defined as the sum of all the material and spiritual values created in the process of social development and the tools that are used to create and hand these values down to next generations and show the extent of the man’s authority and control over their natural and social environment. The term “culture”, which diversifies in each community and so is experienced differently, also affects the way individuals perceive the phenomena such as health, illness, happiness, sadness and the manner these emotions are experienced. The term health, whose nature and meaning is highly variable across different cultures requires care involving cultural recognition, valueing and practice. The nursing profession, which plays an important role in the health team, is often based on a cultural phenomenon. The cultural values, beliefs and practices of the patient are an integral part of holistic nursing care. The aim of nursing is to provide a wholly caring and humanistic service respecting people’s cultural values and lifestyles. Nurses should offer an acceptable and affordable care for the individuals under the conditions of the day. Knowing what cultural practices are done in the target communities and identifying the cultural barriers to offering quality health care positively affects the caring process. Nurses should explore new ways of providing cultural care in multicultural societies, understand how culture affects health-illness definitions and build a bridge for the gap between the caring process and the individuals in different cultures.",book:{id:"6615",slug:"nursing",title:"Nursing",fullTitle:"Nursing"},signatures:"Vasfiye Bayram Değer",authors:[{id:"228268",title:"Dr.",name:"Vasfiye",middleName:null,surname:"Bayram Değer",slug:"vasfiye-bayram-deger",fullName:"Vasfiye Bayram Değer"}]},{id:"72954",title:"Value-Based Healthcare",slug:"value-based-healthcare",totalDownloads:821,totalCrossrefCites:0,totalDimensionsCites:1,abstract:"Value-based healthcare is a new health-care model in which what is important is value to the patient. Value is a broad term, but in essence, it is the best outcome for the patient per dollar spent. To provide value to the patient, the medical practice should be centered around conditions and care cycles and the results must be measured. We now know that the model we have right now, the fee-for-service model, is not linked to quality of the patient. All around the world, many hospitals and clinics are making the transition to this value-based model. To provide the best for the patient, we must have the best medical evidence to follow. In the following chapter, we will cover a few aspects of value-based healthcare, its reimbursement model, the integrated practice units, and the information technology necessary to implement it.",book:{id:"9566",slug:"bioethics-in-medicine-and-society",title:"Bioethics in Medicine and Society",fullTitle:"Bioethics in Medicine and Society"},signatures:"Patrick Rech Ramos",authors:[{id:"321359",title:"Dr.",name:"Patrick",middleName:"Rech",surname:"Rech Ramos",slug:"patrick-rech-ramos",fullName:"Patrick Rech Ramos"}]}],onlineFirstChaptersFilter:{topicId:"167",limit:6,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},subscriptionForm:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[],offset:0,limit:8,total:null},allSeries:{pteSeriesList:[{id:"14",title:"Artificial Intelligence",numberOfPublishedBooks:9,numberOfPublishedChapters:87,numberOfOpenTopics:6,numberOfUpcomingTopics:0,issn:"2633-1403",doi:"10.5772/intechopen.79920",isOpenForSubmission:!0},{id:"7",title:"Biomedical Engineering",numberOfPublishedBooks:12,numberOfPublishedChapters:98,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2631-5343",doi:"10.5772/intechopen.71985",isOpenForSubmission:!0}],lsSeriesList:[{id:"11",title:"Biochemistry",numberOfPublishedBooks:27,numberOfPublishedChapters:287,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2632-0983",doi:"10.5772/intechopen.72877",isOpenForSubmission:!0},{id:"25",title:"Environmental Sciences",numberOfPublishedBooks:1,numberOfPublishedChapters:9,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2754-6713",doi:"10.5772/intechopen.100362",isOpenForSubmission:!0},{id:"10",title:"Physiology",numberOfPublishedBooks:11,numberOfPublishedChapters:139,numberOfOpenTopics:4,numberOfUpcomingTopics:0,issn:"2631-8261",doi:"10.5772/intechopen.72796",isOpenForSubmission:!0}],hsSeriesList:[{id:"3",title:"Dentistry",numberOfPublishedBooks:8,numberOfPublishedChapters:129,numberOfOpenTopics:0,numberOfUpcomingTopics:2,issn:"2631-6218",doi:"10.5772/intechopen.71199",isOpenForSubmission:!1},{id:"6",title:"Infectious Diseases",numberOfPublishedBooks:13,numberOfPublishedChapters:106,numberOfOpenTopics:3,numberOfUpcomingTopics:1,issn:"2631-6188",doi:"10.5772/intechopen.71852",isOpenForSubmission:!0},{id:"13",title:"Veterinary Medicine and Science",numberOfPublishedBooks:10,numberOfPublishedChapters:103,numberOfOpenTopics:3,numberOfUpcomingTopics:0,issn:"2632-0517",doi:"10.5772/intechopen.73681",isOpenForSubmission:!0}],sshSeriesList:[{id:"22",title:"Business, Management and Economics",numberOfPublishedBooks:1,numberOfPublishedChapters:12,numberOfOpenTopics:2,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100359",isOpenForSubmission:!0},{id:"23",title:"Education and Human Development",numberOfPublishedBooks:0,numberOfPublishedChapters:0,numberOfOpenTopics:2,numberOfUpcomingTopics:0,issn:null,doi:"10.5772/intechopen.100360",isOpenForSubmission:!1},{id:"24",title:"Sustainable Development",numberOfPublishedBooks:0,numberOfPublishedChapters:9,numberOfOpenTopics:4,numberOfUpcomingTopics:1,issn:null,doi:"10.5772/intechopen.100361",isOpenForSubmission:!0}],testimonialsList:[{id:"13",text:"The collaboration with and support of the technical staff of IntechOpen is fantastic. The whole process of submitting an article and editing of the submitted article goes extremely smooth and fast, the number of reads and downloads of chapters is high, and the contributions are also frequently cited.",author:{id:"55578",name:"Antonio",surname:"Jurado-Navas",institutionString:null,profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRisIQAS/Profile_Picture_1626166543950",slug:"antonio-jurado-navas",institution:{id:"720",name:"University of Malaga",country:{id:null,name:"Spain"}}}},{id:"6",text:"It is great to work with the IntechOpen to produce a worthwhile collection of research that also becomes a great educational resource and guide for future research endeavors.",author:{id:"259298",name:"Edward",surname:"Narayan",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/259298/images/system/259298.jpeg",slug:"edward-narayan",institution:{id:"3",name:"University of Queensland",country:{id:null,name:"Australia"}}}}]},series:{item:{id:"11",title:"Biochemistry",doi:"10.5772/intechopen.72877",issn:"2632-0983",scope:"Biochemistry, the study of chemical transformations occurring within living organisms, impacts all areas of life sciences, from molecular crystallography and genetics to ecology, medicine, and population biology. Biochemistry examines macromolecules - proteins, nucleic acids, carbohydrates, and lipids – and their building blocks, structures, functions, and interactions. Much of biochemistry is devoted to enzymes, proteins that catalyze chemical reactions, enzyme structures, mechanisms of action and their roles within cells. Biochemistry also studies small signaling molecules, coenzymes, inhibitors, vitamins, and hormones, which play roles in life processes. Biochemical experimentation, besides coopting classical chemistry methods, e.g., chromatography, adopted new techniques, e.g., X-ray diffraction, electron microscopy, NMR, radioisotopes, and developed sophisticated microbial genetic tools, e.g., auxotroph mutants and their revertants, fermentation, etc. More recently, biochemistry embraced the ‘big data’ omics systems. Initial biochemical studies have been exclusively analytic: dissecting, purifying, and examining individual components of a biological system; in the apt words of Efraim Racker (1913 –1991), “Don’t waste clean thinking on dirty enzymes.” Today, however, biochemistry is becoming more agglomerative and comprehensive, setting out to integrate and describe entirely particular biological systems. The ‘big data’ metabolomics can define the complement of small molecules, e.g., in a soil or biofilm sample; proteomics can distinguish all the comprising proteins, e.g., serum; metagenomics can identify all the genes in a complex environment, e.g., the bovine rumen. This Biochemistry Series will address the current research on biomolecules and the emerging trends with great promise.",coverUrl:"https://cdn.intechopen.com/series/covers/11.jpg",latestPublicationDate:"May 18th, 2022",hasOnlineFirst:!0,numberOfPublishedBooks:27,editor:{id:"31610",title:"Dr.",name:"Miroslav",middleName:null,surname:"Blumenberg",slug:"miroslav-blumenberg",fullName:"Miroslav Blumenberg",profilePictureURL:"https://mts.intechopen.com/storage/users/31610/images/system/31610.jpg",biography:"Miroslav Blumenberg, Ph.D., was born in Subotica and received his BSc in Belgrade, Yugoslavia. He completed his Ph.D. at MIT in Organic Chemistry; he followed up his Ph.D. with two postdoctoral study periods at Stanford University. Since 1983, he has been a faculty member of the RO Perelman Department of Dermatology, NYU School of Medicine, where he is codirector of a training grant in cutaneous biology. Dr. Blumenberg’s research is focused on the epidermis, expression of keratin genes, transcription profiling, keratinocyte differentiation, inflammatory diseases and cancers, and most recently the effects of the microbiome on the skin. He has published more than 100 peer-reviewed research articles and graduated numerous Ph.D. and postdoctoral students.",institutionString:null,institution:{name:"New York University Langone Medical Center",institutionURL:null,country:{name:"United States of America"}}},editorTwo:null,editorThree:null},subseries:{paginationCount:4,paginationItems:[{id:"14",title:"Cell and Molecular Biology",coverUrl:"https://cdn.intechopen.com/series_topics/covers/14.jpg",isOpenForSubmission:!0,editor:{id:"165627",title:"Dr.",name:"Rosa María",middleName:null,surname:"Martínez-Espinosa",slug:"rosa-maria-martinez-espinosa",fullName:"Rosa María Martínez-Espinosa",profilePictureURL:"https://mts.intechopen.com/storage/users/165627/images/system/165627.jpeg",biography:"Dr. Rosa María Martínez-Espinosa has been a Spanish Full Professor since 2020 (Biochemistry and Molecular Biology) and is currently Vice-President of International Relations and Cooperation development and leader of the research group 'Applied Biochemistry” (University of Alicante, Spain). Other positions she has held at the university include Vice-Dean of Master Programs, Vice-Dean of the Degree in Biology and Vice-Dean for Mobility and Enterprise and Engagement at the Faculty of Science (University of Alicante). She received her Bachelor in Biology in 1998 (University of Alicante) and her PhD in 2003 (Biochemistry, University of Alicante). She undertook post-doctoral research at the University of East Anglia (Norwich, U.K. 2004-2005; 2007-2008).\nHer multidisciplinary research focuses on investigating archaea and their potential applications in biotechnology. She has an H-index of 21. She has authored one patent and has published more than 70 indexed papers and around 60 book chapters.\nShe has contributed to more than 150 national and international meetings during the last 15 years. Her research interests include archaea metabolism, enzymes purification and characterization, gene regulation, carotenoids and bioplastics production, antioxidant\ncompounds, waste water treatments, and brines bioremediation.\nRosa María’s other roles include editorial board member for several journals related\nto biochemistry, reviewer for more than 60 journals (biochemistry, molecular biology, biotechnology, chemistry and microbiology) and president of several organizing committees in international meetings related to the N-cycle or respiratory processes.",institutionString:null,institution:{name:"University of Alicante",institutionURL:null,country:{name:"Spain"}}},editorTwo:null,editorThree:null},{id:"15",title:"Chemical Biology",coverUrl:"https://cdn.intechopen.com/series_topics/covers/15.jpg",isOpenForSubmission:!0,editor:{id:"441442",title:"Dr.",name:"Şükrü",middleName:null,surname:"Beydemir",slug:"sukru-beydemir",fullName:"Şükrü Beydemir",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y00003GsUoIQAV/Profile_Picture_1634557147521",biography:"Dr. Şükrü Beydemir obtained a BSc in Chemistry in 1995 from Yüzüncü Yıl University, MSc in Biochemistry in 1998, and PhD in Biochemistry in 2002 from Atatürk University, Turkey. He performed post-doctoral studies at Max-Planck Institute, Germany, and University of Florence, Italy in addition to making several scientific visits abroad. He currently works as a Full Professor of Biochemistry in the Faculty of Pharmacy, Anadolu University, Turkey. Dr. Beydemir has published over a hundred scientific papers spanning protein biochemistry, enzymology and medicinal chemistry, reviews, book chapters and presented several conferences to scientists worldwide. He has received numerous publication awards from various international scientific councils. He serves in the Editorial Board of several international journals. Dr. Beydemir is also Rector of Bilecik Şeyh Edebali University, Turkey.",institutionString:null,institution:{name:"Anadolu University",institutionURL:null,country:{name:"Turkey"}}},editorTwo:{id:"13652",title:"Prof.",name:"Deniz",middleName:null,surname:"Ekinci",slug:"deniz-ekinci",fullName:"Deniz Ekinci",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002aYLT1QAO/Profile_Picture_1634557223079",biography:"Dr. Deniz Ekinci obtained a BSc in Chemistry in 2004, MSc in Biochemistry in 2006, and PhD in Biochemistry in 2009 from Atatürk University, Turkey. He studied at Stetson University, USA, in 2007-2008 and at the Max Planck Institute of Molecular Cell Biology and Genetics, Germany, in 2009-2010. Dr. Ekinci currently works as a Full Professor of Biochemistry in the Faculty of Agriculture and is the Head of the Enzyme and Microbial Biotechnology Division, Ondokuz Mayıs University, Turkey. He is a member of the Turkish Biochemical Society, American Chemical Society, and German Genetics society. Dr. Ekinci published around ninety scientific papers, reviews and book chapters, and presented several conferences to scientists. He has received numerous publication awards from several scientific councils. Dr. Ekinci serves as the Editor in Chief of four international books and is involved in the Editorial Board of several international journals.",institutionString:null,institution:{name:"Ondokuz Mayıs University",institutionURL:null,country:{name:"Turkey"}}},editorThree:null},{id:"17",title:"Metabolism",coverUrl:"https://cdn.intechopen.com/series_topics/covers/17.jpg",isOpenForSubmission:!0,editor:{id:"138626",title:"Dr.",name:"Yannis",middleName:null,surname:"Karamanos",slug:"yannis-karamanos",fullName:"Yannis Karamanos",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002g6Jv2QAE/Profile_Picture_1629356660984",biography:"Yannis Karamanos, born in Greece in 1953, completed his pre-graduate studies at the Université Pierre et Marie Curie, Paris, then his Masters and Doctoral degree at the Université de Lille (1983). He was associate professor at the University of Limoges (1987) before becoming full professor of biochemistry at the Université d’Artois (1996). He worked on the structure-function relationships of glycoconjugates and his main project was the investigations on the biological roles of the de-N-glycosylation enzymes (Endo-N-acetyl-β-D-glucosaminidase and peptide-N4-(N-acetyl-β-glucosaminyl) asparagine amidase). From 2002 he contributes to the understanding of the Blood-brain barrier functioning using proteomics approaches. He has published more than 70 papers. His teaching areas are energy metabolism and regulation, integration and organ specialization and metabolic adaptation.",institutionString:null,institution:{name:"Artois University",institutionURL:null,country:{name:"France"}}},editorTwo:null,editorThree:null},{id:"18",title:"Proteomics",coverUrl:"https://cdn.intechopen.com/series_topics/covers/18.jpg",isOpenForSubmission:!0,editor:{id:"200689",title:"Prof.",name:"Paolo",middleName:null,surname:"Iadarola",slug:"paolo-iadarola",fullName:"Paolo Iadarola",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bSCl8QAG/Profile_Picture_1623568118342",biography:"Paolo Iadarola graduated with a degree in Chemistry from the University of Pavia (Italy) in July 1972. He then worked as an Assistant Professor at the Faculty of Science of the same University until 1984. In 1985, Prof. Iadarola became Associate Professor at the Department of Biology and Biotechnologies of the University of Pavia and retired in October 2017. Since then, he has been working as an Adjunct Professor in the same Department at the University of Pavia. His research activity during the first years was primarily focused on the purification and structural characterization of enzymes from animal and plant sources. During this period, Prof. Iadarola familiarized himself with the conventional techniques used in column chromatography, spectrophotometry, manual Edman degradation, and electrophoresis). Since 1995, he has been working on: i) the determination in biological fluids (serum, urine, bronchoalveolar lavage, sputum) of proteolytic activities involved in the degradation processes of connective tissue matrix, and ii) on the identification of biological markers of lung diseases. In this context, he has developed and validated new methodologies (e.g., Capillary Electrophoresis coupled to Laser-Induced Fluorescence, CE-LIF) whose application enabled him to determine both the amounts of biochemical markers (Desmosines) in urine/serum of patients affected by Chronic Obstructive Pulmonary Disease (COPD) and the activity of proteolytic enzymes (Human Neutrophil Elastase, Cathepsin G, Pseudomonas aeruginosa elastase) in sputa of these patients. More recently, Prof. Iadarola was involved in developing techniques such as two-dimensional electrophoresis coupled to liquid chromatography/mass spectrometry (2DE-LC/MS) for the proteomic analysis of biological fluids aimed at the identification of potential biomarkers of different lung diseases. He is the author of about 150 publications (According to Scopus: H-Index: 23; Total citations: 1568- According to WOS: H-Index: 20; Total Citations: 1296) of peer-reviewed international journals. He is a Consultant Reviewer for several journals, including the Journal of Chromatography A, Journal of Chromatography B, Plos ONE, Proteomes, International Journal of Molecular Science, Biotech, Electrophoresis, and others. He is also Associate Editor of Biotech.",institutionString:null,institution:{name:"University of Pavia",institutionURL:null,country:{name:"Italy"}}},editorTwo:{id:"201414",title:"Dr.",name:"Simona",middleName:null,surname:"Viglio",slug:"simona-viglio",fullName:"Simona Viglio",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRKDHQA4/Profile_Picture_1630402531487",biography:"Simona Viglio is an Associate Professor of Biochemistry at the Department of Molecular Medicine at the University of Pavia. She has been working since 1995 on the determination of proteolytic enzymes involved in the degradation process of connective tissue matrix and on the identification of biological markers of lung diseases. She gained considerable experience in developing and validating new methodologies whose applications allowed her to determine both the amount of biomarkers (Desmosine and Isodesmosine) in the urine of patients affected by COPD, and the activity of proteolytic enzymes (HNE, Cathepsin G, Pseudomonas aeruginosa elastase) in the sputa of these patients. Simona Viglio was also involved in research dealing with the supplementation of amino acids in patients with brain injury and chronic heart failure. She is presently engaged in the development of 2-DE and LC-MS techniques for the study of proteomics in biological fluids. The aim of this research is the identification of potential biomarkers of lung diseases. She is an author of about 90 publications (According to Scopus: H-Index: 23; According to WOS: H-Index: 20) on peer-reviewed journals, a member of the “Società Italiana di Biochimica e Biologia Molecolare,“ and a Consultant Reviewer for International Journal of Molecular Science, Journal of Chromatography A, COPD, Plos ONE and Nutritional Neuroscience.",institutionString:null,institution:{name:"University of Pavia",institutionURL:null,country:{name:"Italy"}}},editorThree:null}]},overviewPageOFChapters:{paginationCount:49,paginationItems:[{id:"80495",title:"Iron in Cell Metabolism and Disease",doi:"10.5772/intechopen.101908",signatures:"Eeka Prabhakar",slug:"iron-in-cell-metabolism-and-disease",totalDownloads:1,totalCrossrefCites:0,totalDimensionsCites:null,authors:null,book:{title:"Iron Metabolism - Iron a Double‐Edged Sword",coverURL:"https://cdn.intechopen.com/books/images_new/10842.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"81799",title:"Cross Talk of Purinergic and Immune Signaling: Implication in Inflammatory and Pathogenic Diseases",doi:"10.5772/intechopen.104978",signatures:"Richa Rai",slug:"cross-talk-of-purinergic-and-immune-signaling-implication-in-inflammatory-and-pathogenic-diseases",totalDownloads:7,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Purinergic System",coverURL:"https://cdn.intechopen.com/books/images_new/10801.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"81764",title:"Involvement of the Purinergic System in Cell Death in Models of Retinopathies",doi:"10.5772/intechopen.103935",signatures:"Douglas Penaforte Cruz, Marinna Garcia Repossi and Lucianne Fragel Madeira",slug:"involvement-of-the-purinergic-system-in-cell-death-in-models-of-retinopathies",totalDownloads:4,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Purinergic System",coverURL:"https://cdn.intechopen.com/books/images_new/10801.jpg",subseries:{id:"17",title:"Metabolism"}}},{id:"81756",title:"Alteration of Cytokines Level and Oxidative Stress Parameters in COVID-19",doi:"10.5772/intechopen.104950",signatures:"Marija Petrusevska, Emilija Atanasovska, Dragica Zendelovska, Aleksandar Eftimov and Katerina Spasovska",slug:"alteration-of-cytokines-level-and-oxidative-stress-parameters-in-covid-19",totalDownloads:8,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Chemokines Updates",coverURL:"https://cdn.intechopen.com/books/images_new/11672.jpg",subseries:{id:"18",title:"Proteomics"}}}]},overviewPagePublishedBooks:{paginationCount:27,paginationItems:[{type:"book",id:"7006",title:"Biochemistry and Health Benefits of Fatty Acids",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7006.jpg",slug:"biochemistry-and-health-benefits-of-fatty-acids",publishedDate:"December 19th 2018",editedByType:"Edited by",bookSignature:"Viduranga Waisundara",hash:"c93a00abd68b5eba67e5e719f67fd20b",volumeInSeries:1,fullTitle:"Biochemistry and Health Benefits of Fatty Acids",editors:[{id:"194281",title:"Dr.",name:"Viduranga Y.",middleName:null,surname:"Waisundara",slug:"viduranga-y.-waisundara",fullName:"Viduranga Y. Waisundara",profilePictureURL:"https://mts.intechopen.com/storage/users/194281/images/system/194281.jpg",biography:"Dr. Viduranga Waisundara obtained her Ph.D. in Food Science and Technology from the Department of Chemistry, National University of Singapore, in 2010. She was a lecturer at Temasek Polytechnic, Singapore from July 2009 to March 2013. She relocated to her motherland of Sri Lanka and spearheaded the Functional Food Product Development Project at the National Institute of Fundamental Studies from April 2013 to October 2016. She was a senior lecturer on a temporary basis at the Department of Food Technology, Faculty of Technology, Rajarata University of Sri Lanka. She is currently Deputy Principal of the Australian College of Business and Technology – Kandy Campus, Sri Lanka. She is also the Global Harmonization Initiative (GHI) Ambassador to Sri Lanka.",institutionString:"Australian College of Business & Technology",institution:null}]},{type:"book",id:"6820",title:"Keratin",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/6820.jpg",slug:"keratin",publishedDate:"December 19th 2018",editedByType:"Edited by",bookSignature:"Miroslav Blumenberg",hash:"6def75cd4b6b5324a02b6dc0359896d0",volumeInSeries:2,fullTitle:"Keratin",editors:[{id:"31610",title:"Dr.",name:"Miroslav",middleName:null,surname:"Blumenberg",slug:"miroslav-blumenberg",fullName:"Miroslav Blumenberg",profilePictureURL:"https://mts.intechopen.com/storage/users/31610/images/system/31610.jpg",biography:"Miroslav Blumenberg, Ph.D., was born in Subotica and received his BSc in Belgrade, Yugoslavia. He completed his Ph.D. at MIT in Organic Chemistry; he followed up his Ph.D. with two postdoctoral study periods at Stanford University. Since 1983, he has been a faculty member of the RO Perelman Department of Dermatology, NYU School of Medicine, where he is codirector of a training grant in cutaneous biology. Dr. Blumenberg’s research is focused on the epidermis, expression of keratin genes, transcription profiling, keratinocyte differentiation, inflammatory diseases and cancers, and most recently the effects of the microbiome on the skin. He has published more than 100 peer-reviewed research articles and graduated numerous Ph.D. and postdoctoral students.",institutionString:null,institution:{name:"New York University Langone Medical Center",institutionURL:null,country:{name:"United States of America"}}}]},{type:"book",id:"7978",title:"Vitamin A",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7978.jpg",slug:"vitamin-a",publishedDate:"May 15th 2019",editedByType:"Edited by",bookSignature:"Leila Queiroz Zepka, Veridiana Vera de Rosso and Eduardo Jacob-Lopes",hash:"dad04a658ab9e3d851d23705980a688b",volumeInSeries:3,fullTitle:"Vitamin A",editors:[{id:"261969",title:"Dr.",name:"Leila",middleName:null,surname:"Queiroz Zepka",slug:"leila-queiroz-zepka",fullName:"Leila Queiroz Zepka",profilePictureURL:"https://mts.intechopen.com/storage/users/261969/images/system/261969.png",biography:"Prof. Dr. Leila Queiroz Zepka is currently an associate professor in the Department of Food Technology and Science, Federal University of Santa Maria, Brazil. She has more than fifteen years of teaching and research experience. She has published more than 550 scientific publications/communications, including 15 books, 50 book chapters, 100 original research papers, 380 research communications in national and international conferences, and 12 patents. She is a member of the editorial board of five journals and acts as a reviewer for several national and international journals. Her research interests include microalgal biotechnology with an emphasis on microalgae-based products.",institutionString:"Universidade Federal de Santa Maria",institution:{name:"Universidade Federal de Santa Maria",institutionURL:null,country:{name:"Brazil"}}}]},{type:"book",id:"7953",title:"Bioluminescence",subtitle:"Analytical Applications and Basic Biology",coverURL:"https://cdn.intechopen.com/books/images_new/7953.jpg",slug:"bioluminescence-analytical-applications-and-basic-biology",publishedDate:"September 25th 2019",editedByType:"Edited by",bookSignature:"Hirobumi Suzuki",hash:"3a8efa00b71abea11bf01973dc589979",volumeInSeries:4,fullTitle:"Bioluminescence - Analytical Applications and Basic Biology",editors:[{id:"185746",title:"Dr.",name:"Hirobumi",middleName:null,surname:"Suzuki",slug:"hirobumi-suzuki",fullName:"Hirobumi Suzuki",profilePictureURL:"https://mts.intechopen.com/storage/users/185746/images/system/185746.png",biography:"Dr. Hirobumi Suzuki received his Ph.D. in 1997 from Tokyo Metropolitan University, Japan, where he studied firefly phylogeny and the evolution of mating systems. He is especially interested in the genetic differentiation pattern and speciation process that correlate to the flashing pattern and mating behavior of some fireflies in Japan. He then worked for Olympus Corporation, a Japanese manufacturer of optics and imaging products, where he was involved in the development of luminescence technology and produced a bioluminescence microscope that is currently being used for gene expression analysis in chronobiology, neurobiology, and developmental biology. Dr. Suzuki currently serves as a visiting researcher at Kogakuin University, Japan, and also a vice president of the Japan Firefly Society.",institutionString:"Kogakuin University",institution:null}]}]},openForSubmissionBooks:{},onlineFirstChapters:{},subseriesFiltersForOFChapters:[],publishedBooks:{},subseriesFiltersForPublishedBooks:[],publicationYearFilters:[],authors:{}},subseries:{item:{id:"40",type:"subseries",title:"Ecosystems and Biodiversity",keywords:"Ecosystems, Biodiversity, Fauna, Taxonomy, Invasive species, Destruction of habitats, Overexploitation of natural resources, Pollution, Global warming, Conservation of natural spaces, Bioremediation",scope:"
\r\n\tIn general, the harsher the environmental conditions in an ecosystem, the lower the biodiversity. Changes in the environment caused by human activity accelerate the impoverishment of biodiversity.
\r\n
\r\n\tBiodiversity refers to “the variability of living organisms from any source, including terrestrial, marine and other aquatic ecosystems and the ecological complexes of which they are part; it includes diversity within each species, between species, and that of ecosystems”.
\r\n
\r\n\tBiodiversity provides food security and constitutes a gene pool for biotechnology, especially in the field of agriculture and medicine, and promotes the development of ecotourism.
\r\n
\r\n\tCurrently, biologists admit that we are witnessing the first phases of the seventh mass extinction caused by human intervention. It is estimated that the current rate of extinction is between a hundred and a thousand times faster than it was when man first appeared. The disappearance of species is caused not only by an accelerated rate of extinction, but also by a decrease in the rate of emergence of new species as human activities degrade the natural environment. The conservation of biological diversity is "a common concern of humanity" and an integral part of the development process. Its objectives are “the conservation of biological diversity, the sustainable use of its components, and the fair and equitable sharing of the benefits resulting from the use of genetic resources”.
\r\n
\r\n\tThe following are the main causes of biodiversity loss:
\r\n
\r\n\t• The destruction of natural habitats to expand urban and agricultural areas and to obtain timber, minerals and other natural resources.
\r\n
\r\n\t• The introduction of alien species into a habitat, whether intentionally or unintentionally which has an impact on the fauna and flora of the area, and as a result, they are reduced or become extinct.
\r\n
\r\n\t• Pollution from industrial and agricultural products, which devastate the fauna and flora, especially those in fresh water.
\r\n
\r\n\t• Global warming, which is seen as a threat to biological diversity, and will become increasingly important in the future.
",coverUrl:"https://cdn.intechopen.com/series_topics/covers/40.jpg",hasOnlineFirst:!1,hasPublishedBooks:!1,annualVolume:11968,editor:{id:"209149",title:"Prof.",name:"Salustiano",middleName:null,surname:"Mato",slug:"salustiano-mato",fullName:"Salustiano Mato",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRLREQA4/Profile_Picture_2022-03-31T10:23:50.png",biography:"Salustiano Mato de la Iglesia (Santiago de Compostela, 1960) is a doctor in biology from the University of Santiago and a Professor of zoology at the Department of Ecology and Animal Biology at the University of Vigo. He has developed his research activity in the fields of fauna and soil ecology, and in the treatment of organic waste, having been the founder and principal investigator of the Environmental Biotechnology Group of the University of Vigo.\r\nHis research activity in the field of Environmental Biotechnology has been focused on the development of novel organic waste treatment systems through composting. The result of this line of work are three invention patents and various scientific and technical publications in prestigious international journals.",institutionString:null,institution:{name:"University of Vigo",institutionURL:null,country:{name:"Spain"}}},editorTwo:{id:"60498",title:"Prof.",name:"Josefina",middleName:null,surname:"Garrido",slug:"josefina-garrido",fullName:"Josefina Garrido",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRj1VQAS/Profile_Picture_2022-03-31T10:06:51.jpg",biography:"Josefina Garrido González (Paradela de Abeleda, Ourense 1959), is a doctor in biology from the University of León and a Professor of Zoology at the Department of Ecology and Animal Biology at the University of Vigo. She has focused her research activity on the taxonomy, fauna and ecology of aquatic beetles, in addition to other lines of research such as the conservation of biodiversity in freshwater ecosystems; conservation of protected areas (Red Natura 2000) and assessment of the effectiveness of wetlands as priority areas for the conservation of aquatic invertebrates; studies of water quality in freshwater ecosystems through biological indicators and physicochemical parameters; surveillance and research of vector arthropods and invasive alien species.",institutionString:null,institution:{name:"University of Vigo",institutionURL:null,country:{name:"Spain"}}},editorThree:{id:"464288",title:"Dr.",name:"Francisco",middleName:null,surname:"Ramil",slug:"francisco-ramil",fullName:"Francisco Ramil",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0033Y00003RI7lHQAT/Profile_Picture_2022-03-31T10:15:35.png",biography:"Fran Ramil Blanco (Porto de Espasante, A Coruña, 1960), is a doctor in biology from the University of Santiago de Compostela and a Professor of Zoology at the Department of Ecology and Animal Biology at the University of Vigo. His research activity is linked to the taxonomy, fauna and ecology of marine benthic invertebrates and especially the Cnidarian group. Since 2004, he has been part of the EcoAfrik project, aimed at the study, protection and conservation of biodiversity and benthic habitats in West Africa. He also participated in the study of vulnerable marine ecosystems associated with seamounts in the South Atlantic and is involved in training young African researchers in the field of marine research.",institutionString:null,institution:{name:"University of Vigo",institutionURL:null,country:{name:"Spain"}}},series:{id:"25",title:"Environmental Sciences",doi:"10.5772/intechopen.100362",issn:"2754-6713"},editorialBoard:[{id:"220987",title:"Dr.",name:"António",middleName:"Onofre",surname:"Soares",slug:"antonio-soares",fullName:"António Soares",profilePictureURL:"https://s3.us-east-1.amazonaws.com/intech-files/0030O00002bRNtzQAG/Profile_Picture_1644499672340",institutionString:null,institution:{name:"University of the Azores",institutionURL:null,country:{name:"Portugal"}}}]},onlineFirstChapters:{paginationCount:17,paginationItems:[{id:"81647",title:"Diabetes and Epigenetics",doi:"10.5772/intechopen.104653",signatures:"Rasha A. Alhazzaa, Thomas Heinbockel and Antonei B. Csoka",slug:"diabetes-and-epigenetics",totalDownloads:10,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Epigenetics to Optogenetics - A New Paradigm in the Study of Biology",coverURL:"https://cdn.intechopen.com/books/images_new/9672.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"81099",title:"SK Channels and Heart Disease",doi:"10.5772/intechopen.104115",signatures:"Katherine Zhong, Shawn Kant, Frank Sellke and Jun Feng",slug:"sk-channels-and-heart-disease",totalDownloads:16,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Ion Channels - From Basic Properties to Medical Treatment",coverURL:"https://cdn.intechopen.com/books/images_new/10838.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"80967",title:"Hot on the Trail of Skin Inflammation: Focus on TRPV1/TRPV3 Channels in Psoriasis",doi:"10.5772/intechopen.103792",signatures:"Lisa S. Martin, Emma Fraillon, Fabien P. Chevalier and Bérengère Fromy",slug:"hot-on-the-trail-of-skin-inflammation-focus-on-trpv1-trpv3-channels-in-psoriasis",totalDownloads:24,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Ion Channels - From Basic Properties to Medical Treatment",coverURL:"https://cdn.intechopen.com/books/images_new/10838.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"80952",title:"TRPV Family Ion Channels in the Mammary Epithelium: Role in Normal Tissue Homeostasis and along Breast Cancer Progression",doi:"10.5772/intechopen.103665",signatures:"Sari Susanna Tojkander",slug:"trpv-family-ion-channels-in-the-mammary-epithelium-role-in-normal-tissue-homeostasis-and-along-breas",totalDownloads:17,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Ion Channels - From Basic Properties to Medical Treatment",coverURL:"https://cdn.intechopen.com/books/images_new/10838.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"80484",title:"The Use of Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) to Study Ivermectin-Mediated Molecular Pathway Changes in Human Ovarian Cancer Cells",doi:"10.5772/intechopen.102092",signatures:"Na Li and Xianquan Zhan",slug:"the-use-of-stable-isotope-labeling-with-amino-acids-in-cell-culture-silac-to-study-ivermectin-mediat",totalDownloads:78,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Cell Culture - Advanced Technology and Applications in Medical and Life Sciences",coverURL:"https://cdn.intechopen.com/books/images_new/10797.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"80157",title:"Structural Determinants for Ligand Accommodation in Voltage Sensors",doi:"10.5772/intechopen.102094",signatures:"Abigail García-Morales, Aylin López-Palestino and Daniel Balleza",slug:"structural-determinants-for-ligand-accommodation-in-voltage-sensors",totalDownloads:86,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Ion Channels - From Basic Properties to Medical Treatment",coverURL:"https://cdn.intechopen.com/books/images_new/10838.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"79690",title:"Mitochondrial Channels and their Role in Cardioprotection",doi:"10.5772/intechopen.101127",signatures:"Keerti Mishra and Min Luo",slug:"mitochondrial-channels-and-their-role-in-cardioprotection",totalDownloads:84,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Ion Channels - From Basic Properties to Medical Treatment",coverURL:"https://cdn.intechopen.com/books/images_new/10838.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"79031",title:"Isolation and Expansion of Mesenchymal Stem/Stromal Cells, Functional Assays and Long-Term Culture Associated Alterations of Cellular Properties",doi:"10.5772/intechopen.100286",signatures:"Chenghai Li",slug:"isolation-and-expansion-of-mesenchymal-stem-stromal-cells-functional-assays-and-long-term-culture-as",totalDownloads:74,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Cell Culture - Advanced Technology and Applications in Medical and Life Sciences",coverURL:"https://cdn.intechopen.com/books/images_new/10797.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"78960",title:"Two-Dimensional and Three-Dimensional Cell Culture and Their Applications",doi:"10.5772/intechopen.100382",signatures:"Sangeeta Ballav, Ankita Jaywant Deshmukh, Shafina Siddiqui, Jyotirmoi Aich and Soumya Basu",slug:"two-dimensional-and-three-dimensional-cell-culture-and-their-applications",totalDownloads:249,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Cell Culture - Advanced Technology and Applications in Medical and Life Sciences",coverURL:"https://cdn.intechopen.com/books/images_new/10797.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"78812",title:"Nanotechnology Application and Intellectual Property Right Prospects of Mammalian Cell Culture",doi:"10.5772/intechopen.99146",signatures:"Harikrishnareddy Rachamalla, Anubhab Mukherjee and Manash K. Paul",slug:"nanotechnology-application-and-intellectual-property-right-prospects-of-mammalian-cell-culture",totalDownloads:119,totalCrossrefCites:1,totalDimensionsCites:1,authors:null,book:{title:"Cell Culture - Advanced Technology and Applications in Medical and Life Sciences",coverURL:"https://cdn.intechopen.com/books/images_new/10797.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"78274",title:"A Brief Concept of Cell Culture: Challenges, Prospects and Applications",doi:"10.5772/intechopen.99387",signatures:"Md. Salauddin",slug:"a-brief-concept-of-cell-culture-challenges-prospects-and-applications",totalDownloads:171,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Cell Culture - Advanced Technology and Applications in Medical and Life Sciences",coverURL:"https://cdn.intechopen.com/books/images_new/10797.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"78415",title:"Epigenetic",doi:"10.5772/intechopen.99964",signatures:"Mehmet Ünal",slug:"epigenetic",totalDownloads:135,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Epigenetics to Optogenetics - A New Paradigm in the Study of Biology",coverURL:"https://cdn.intechopen.com/books/images_new/9672.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"77443",title:"Cyanobacterial Phytochromes in Optogenetics",doi:"10.5772/intechopen.97522",signatures:"Sivasankari Sivaprakasam, Vinoth Mani, Nagalakshmi Balasubramaniyan and David Ravindran Abraham",slug:"cyanobacterial-phytochromes-in-optogenetics",totalDownloads:184,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Epigenetics to Optogenetics - A New Paradigm in the Study of Biology",coverURL:"https://cdn.intechopen.com/books/images_new/9672.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"75979",title:"Spatiotemporal Regulation of Cell–Cell Adhesions",doi:"10.5772/intechopen.97009",signatures:"Brent M. Bijonowski",slug:"spatiotemporal-regulation-of-cell-cell-adhesions",totalDownloads:170,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Epigenetics to Optogenetics - A New Paradigm in the Study of Biology",coverURL:"https://cdn.intechopen.com/books/images_new/9672.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"76646",title:"Functional Mechanism of Proton Pump-Type Rhodopsins Found in Various Microorganisms as a Potential Effective Tool in Optogenetics",doi:"10.5772/intechopen.97589",signatures:"Jun Tamogami and Takashi Kikukawa",slug:"functional-mechanism-of-proton-pump-type-rhodopsins-found-in-various-microorganisms-as-a-potential-e",totalDownloads:197,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Epigenetics to Optogenetics - A New Paradigm in the Study of Biology",coverURL:"https://cdn.intechopen.com/books/images_new/9672.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}},{id:"76510",title:"Evolution of Epigenome as the Blueprint for Carcinogenesis",doi:"10.5772/intechopen.97379",signatures:"Zeenat Farooq, Ambreen Shah, Mohammad Tauseef, Riyaz A. Rather and Mumtaz Anwar",slug:"evolution-of-epigenome-as-the-blueprint-for-carcinogenesis",totalDownloads:190,totalCrossrefCites:0,totalDimensionsCites:0,authors:null,book:{title:"Epigenetics to Optogenetics - A New Paradigm in the Study of Biology",coverURL:"https://cdn.intechopen.com/books/images_new/9672.jpg",subseries:{id:"14",title:"Cell and Molecular Biology"}}}]},publishedBooks:{paginationCount:4,paginationItems:[{type:"book",id:"9869",title:"Self-Driving Vehicles and Enabling Technologies",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/9869.jpg",slug:"self-driving-vehicles-and-enabling-technologies",publishedDate:"September 22nd 2021",editedByType:"Edited by",bookSignature:"Marian Găiceanu",hash:"fd451ca2e4785ef098e04b7d695a18d9",volumeInSeries:6,fullTitle:"Self-Driving Vehicles and Enabling Technologies",editors:[{id:"169608",title:"Prof.",name:"Marian",middleName:null,surname:"Găiceanu",slug:"marian-gaiceanu",fullName:"Marian Găiceanu",profilePictureURL:"https://mts.intechopen.com/storage/users/169608/images/system/169608.png",institutionString:'"Dunarea de Jos" University of Galati',institution:{name:'"Dunarea de Jos" University of Galati',institutionURL:null,country:{name:"Romania"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"9958",title:"Artificial Intelligence",subtitle:"Latest Advances, New Paradigms and Novel Applications",coverURL:"https://cdn.intechopen.com/books/images_new/9958.jpg",slug:"artificial-intelligence-latest-advances-new-paradigms-and-novel-applications",publishedDate:"September 1st 2021",editedByType:"Edited by",bookSignature:"Eneko Osaba, Esther Villar, Jesús L. Lobo and Ibai Laña",hash:"39648fbfdaa11385097d62b1f13aad54",volumeInSeries:5,fullTitle:"Artificial Intelligence - Latest Advances, New Paradigms and Novel Applications",editors:[{id:"221364",title:"Dr.",name:"Eneko",middleName:null,surname:"Osaba",slug:"eneko-osaba",fullName:"Eneko Osaba",profilePictureURL:"https://mts.intechopen.com/storage/users/221364/images/system/221364.jpg",institutionString:"TECNALIA Research & Innovation",institution:{name:"Tecnalia",institutionURL:null,country:{name:"Spain"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"7656",title:"Fuzzy Logic",subtitle:null,coverURL:"https://cdn.intechopen.com/books/images_new/7656.jpg",slug:"fuzzy-logic",publishedDate:"February 5th 2020",editedByType:"Edited by",bookSignature:"Constantin Volosencu",hash:"54f092d4ffe0abf5e4172a80025019bc",volumeInSeries:3,fullTitle:"Fuzzy Logic",editors:[{id:"1063",title:"Prof.",name:"Constantin",middleName:null,surname:"Volosencu",slug:"constantin-volosencu",fullName:"Constantin Volosencu",profilePictureURL:"https://mts.intechopen.com/storage/users/1063/images/system/1063.png",institutionString:"Polytechnic University of Timişoara",institution:{name:"Polytechnic University of Timişoara",institutionURL:null,country:{name:"Romania"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null},{type:"book",id:"7723",title:"Artificial Intelligence",subtitle:"Applications in Medicine and Biology",coverURL:"https://cdn.intechopen.com/books/images_new/7723.jpg",slug:"artificial-intelligence-applications-in-medicine-and-biology",publishedDate:"July 31st 2019",editedByType:"Edited by",bookSignature:"Marco Antonio Aceves-Fernandez",hash:"a3852659e727f95c98c740ed98146011",volumeInSeries:1,fullTitle:"Artificial Intelligence - Applications in Medicine and Biology",editors:[{id:"24555",title:"Dr.",name:"Marco Antonio",middleName:null,surname:"Aceves Fernandez",slug:"marco-antonio-aceves-fernandez",fullName:"Marco Antonio Aceves Fernandez",profilePictureURL:"https://mts.intechopen.com/storage/users/24555/images/system/24555.jpg",institutionString:"Universidad Autonoma de Queretaro",institution:{name:"Autonomous University of Queretaro",institutionURL:null,country:{name:"Mexico"}}}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null}]},testimonialsList:[{id:"18",text:"It was great publishing with IntechOpen, the process was straightforward and I had support all along.",author:{id:"71579",name:"Berend",surname:"Olivier",institutionString:"Utrecht University",profilePictureURL:"https://mts.intechopen.com/storage/users/71579/images/system/71579.jpg",slug:"berend-olivier",institution:{id:"253",name:"Utrecht University",country:{id:null,name:"Netherlands"}}}},{id:"27",text:"The opportunity to work with a prestigious publisher allows for the possibility to collaborate with more research groups interested in animal nutrition, leading to the development of new feeding strategies and food valuation while being more sustainable with the environment, allowing more readers to learn about the subject.",author:{id:"175967",name:"Manuel",surname:"Gonzalez Ronquillo",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/175967/images/system/175967.png",slug:"manuel-gonzalez-ronquillo",institution:{id:"6221",name:"Universidad Autónoma del Estado de México",country:{id:null,name:"Mexico"}}}},{id:"8",text:"I work with IntechOpen for a number of reasons: their professionalism, their mission in support of Open Access publishing, and the quality of their peer-reviewed publications, but also because they believe in equality.",author:{id:"202192",name:"Catrin",surname:"Rutland",institutionString:null,profilePictureURL:"https://mts.intechopen.com/storage/users/202192/images/system/202192.png",slug:"catrin-rutland",institution:{id:"134",name:"University of Nottingham",country:{id:null,name:"United Kingdom"}}}}]},submityourwork:{pteSeriesList:[],lsSeriesList:[],hsSeriesList:[],sshSeriesList:[],subseriesList:[],annualVolumeBook:{},thematicCollection:[],selectedSeries:null,selectedSubseries:null},seriesLanding:{item:null},libraryRecommendation:{success:null,errors:{},institutions:[]},route:{name:"chapter.detail",path:"/chapters/49611",hash:"",query:{},params:{id:"49611"},fullPath:"/chapters/49611",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()